{"AllianceGenome": "8975", "HGNC": "8975", "MIM": "171834", "_id": "5290", "_version": 3, "accession": {"genomic": ["AC076966.25", "CH471052.2", "CP068275.2", "GM752103.1", "GM865566.1", "HM459602.1", "HM459604.1", "JC006870.1", "KC208483.1", "MG897308.1", "MH507557.1", "MT856701.1", "MT991403.1", "MT991404.1", "MT991405.1", "NC_000003.12", "NC_060927.1", "NG_012113.2"], "protein": ["AAB39753.1", "AAI13602.1", "AAI13604.1", "ABI95433.1", "ADN43072.1", "ADQ00185.1", "ADQ00187.1", "AUZ99694.1", "AYM46768.1", "BAE06102.2", "BAF85629.1", "BAG59688.1", "BAG63856.1", "CAA82333.1", "CAT16714.1", "CAV28702.1", "CDL93485.1", "EAW78423.1", "NP_006209.2", "P42336.2", "QSV17871.1", "UHM42371.1", "UHM42372.1", "UHM42373.1", "XP_006713721.1", "XP_054202817.1", "XP_054202818.1", "XP_054202819.1", "XP_054202820.1", "XP_054202821.1", "XP_054202822.1", "XP_054202823.1"], "rna": ["AB210020.1", "AI379480.1", "AK021510.1", "AK292940.1", "AK297203.1", "AK302608.1", "AU129890.2", "AW445128.1", "BC113601.1", "BC113603.1", "BQ228953.1", "BX437219.2", "BX473473.1", "BX484734.1", "DQ910907.1", "HM437241.1", "NM_006218.4", "U79143.1", "XM_006713658.5", "XM_054346842.1", "XM_054346843.1", "XM_054346844.1", "XM_054346845.1", "XM_054346846.1", "XM_054346847.1", "XM_054346848.1", "Z29090.1"], "translation": [{"protein": "AAB39753.1", "rna": "U79143.1"}, {"protein": "ABI95433.1", "rna": "DQ910907.1"}, {"protein": "ADN43072.1", "rna": "HM437241.1"}, {"protein": "BAF85629.1", "rna": "AK292940.1"}, {"protein": "XP_054202820.1", "rna": "XM_054346845.1"}, {"protein": "AAI13602.1", "rna": "BC113601.1"}, {"protein": "XP_006713721.1", "rna": "XM_006713658.5"}, {"protein": "XP_054202817.1", "rna": "XM_054346842.1"}, {"protein": "BAE06102.2", "rna": "AB210020.1"}, {"protein": "XP_054202821.1", "rna": "XM_054346846.1"}, {"protein": "XP_054202819.1", "rna": "XM_054346844.1"}, {"protein": "NP_006209.2", "rna": "NM_006218.4"}, {"protein": "XP_054202822.1", "rna": "XM_054346847.1"}, {"protein": "XP_054202823.1", "rna": "XM_054346848.1"}, {"protein": "BAG59688.1", "rna": "AK297203.1"}, {"protein": "BAG63856.1", "rna": "AK302608.1"}, {"protein": "XP_054202818.1", "rna": "XM_054346843.1"}, {"protein": "AAI13604.1", "rna": "BC113603.1"}, {"protein": "CAA82333.1", "rna": "Z29090.1"}]}, "alias": ["CCM4", "CLAPO", "CLOVE", "CWS5", "HMH", "MCAP", "MCM", "MCMTC", "PI3K", "PI3K-alpha", "p110-alpha"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": [{"classification": "refuted", "classification_date": "2023-12-21T18:00:00.000Z", "disease_label": "hereditary breast carcinoma", "gcep": "Hereditary Cancer Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0016419", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7ce3540a-5a7f-4f47-aeb3-520767016539-2023-12-21T180000.000Z", "sop": "SOP9"}, {"classification": "definitive", "classification_date": "2021-07-29T21:31:57.366Z", "disease_label": "overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes", "gcep": "Brain Malformations Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0100283", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c670e6ce-97b6-4383-bea6-5c216ab2a4a0-2021-07-29T213157.366Z", "sop": "SOP8"}, {"classification": "no known disease relationship", "classification_date": "2017-02-08T00:00:00", "disease_label": "familial ovarian cancer", "gcep": "Breast/Ovarian Cancer Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0016248", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8694", "sop": "SOP4"}]}, "ec": ["2.7.1.137", "2.7.1.153", "2.7.11.1"], "ensembl": {"gene": "ENSG00000121879", "protein": ["ENSP00000263967", "ENSP00000417479", "ENSP00000418145", "ENSP00000493507", "ENSP00000502323", "ENSP00000502417"], "transcript": ["ENST00000263967", "ENST00000462255", "ENST00000468036", "ENST00000477735", "ENST00000643187", "ENST00000674534", "ENST00000674622", "ENST00000675467", "ENST00000675786", "ENST00000675796"], "translation": [{"protein": "ENSP00000418145", "rna": "ENST00000477735"}, {"protein": "ENSP00000263967", "rna": "ENST00000263967"}, {"protein": "ENSP00000493507", "rna": "ENST00000643187"}, {"protein": "ENSP00000502323", "rna": "ENST00000675786"}, {"protein": "ENSP00000417479", "rna": "ENST00000468036"}, {"protein": "ENSP00000502417", "rna": "ENST00000674622"}], "type_of_gene": "protein_coding"}, "entrezgene": "5290", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 50.3760557243, "exp_mis": 311.614935804, "exp_syn": 111.200169599, "lof_z": 6.61205570139948, "mis_z": 5.42012466953393, "mu_lof": 3.82187767471e-06, "mu_mis": 2.74303804314e-05, "mu_syn": 9.3136533438e-06, "n_lof": 3.0, "n_mis": 116.0, "n_syn": 95.0, "p_li": 0.99999851122751, "p_null": 1.13681499478358e-17, "p_rec": 1.48877249045211e-06, "syn_z": 0.952394888768742}, "bp": 3207, "cds_end": 178952152, "cds_start": 178916613, "n_exons": 20, "nonpsych": {"exp_lof": 45.1939725895, "exp_mis": 281.640375677, "exp_syn": 100.245662972, "lof_z": 6.45616702730183, "mis_z": 5.45917106337519, "mu_lof": 3.82187767471e-06, "mu_mis": 2.74303804314e-05, "mu_syn": 9.3136533438e-06, "n_lof": 1.0, "n_mis": 100.0, "n_syn": 83.0, "p_li": 0.999999666402264, "p_null": 8.85837425272147e-18, "p_rec": 3.3359773580947e-07, "syn_z": 1.08445475698312}, "nontcga": {"exp_lof": 46.3068650998, "exp_mis": 286.646653256, "exp_syn": 102.265050474, "lof_z": 6.27791313345448, "mis_z": 5.69831420712691, "mu_lof": 3.82187767471e-06, "mu_mis": 2.74303804314e-05, "mu_syn": 9.3136533438e-06, "n_lof": 3.0, "n_mis": 93.0, "n_syn": 86.0, "p_li": 0.999993452604339, "p_null": 4.18450629386085e-16, "p_rec": 6.54739566020983e-06, "syn_z": 1.01839277291256}, "transcript": "ENST00000263967.3"}, "exons": [{"cdsend": 179234364, "cdsstart": 179198825, "chr": "3", "position": [[179148356, 179148603], [179198749, 179199177], [179199689, 179199899], [179201289, 179201540], [179203543, 179203789], [179204502, 179204588], [179209594, 179209700], [179210185, 179210338], [179210430, 179210565], [179218209, 179218334], [179219195, 179219277], [179219570, 179219735], [179219948, 179220052], [179220985, 179221157], [179224080, 179224187], [179224699, 179224821], [179225961, 179226040], [179229271, 179229442], [179230003, 179230121], [179230224, 179230376], [179234093, 179240093]], "strand": 1, "transcript": "NM_006218", "txend": 179240093, "txstart": 179148356}], "exons_hg19": [{"cdsend": 178952152, "cdsstart": 178916613, "chr": "3", "position": [[178866144, 178866391], [178916537, 178916965], [178917477, 178917687], [178919077, 178919328], [178921331, 178921577], [178922290, 178922376], [178927382, 178927488], [178927973, 178928126], [178928218, 178928353], [178935997, 178936122], [178936983, 178937065], [178937358, 178937523], [178937736, 178937840], [178938773, 178938945], [178941868, 178941975], [178942487, 178942609], [178943749, 178943828], [178947059, 178947230], [178947791, 178947909], [178948012, 178948164], [178951881, 178957881]], "strand": 1, "transcript": "NM_006218", "txend": 178957881, "txstart": 178866144}], "generif": [{"pubmed": 2174051, "text": "This paper reports the first purification of a phosphoinositide 3-kinase and shows that the protein is a heterodimer of an 85 kd regulatory subunit that mediates binding to phosphorylated proteins and a 110 kd catalytic subunit."}, {"pubmed": 11959846, "text": "In squamous cell carcinomas the negative effect of p53 induction on cell survival involves transcriptional inhibition of PIK3CA that is independent of PTEN activity, as PTEN is not expressed in the primary tumors"}, {"pubmed": 12704201, "text": "agonist binding to Gq-coupled receptors blocks Akt activation via the release of active Galphaq subunits that inhibit PI3K via an inhibitory interaction between Galphaq and p110alpha PI3K."}, {"pubmed": 15016963, "text": "data suggest that mutant PIK3CA is likely to function as an oncogene in human cancers; PIK3CA may prove useful for diagnostic and therapeutic purposes"}, {"pubmed": 15254419, "text": "Missense Mutation in PIK3CA is associated with breast cancers"}, {"pubmed": 15289301, "text": "Mutations of PIK3CA is associated with anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas"}, {"pubmed": 15467468, "text": "oncogenic mutations in human cancers"}, {"pubmed": 15605984, "text": "Genetic alterations of class IA PI3K subunit genes can occasionally play a role in human glioblastoma by activating the PI3K-AKT signaling pathway independently of PTEN mutation."}, {"pubmed": 15632060, "text": "Data show that glucose is a crucial regulator of V-ATPase in renal epithelial cells and that the effect of glucose is mediated by phosphatidylinositol 3-kinase (PI3K)."}, {"pubmed": 15647370, "text": "determined the growth-regulatory and signaling properties of the three most frequently observed PIK3CA mutations: E542K, E545K, and H1047R"}, {"pubmed": 15712344, "text": "PIK3CA mutations in exons 9 & 20 were directly sequenced. A novel silent mutation was found. PIK3CA mutation may be an early event in ovarian carcinogenesis."}, {"pubmed": 15784156, "text": "Activation of the PI3K signalling pathway in gastric cancer may be achieved through up-regulation or mutation of PIK3CA, in which the latter may be a consequence of mismatch repair deficiency."}, {"pubmed": 15805248, "text": "Mutation of PIK3CA is frequent, occurs early in carcinoma development, and has prognostic and therapeutic implications for breast cancer."}, {"pubmed": 15837735, "text": "Data indicate that mutations of PIK3CA play an oncogenic role in substantial fractions of ovarian and breast carcinomas."}, {"pubmed": 15928251, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15928251, "text": "mutation of the PIK3CA gene is not common, but its amplification is relatively common and may be a novel mechanism in activating the PI3K/Akt pathway in some thyroid tumors"}, {"pubmed": 15930273, "text": "Colon cancer-associated PIK3CA mutations are functionally active so that they are likely to be involved in carcinogenesis."}, {"pubmed": 15950905, "text": "Amino acid substitutions in PIK3CA from human colorectal cancer cell lines constitutively activate the AKT pathway, and consequently, promote tumor cell growth and invasion."}, {"pubmed": 15994075, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16034135, "text": "PI-3 kinase p110alpha subunit expression and recombinant heparin-binding epidermal growth factor-like growth factor (HB-EGF) synergistically decrease inducible nitric oxide synthase expression and nitric oxide production in intestinal epithelial cells"}, {"pubmed": 16114017, "text": "copy number gains, instead of mutation, may be a common mechanism for activation of PIK3CA in tumorigenesis of primary nasopharyngeal carcinoma"}, {"pubmed": 16150119, "text": "an important role of PIK3CA gene aberrations in the molecular pathogenesis of primary glioblastomas"}, {"pubmed": 16150444, "text": "this study has shown that the mutations detected in the helical and kinase domains of PIK3CA do not seem to affect the PI3-K pathway characteristics of the eight cell lines studied"}, {"pubmed": 16168105, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16168105, "text": "The frequent and clustered mutations within PIK3CA make it an attractive molecular marker for early detection and a promising therapeutic target in breast cancer."}, {"pubmed": 16203798, "text": "analysis of PIK3CA mutations in ovarian cancer [letter]"}, {"pubmed": 16287065, "text": "increased activation state of AKT kinase appears to be present in cervical carcinogenesis, and may be accounted for by PIK3CA amplification, whereas PTEN mutation seems to be of little importance"}, {"pubmed": 16288007, "text": "Mutant PIK3CA is likely to function as an oncogene in anaplastic thyroid cancer and less frequently well-differentiated thyroid carcinomas."}, {"pubmed": 16317585, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16317585, "text": "PIK3CA mutations are associated with breast cancer"}, {"pubmed": 16339173, "text": "Data show that alpha6 and alpha3 integrin subunits interact with laminin 5 to increase expression of E-cadherin, and suggest that phosphoinositide 3-kinase (PI 3-kinase) activation plays a key role in this cross-talk."}, {"pubmed": 16339315, "text": "although introduction of activating mutations from p110alpha at the corresponding sites in p110beta failed to render the enzyme oncogenic in human cells, the possibility remains that other mutations might activate the beta isoform"}, {"pubmed": 16341083, "text": "cancer-specific mutations in PIK3CA have made p110alpha an ideal drug target [Review]"}, {"pubmed": 16353168, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16376301, "text": "A mutation status profile of the PIK3Ca gene in the National Cancer Institute (NCI)-60 panel of human cancer cell lines provides insights into the role of mutant PIK3Ca in oncogenic signaling"}, {"pubmed": 16380997, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16380997, "text": "study extends previous observations in other tumor types by demonstrating presence of somatic PIK3CA mutations in both SCC and adenocarcinoma of the esophagus, thus implicating the PI3K pathway in the initiation and/or progression of esophageal cancers"}, {"pubmed": 16397024, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16406609, "text": "These results indicate that PI3K plays different roles in the activation of Ras/ERK1/2 signaling by insulin and EGF, and that insulin-stimulated, but not EGF-stimulated, ERK1/2 and Akt signalings diverge at PI3K."}, {"pubmed": 16522324, "text": "AT(1) receptor-mediated activation of PI 3-K/Akt cascades occurs at least partially via the transactivation of EGF receptor, which is under a negative control by AT(2) receptor in hypertrophic scar fibroblasts."}, {"pubmed": 16533766, "text": "PIK3CA mutations are associated with head and neck squamous cell carcinoma"}, {"pubmed": 16569657, "text": "Although a key factor in TRAF6-dependent activation of PI 3-kinase, ectopic expression of Src was insufficient for NF-kappaB activation and, in contrast to NF-kappaB, was not inhibited by IRAK2."}, {"pubmed": 16582596, "text": "Mutation of PIK3CA is associated with breast cancer"}, {"pubmed": 16618717, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16627990, "text": "Somatic mutations of PIK3CA, encoding p110alpha catalytic subunit of Class IA PI3Ks, have been found in various cancers."}, {"pubmed": 16682946, "text": "inhibition of PI 3-kinase activity reduced hypoxic HIF-1alpha protein levels to a similar extent as serum deprivation"}, {"pubmed": 16728507, "text": "PI3K-IA activity is necessary for both high NaCl- and ionizing radiation-induced activation of ATM and (ii) high NaCl activates PI3K-IA, which, in turn, contributes to full activation of TonEBP/OREBP via ATM."}, {"pubmed": 16764926, "text": "Various mutations in a variety of cancers, including a pseudogene and polymorphisms."}, {"pubmed": 16775835, "text": "p110alpha play an important role in tumor growth by inducing angiogenesis and by increasing HIF-1alpha and VEGF expression. This work provides a better understanding of the molecular mechanism of human cancer induced by the activation of PI3K signaling."}, {"pubmed": 16778113, "text": "First report of PIK3CA mutation in pancreatic cancer, providing evidence of its oncogenic properties."}, {"pubmed": 16788758, "text": "Increased expression for PIK3CA mrna is associated with regional lymph node metastasis in esophageal squamous cell carcinoma"}, {"pubmed": 16790501, "text": "Acidic pH exposure protects HEMEC through induction of Hsps and activation of MAPK and PI3 kinase pathway."}, {"pubmed": 16815198, "text": "PIK3CA amplification is uncommon and appears to be late event in the development of ethmoid sinus adenocarcinoma."}, {"pubmed": 16820791, "text": "TGF-beta1 regulates COX-2 expression in human mesangial cells through the activation of ERK1/2, p38 MAPK, and PI3K."}, {"pubmed": 16822308, "text": "Pik3ca, Ras family, and Braf activating mutations occur rarely in human neuroblastomas or in a murine model driven by neural-restricted MYCN overexpression."}, {"pubmed": 16837650, "text": "These studies demonstrate that induction of fibulin 5 gene expression in lung fibroblasts is mediated via canonical TGF-beta/Smad signaling and requires the PI3-kinase/Akt pathway."}, {"pubmed": 16839745, "text": "The expression of p110alpha siRNA significantly decreased cell migration, invasion and proliferation."}, {"pubmed": 16840732, "text": "Outside-in signaling via P2Y12 and both PI3Kbeta and PI3Kgamma isoforms is required for maintenance of a platelet aggregate."}, {"pubmed": 16885334, "text": "PIK3CA mutations were strongly associated with FGFR3 mutations in superficial papillary bladder tumors."}, {"pubmed": 16930767, "text": "PIK3CA mutation incidence was significantly lower in lung adenocarcinoma than in lung squamous cell carcinoma; among eight patients with a PIK3CA mutation, three patients also harbored an EGFR somatic mutation."}, {"pubmed": 16949921, "text": "results confirm that PIK3CA mutations are frequent in endometrial carcinoma and support the hypothesis that PIK3CA mutations may have an additive effect to PTEN monoallelic inactivation in endometrial carcinoma"}, {"pubmed": 16968743, "text": "PI3K is an important intracellular regulator of epidermal homeostasis and repair."}, {"pubmed": 17006756, "text": "It has recently been shown that Akt activation is associated with a worse outcome among endocrine treated breast cancer patients and that it also inhibits the progesterone receptor (PR) expression via the PI3K/Akt pathway in breast cancer cells."}, {"pubmed": 17050665, "text": "This is the first study showing PIK3CA mutations in pediatric glioblastomas, thus providing a molecular target in this important pediatric malignancy."}, {"pubmed": 17052259, "text": "Mutations of the PIK3CA gene is associated with the development of oral squamous cell carcinoma"}, {"pubmed": 17060456, "text": "Activation of PI3K signaling by mutations in PTEN or PIK3CA can lead to activation of p53-mediated growth suppression."}, {"pubmed": 17062663, "text": "PIK3CA may serve as a marker of invasion in endometrial cancer."}, {"pubmed": 17141917, "text": "Results show that coculture with ECs enhances VSMC adhesion and spreading by up-regulating beta(1)-integrin expression and activating the PI3K/Akt pathway. Interaction between ECs and VSMCs serves a role in vascular homeostasis and remodeling."}, {"pubmed": 17202311, "text": "PIK3CA mutations might exert their effects through activation of the phosphatidylinositol 3-kinase/AKT/ER-alpha pathway"}, {"pubmed": 17219054, "text": "Results indicate that stimulation of heme oxygenase-1 expression by hypericin-PDT is a cytoprotective mechanism governed by the p38(MAPK) and PI3K pathways."}, {"pubmed": 17222361, "text": "PIK3CA exon 9 and exon 20 rarely mutate in nasopharyngeal carcinoma."}, {"pubmed": 17235514, "text": "PIK3CA alterations in primary (de novo) and secondary glioblastomas."}, {"pubmed": 17237249, "text": "Thus EPO promotes survival of endothelial cells through PI3K-dependent Bcl-x(L)-induction and BIM regulation, as well as through a separate mechanism involving the ERK pathway."}, {"pubmed": 17307335, "text": "These results demonstrate that hypoxic condition-and high cell density-induced expression of Redd1 is mediated by coactivation of Sp1 and HIF-1alpha downstream of the PI3K/Akt signaling pathway."}, {"pubmed": 17314276, "text": "These results suggest that there is a fine distinction between the signaling activators and downstream effectors of the oncogenic PI3K and RAS pathways in breast epithelium and those in other tissues."}, {"pubmed": 17317825, "text": "The data suggest that aberrant activation of PI3K/Akt pathway plays an extensive role in thyroid tumorigenesis, particularly in FTC and ATC, and promotes progression of BTA to FTC and to ATC as the genetic alterations of this pathway accumulate."}, {"pubmed": 17341442, "text": "These data demonstrate that IGF-I induces COX-2 expression in human ovarian cancer cells, which is mediated by three parallel signaling cascades--PI3K, MAPK, and PKC pathways that differentially regulate COX-2 expression."}, {"pubmed": 17363507, "text": "studies show that mutant PIK3CA increases the capacity for proliferation and survival under environmental stresses, such as growth factor deprivation stress while also imparting greater dependency on the PI3K pathway for proliferation and survival"}, {"pubmed": 17369495, "text": "p110alpha PI-3K appears to uniquely regulate important monocyte functions, where other PI-3K isoforms are uninvolved or unable to fully compensate."}, {"pubmed": 17376864, "text": "PIK3CA mutations may have a role in cancer"}, {"pubmed": 17377809, "text": "PIK3CA amplification and Ki-67 index were strong predictors for an early tumor-associated death in ovarian cancer patients."}, {"pubmed": 17426084, "text": "data from a Chinese cohort provide further genetic evidence suggesting that dysregulated PI3K/Akt pathway plays a significant role in the pathogenesis of thyroid tumors"}, {"pubmed": 17449641, "text": "TLR3, PI3K, and IRF3 are involved in the poly IC-induced galectin-9 expression in HUVECs"}, {"pubmed": 17468516, "text": "PI3K/ILK/Akt/NF-kappaB axis is a promising target for therapeutic intervention in renal cell carcinoma."}, {"pubmed": 17471559, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17487277, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17507466, "text": "Data suggest that lipid rafts play critical roles in KSHV infection and gene expression, probably due to their roles in modulating KSHV-induced PI3-K, RhoA-GTPase, and Dia-2 molecules essential for postbinding and entry stages of infection."}, {"pubmed": 17546593, "text": "Data suggest that PIK3CA mutations contribute to the invasion step from intramucosal carcinoma to invasive carcinoma in colorectal carcinogenesis."}, {"pubmed": 17546593, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17549376, "text": "PIK3CA copy number gain and amplification is associated with head and neck squamous cell carcinoma"}, {"pubmed": 17575221, "text": "PIK3CA mutations and PTEN loss were not mutually exclusive events and associated with similar prognostic factors"}, {"pubmed": 17586693, "text": "Whereas PI3K is downstream of MUC1 activation and negatively regulates TLR5 signaling, it is not responsible for MUC1-induced suppression of TLR5 signaling."}, {"pubmed": 17590872, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17590872, "text": "PIK3CA mutation was significantly associated with shorter relapse-free survival in stage II/III patients, and shorter disease-specific survival in all patients."}, {"pubmed": 17635910, "text": "Phosphoinositide 3-kinase-independent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains"}, {"pubmed": 17657213, "text": "PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma"}, {"pubmed": 17669465, "text": "Coexistent mutations/epigenetic inactivations in PI3K/AKT pathway may be responsible for the unusually aggressive course of ACC."}, {"pubmed": 17673550, "text": "oncogenic PIK3CA mutations contribute to the pathogenesis of skin tumors lacking malignant potential"}, {"pubmed": 17681398, "text": "There was significant difference in survival between the lung cancer patients with PIK3CA normal copy number and the patients with PIK3CA amplification"}, {"pubmed": 17803655, "text": "PIK3CA has an important role in human lung carcinogenesis, possibly by promoting malignant transformation."}, {"pubmed": 17827385, "text": "IGF-1 plays a role in potentiating platelet aggregation by complementing G(i)- but not G(q)-signaling pathways via PI3-K p110alpha."}, {"pubmed": 17855350, "text": "plexin-B1 promotes endothelial cell motility through RhoA and ROK by regulating the integrin-dependent signaling networks that result in the activation of PI3K and Akt"}, {"pubmed": 17875942, "text": "Data suggest that PI3K-C2beta and AKT are epistatic to intersectin, and show that ITSN, independent of its role in endocytosis, regulates a critical cellular signaling pathway necessary for cell survival."}, {"pubmed": 17877460, "text": "The three most common tumour-derived alleles of p110alpha were shown to potently activate phosphoinositide 3-kinase signalling in human epithelial cells."}, {"pubmed": 17923698, "text": "Engagement of NKG2D by itself is sufficient to stimulate the formation of the natural killer cells immunological synapse (NKIS), with recruitment of NKG2D to the center synapse."}, {"pubmed": 17924977, "text": "High levels of p-AKT expression occurred independently of the presence of PTEN or PIK3CA mutations in endometrial cancer."}, {"pubmed": 17936563, "text": "In trastuzumab-treated breast cancer patients combined analysis of PTEN and PIK3CA identified twice as many patients at increased risk for progression compared to PTEN alone."}, {"pubmed": 17936563, "text": "Observational study of gene-disease association, gene-gene interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17942548, "text": "rotavirus-induced PI3K activation causes regulation of integrin expression in intestinal cells, leading to prolonged adherence of infected cells to collagen and increased virus production."}, {"pubmed": 17947469, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17947469, "text": "exon 9 PIK3CA mutations are typical of infiltrating lobular carcinomas"}, {"pubmed": 17971428, "text": "The C allele of rs361072 attenuates insulin resistance in superobese European children."}, {"pubmed": 17982280, "text": "The results presented here indicate that actin reorganization through FAK/PI3-K/Rac-1 activation operates in various human cancer cell systems supporting a functional role for FAK/PI-3K/Rac1/actin signaling in controlling cell motility."}, {"pubmed": 17986027, "text": "An impaired control of glycogen synthase kinase-3beta activity by insulin receptor-mediated signalling plays a role in the pathogenesis of AD, facilitating tau protein phosphorylation and neurofibrillary tangle formation."}, {"pubmed": 17990317, "text": "Using both direct genomic DNA sequencing and novel mutant-enriched sequencing methods developed specifically for the 3 hot-spot mutations (H1047R, E545K and E452K) of PIK3CA, we detected 5 mutations of PIK3CA in the 24 pharyngeal cancers (20.8%)."}, {"pubmed": 18000091, "text": "A higher incidence of PIK3CA alterations and the possible synergistic effect of these alterations and BRAF mutations suggest their major role in Middle Eastern papillary thyroid neoplasms."}, {"pubmed": 18000091, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18022911, "text": "Sexual dimorphisms and tissue specific factors might directly or indirectly influence the occurrence of PI3KCA cancer alleles."}, {"pubmed": 18064631, "text": "These data provide the first evidence that IL-18 and FN stimulate each other's expression"}, {"pubmed": 18070887, "text": "Phosphatidylinositol 3-kinase-dependent membrane recruitment of Rac-1 and p47phox is critical for alpha-platelet-derived growth factor receptor-induced production of reactive oxygen species."}, {"pubmed": 18074223, "text": "different PIK3CA mutations differentially contribute to breast cancer transformation"}, {"pubmed": 18079394, "text": "study reports a 3.0 angstrom resolution structure of a complex between p110alpha and a polypeptide containing the p110alpha-binding domains of p85alpha; results suggest specific mechanisms for the effect of oncogenic mutations in p110alpha and p85alpha"}, {"pubmed": 18084252, "text": "PIK3CA mutations are associated with myometrial invasion and tumors with PIK3CA mutations in exon 20 are frequently high-grade, invasive endometrial carcinomas."}, {"pubmed": 18097548, "text": "PIK3CA mutations in HNSCC are likely to be oncogenic and may significantly contribute to HNSCC carcinogenesis and pave attractive target for therapeutic prevention."}, {"pubmed": 18180098, "text": "In this study, we were unable to find a clear association between PIK3CA mutations and gene amplifications, nor with tumor histological subtypes or staging"}, {"pubmed": 18181165, "text": "somatic PIK3CA mutations contribute to the frequent activation of the PI3K/AKT pathway in carcinomas of the biliary tract and liver"}, {"pubmed": 18183466, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18183466, "text": "PIK3CA mutations are common in invasive ductal carcinomas of the breast and PIK3CA exon 20 mutation is an independent risk factor for poor prognosis in breast cancer patients."}, {"pubmed": 18193083, "text": "analysis of PIK3CA mutations in Saudi Arabian colorectal cancer patience"}, {"pubmed": 18216097, "text": "Poliovirus simultaneously activates the phosphatidylinositol 3-kinase (PI3K)/Akt survival signaling pathway in these cells, limiting the extent of JNK activation and thereby cell death."}, {"pubmed": 18221484, "text": "genetic alterations of KRAS and PIK3CA may play equivalent roles in endometrial carcinogenesis"}, {"pubmed": 18224685, "text": "Mutations in the PIK3CA is associated with colon cancers"}, {"pubmed": 18224685, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 18262558, "text": "In exon 9, a somatic mutation was found in two patients (2.2%) and in two cell lines; mutations included three E545K (G1633A) mutations and one E545Q (G1633C) mutation, in exon 20, no mutation was observed in our esophageal cancer patients"}, {"pubmed": 18270270, "text": "The demonstration that p53 binds directly to the PIK3CA promoter and inhibits its activity identifies a novel mechanism whereby these two mediators regulate cellular functions."}, {"pubmed": 18285463, "text": "PI3Kalpha and -beta present distinct activation requirements and kinetics in G(1) phase, with a selective action of PI3Kalpha at the G(0)/G(1) phase transition"}, {"pubmed": 18317450, "text": "point mutations in the p110alpha subunit of class IA PI3K confer factor independence to hematopoietic cells in vitro and leukemogenic potential in vivo, but have lower transforming activity than a deregulated class III receptor tyrosine kinase."}, {"pubmed": 18335034, "text": "identified and characterized the PIK3CA 5' upstream transcriptional regulatory region and confirmed that PIK3CA is transcriptionally regulated through NF-kappaB pathway"}, {"pubmed": 18343945, "text": "Our data provide evidence that PIK3CA and BRAF contribute to the tumorigenesis of IPMN/IPMC, but at a lower frequency than KRAS."}, {"pubmed": 18355852, "text": "high frequency of mutations in the PIK3CA, HRAS and KRAS genes leads us to believe that dysregulation of the phosphatidylinositol 3-kinase or Ras pathway is significant for the development and progression of penile carcinoma."}, {"pubmed": 18371219, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18371219, "text": "PIK3CA mutation was associated with a decreased rate of node-positive disease, particularly among ER-positive tumors."}, {"pubmed": 18382359, "text": "PIK3CA is rarely mutated in diffuse large B-cell lymphoma"}, {"pubmed": 18418043, "text": "structure of the complex between the catalytic subunit of PI3Kalpha, p110alpha, & a portion of its regulatory subunit, p85alpha reveals the majority of the oncogenic mutations occur at the interfaces between p110 domains & between p110 & p85 domains"}, {"pubmed": 18449193, "text": "results provide the first in vivo evidence for p110-isoform selectivity in endothelial PI3K signalling during angiogenesis"}, {"pubmed": 18503601, "text": "FGFR3 and PIK3CA germline mutations can be excluded as an underlying genetic basis, therefore alternative mechanisms have to contribute to familial Seborrheic Keratoses."}, {"pubmed": 18516290, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18516290, "text": "PIK3CA mutation is significantly associated with key molecular events in colorectal cancer, and MGMT loss likely contributes to the development of PIK3CA G>A mutation"}, {"pubmed": 18621636, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18641990, "text": "Overexpression of PI3K and Akt is associated with malignant rhabdoid tumor"}, {"pubmed": 18660489, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18669866, "text": "KRAS mutations and PI3KCA/PTEN deregulation significantly correlate with resistance to cetuximab."}, {"pubmed": 18669866, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18676830, "text": "PIK3CA mutations, in comparison with PTEN loss and AKT1 mutations, were associated with significantly less and inconsistent activation of AKT and of downstream PI3K/AKT signaling in tumors and cell lines"}, {"pubmed": 18679714, "text": "Exon 20 PIK3CA mutations are relatively frequent in Her-2+ breast tumors and shorten survival, whereas neither exons 9 and 20 mutations seem related with \"triple negative\" breast carcinomas"}, {"pubmed": 18679714, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18691552, "text": "study identified a potential hotspot for resistance mutations (I800), a drug-sensitizing mutation (L814C), and a surprising lack of resistance mutations at the \"gatekeeper\" residue"}, {"pubmed": 18757405, "text": "RNA interference-mediated knockdown of PIK3CA inhibited colony formation of cell lines with PIK3CA mutations or gains but was not effective in PIK3CA wild-type cells. PIK3CA mutations or gains are present in a subset of lung cancers"}, {"pubmed": 18769113, "text": "TGFbeta activates PI3K to downregulate PTEN for enhancement of cell proliferation that is independent of SMAD proteins"}, {"pubmed": 18782444, "text": "BRAF, KRAS and PIK3CA mutations occur prior to malignant transformation demonstrating that these oncogenic alterations are primary genetic events in colorectal carcinogenesis"}, {"pubmed": 18782444, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18794094, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18794883, "text": "Inhibitors that target exclusively the cancer-specific mutants of p110 alpha constitute an important goal and challenge for current drug development."}, {"pubmed": 18798071, "text": "Higher BRCA1 mRNA expression is significantly correlated with advanced disease and ERBB2 overexpression in breast cancers."}, {"pubmed": 18798071, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18829572, "text": "In tumors with co-occurring mutations in multiple components of the PI3K pathway, selective inhibition of the alpha isoform of p110 is an attractive therapeutic strategy, especially for late-stage tumors."}, {"pubmed": 18835245, "text": "These data establish a new function for the NBS1 protein as a regulator of PI3K activity via SFK members."}, {"pubmed": 18852163, "text": "strong genetic evidence supporting a role of the PI3K/AKT signaling pathway in the tumorigenesis of pituitary tumors, particularly the invasive types"}, {"pubmed": 18951408, "text": "Mutant-specific differences in the catalytic cleft and activation loop behavior suggest that structure-based mutant-specific inhibitors can be designed for PIK3CA-positive breast cancers."}, {"pubmed": 18980969, "text": "our data reveal a novel function of p110alpha in medulloblastoma growth and survival."}, {"pubmed": 18990689, "text": "ARF1 regulates epidermal growth factor-dependent breast cancer cell growth and invasion during cancer progression by controlling the activation of the phosphatidylinositol 3-kinase pathway"}, {"pubmed": 18996102, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19003996, "text": "JAK2, EGFR and PI3KCA hot spot mutations are uncommon in endocrine tumors"}, {"pubmed": 19012001, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19012001, "text": "The result showed that the mutation rate of PIK3CA in nasopharyngeal carcinomas (n = 73) was 9.6%, whereas both BRAF (n = 65) and RAS (n = 45) were wild type in every specimen with adequate DNA for analysis."}, {"pubmed": 19027487, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19027487, "text": "data showed a higher incidence of PIK3CA mutations in Malaysian breast cancers compared to colorectal & nasopharyngeal tumor tissue; findings also indicate PIK3CA mutations play a pivotal role in activation of the PI3 K signaling pathway in breast cancer"}, {"pubmed": 19029838, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19029838, "text": "PIK3CA amplification and single nucleotide polymorphism may be a marker predicting ovarian cancer response and resistance to chemotherapy."}, {"pubmed": 19029981, "text": "inhibitors of the PI3K-mTOR pathway may be active in cancers with PIK3CA mutations and, when combined with MEK inhibitors, may effectively treat KRAS mutated lung cancers"}, {"pubmed": 19064572, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19069650, "text": "Zinc sulfate stimulation could activate the EGFR and the PI3K/Akt signaling pathway, further leading to upregulation of ICAM-1 expression in human airway epithelial cells."}, {"pubmed": 19076977, "text": "results suggest that FGFR3 and PIK3CA mutations are involved in the pathogenesis of solar lentigo and occurrence of these mutations in both SL and SK suggests a common genetic basis."}, {"pubmed": 19143676, "text": "a selective downregulation of the p110alpha catalytic isoform in pregnancy"}, {"pubmed": 19148475, "text": "Missense mutations of PIK3CA are identified in 81% of cervical cancer cell lines, with mutation rate higher in older women."}, {"pubmed": 19148475, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19164214, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19164214, "text": "genetic variations in PIK3CA may be associated with survival in esophageal cancer"}, {"pubmed": 19172191, "text": "activation of PIK3CA may be an important molecular event contributing to the maintenance of OSE transformation initiated by oncogenes such as K-ras"}, {"pubmed": 19196980, "text": "findings suggest GSK3beta is an important effector of mutant PIK3CA, and that lithium, an FDA-approved therapy for bipolar disorders, has selective antineoplastic properties against cancers that harbor these mutation"}, {"pubmed": 19223544, "text": "PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies."}, {"pubmed": 19233141, "text": "In this study they investigated the effect that the two major classes of PIK3CA mutation have on the biochemical properties of p110alpha."}, {"pubmed": 19234438, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19234438, "text": "PIK3CA mutations are frequent events in endometrial carcinomas of any histological type"}, {"pubmed": 19237633, "text": "Compared with patients with PIK3CA wild-type tumors, those with PIK3CA-mutated tumors experienced an increase in colon cancer-specific mortality according to univariate analysis."}, {"pubmed": 19237633, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19240718, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19261849, "text": "Amplifications of 3q26.32 harboring the oncogene PIK3CA were associated with poor prognosis and segregated with the aggressive transcriptional cluster."}, {"pubmed": 19272638, "text": "In the current study of primary uterine serous carcinoma (USC) tumors, oncogenic mutations of the PIK3CA gene were seen in 15% of USC cases"}, {"pubmed": 19276248, "text": "There was an association of PIK3CA mutation (kinase domain) with increased androgen receptor levels in breast cancer."}, {"pubmed": 19330652, "text": "low frequency of PIK3CA mutations in CLL suggests that such mutations are unlikely to cause any major transforming activity in CLL in general."}, {"pubmed": 19349352, "text": "Frequent activating mutations of PIK3CA is associated with ovarian clear cell carcinoma."}, {"pubmed": 19351817, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19366826, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19366826, "text": "PIK3CA mutations are not a major determinant of resistance to the epidermal growth factor receptor inhibitor cetuximab in metastatic colorectal cancer."}, {"pubmed": 19380724, "text": "GILZ1 and SGK1 provide a physical and functional link between the PI3K- and Raf-1-dependent signaling modules"}, {"pubmed": 19383818, "text": "PIK3 kinase expression is higher in metastatic melanoma."}, {"pubmed": 19394761, "text": "This study for the first time uncovered PIK3CA alterations in small cell lung cancer"}, {"pubmed": 19418217, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19418217, "text": "complete concordance of PIK3CA and AKT1 mutations in matched samples of invasive and in situ tumor indicates that these mutations occur early in breast cancer development"}, {"pubmed": 19420344, "text": "Mutation E17K/AKT1 was not detected in the 24 samples of retinoblastoma analyzed. K-RAS mutations were identified in two samples. There were no mutations in any of the other genes analyzed."}, {"pubmed": 19420344, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19440000, "text": "RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of ovarian cancer."}, {"pubmed": 19440799, "text": "oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors"}, {"pubmed": 19443396, "text": "results suggest that genetic alterations in the PI3K pathway are common in prostate cancer, and occur mainly through PIK3CA amplification and PTEN hemizygous or homozygous deletion"}, {"pubmed": 19487299, "text": "Absence of PIK3CA/AKT1 mutations in one specimen may not reflect the status at other sites because these mutations arise during progression."}, {"pubmed": 19487299, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19549383, "text": "PI3-K accelerates the short course of GPIb centralisation for two PAR signal pathways during the course of thrombin receptor activation in platelets."}, {"pubmed": 19573809, "text": "Phosphatidylinositol 3-kinase (PI3K) signaling pathway occurs frequently in human cancer; PTEN tumor suppressor or PIK3CA oncogene mutations both direct PI3K-dependent tumorigenesis in breast cancers"}, {"pubmed": 19584164, "text": "Findings show that PI3K inhibition diminished hepatoblastoma cell growth being accompanied by reduced AKT and GSK-3beta phosphorylation."}, {"pubmed": 19603024, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19603024, "text": "PIK3CA (P=0.01) mutations predicted reduced progress free survival in response to cetuximab salvage therapy in patients with metastatic colorectal cancer ."}, {"pubmed": 19608668, "text": "Data show that no mutations were detected in PIK3CA and CTNNB1/beta-catenin hotspot sequences."}, {"pubmed": 19622295, "text": "SHIP gene can inhibit K562 cell proliferation and promote cell apoptosis via inactivating PI3K/Akt pathway."}, {"pubmed": 19633047, "text": "PIK3CA mutations are associated with resistance to HER2-targeted agents."}, {"pubmed": 19638206, "text": "Investigated PI3K/AKT genetic alterations such as PIK3CA amplification, PIK3CA mutation, PTEN protein loss.  PIK3CA amplification was seen in 54 of 152 epithelial ovarian cancer (EOC) cases analyzed."}, {"pubmed": 19654299, "text": "Nicotine increases PPARbeta/delta gene expression through alpha7 nAChR-mediated activation of PI3K/mTOR signals that inhibit AP-2alpha protein expression and DNA binding activity to the PPARbeta/delta gene promoter."}, {"pubmed": 19671852, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19671852, "text": "Positive prognostic significance of PIK3CA mutations in breast cancer."}, {"pubmed": 19679877, "text": "a link between PI3K(p110alpha) and atrial fibrillation"}, {"pubmed": 19685490, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19686742, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19701705, "text": "Associations between PIK3CA expression and clinicopathological variables, molecular classes, and patients' outcome were investigated. PIK3CA is an oncogenic biomarker associated with poor prognosis in breast cancer."}, {"pubmed": 19704056, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19706770, "text": "Mutation analysis showed activation mutations in the PIK3CA gene in tumors that also had DNA copy number increases in the PIK3CA locus, suggesting an additive effect of coexisting activating amino acid substitution and dosage increase from amplification."}, {"pubmed": 19735264, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19735264, "text": "association of PIK3CA gene amplification with worse prognosis in nasopharyngeal carcinoma."}, {"pubmed": 19789314, "text": "PI3K pathway alterations are common in bladder cancer."}, {"pubmed": 19789368, "text": "VDR overexpression in colorectal cancer is independently associated with PIK3CA and KRAS mutations."}, {"pubmed": 19805105, "text": "The structural and biochemical data suggest a previously undescribed mechanism for mutational activation of PIK3CA that involves perturbation of its interaction with the cellular membrane."}, {"pubmed": 19815551, "text": "phosphoinositide 3-kinase isoforms alpha and beta have roles in glycoprotein VI-induced platelet signaling and thrombus formation"}, {"pubmed": 19818761, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19818761, "text": "PIK3CA mutations mostly began to develop at the stage from the DIN1B to the carcinoma in situ (DCIS), which is a late event of breast oncogenesis."}, {"pubmed": 19822807, "text": "Age-associated changes in transgenic murine heart lead to suppression of the p110 alpha isoform of phosphoinositide 3-kinase activity that modifies cardiac aging."}, {"pubmed": 19826477, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19839777, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19839777, "text": "Rare mutations in the PIK3CA gene contributing to aggressive endometrial cancer - has been shown."}, {"pubmed": 19844234, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19844788, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19844788, "text": "PIK3CA KD mutation was a favorable prognostic factor for relapse-free survival in response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer."}, {"pubmed": 19845664, "text": "Three of five stucco keratosis samples revealed a PIK3CA mutation(E542K, E545K), but no FGFR3 mutation was found. In contrast, both dermatosis papulosa nigra samples harboured an FGFR3 mutation (R248C, S249C) but no PIK3CA mutation."}, {"pubmed": 19853286, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19861897, "text": "In hereditary breast cancer, PIK3CA mutations were found only in the BRCA2 group."}, {"pubmed": 19861897, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19874421, "text": "PI3K physically interacts with the glucocorticoid receptor (GR)through two putative PI3K recruitment consensus YxxM binding motifs in the GR suggesting that some functions regulated by this receptor might occur through kinase interaction."}, {"pubmed": 19891769, "text": "Aurora-A, via activating Akt, stimulated nuclear factor-kappaB signaling pathway to promote cancer cell survival."}, {"pubmed": 19898424, "text": "approximately two-thirds of papillomas are driven by mutations in the PI3CA/AKT pathway"}, {"pubmed": 19903786, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19903786, "text": "PIK3CA mutations may have a role in recurrence of rectal cancer"}, {"pubmed": 19903845, "text": "Tumors expressing the p110alpha helical domain mutant showed a increase in tumor cell intravasation into the blood and tumor cell extravasation into the lung compared with tumors expressing wild-type p110alpha or the kinase domain mutant."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20008098, "text": "Leptin plays an important role in papillary thyroid carcinoma pathogenesis through PI3K/AKT pathway via Ob-R and is a potential prognostic marker associated with an aggressive phenotype and poor disease-free survival."}, {"pubmed": 20022634, "text": "PI3K/AKT mutations may not play a major role in multiple myeloma."}, {"pubmed": 20028853, "text": "These findings demonstrate the importance of cross-talk between the PI3K/Akt and beta-catenin pathways in medulloblastoma"}, {"pubmed": 20030946, "text": "PI3-kinase regulates the thrombin-induced actin cytoskeleton reconstitution in platelets by the RhoA-mDia1 pathway."}, {"pubmed": 20034918, "text": "Expression of PIK3CA was higher in the hepatocellular carcinoma tissue than in the corresponding adjacent tissue."}, {"pubmed": 20056178, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20098682, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 20101210, "text": "mutations in critical genes within the PI3-kinase (PI3K) pathway are not functionally equivalent, and that other cooperative genetic events may be necessary to achieve oncogenic PI3K pathway activation in cancers that contain the AKT1 E17K mutation."}, {"pubmed": 20103642, "text": "Data show that similar responses were seen in cancer cells with wild-type or activated mutant PI3K genes treated with p110alpha/delta or p110alpha/beta/delta inhibitors in cell viability assays."}, {"pubmed": 20107891, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 20107891, "text": "PIK3CA mutations were detected in 13/46 (28%) plasma-derived and 10/46 (21%) serum-derived cfDNA samples from metastatic breast cancer patients."}, {"pubmed": 20130133, "text": "The results showed that inhibition of PI3K and Akt-2 was associated with reduced SREBP-1 activation by genotype 3a hepatitis c virus core protein."}, {"pubmed": 20167866, "text": "TLR2 cooperates with MyD88, PI3K, and Rac1 in lipoteichoic acid-induced cPLA2/COX-2-dependent airway inflammatory responses"}, {"pubmed": 20177704, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20177704, "text": "PIK3CA alterations specifically correlate with clinicopathological characteristics of Bulgarian patients with breast cancer."}, {"pubmed": 20186503, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20186503, "text": "We evaluated the presence of mutations in PIK3CA, AKT1, AKT2, AKT3, PTEN, and PDPK1 genes in 83 papillary thyroid carcinomas"}, {"pubmed": 20237496, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20308328, "text": "Data show that PTPN11 mutations causing Leopard syndrome (LS) facilitate EGF-induced PI3K/AKT/GSK-3beta stimulation through impaired GAB1 dephosphorylation, resulting in deregulation of a novel signaling pathway that could be involved in LS pathology."}, {"pubmed": 20308428, "text": "The p110alpha selectively mediates activation of the Tyr kinase Pyk2 to regulate barrier function."}, {"pubmed": 20331378, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20379197, "text": "Mutant PIK3CA interferes with apoptosis downstream of death receptor-signal complex, allowing caspase-8 activation without apoptosis. Cleavage of ROCK-1 by caspase-8 triggers amoeboid shape and invasiveness of HCT116 cells in response to TRAIL and CD95L."}, {"pubmed": 20398348, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20398348, "text": "PIK3CA mutations in gastric carcinoma may be a signature of cancer type"}, {"pubmed": 20407443, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20413299, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20416077, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20416519, "text": "No hotspot mutations were detected in any of the samples. PIK3CA hotspot mutations are unlikely to play a major role in the pathogenesis of OSCC in the Greek population."}, {"pubmed": 20447721, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20453000, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20479250, "text": "Although the PIK3CA gene signature was not associated with prognosis in ER- and HER2+ breast cancer, it could identify better clinical outcomes in ER+/HER2- disease."}, {"pubmed": 20479250, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20491626, "text": "Studies indicate that the high-frequency somatic mutations of PIK3CA observed in different human cancers further strengthen the notion that PI3Ks are optimal targets for therapeutic intervention."}, {"pubmed": 20493625, "text": "Direct sequencing analysis of endometrial DNA analysis did not reveal any activating somatic mutations in either PI3KCA or AKT1 gene, indicating that these mutations are rarely associated with endometriosis in South Indian women."}, {"pubmed": 20493625, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20495538, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20508983, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20514448, "text": "Decreased expression of PTEN together with overexpression of PI3K and AKT contribute to gastric cancer progression."}, {"pubmed": 20526288, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20535651, "text": "the relevance of PIK3CA mutations to a wide range of common human tumor types (Review)"}, {"pubmed": 20551053, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20551053, "text": "Results suggest that mutation of PIK3CA is an early event in breast cancer that is more likely to play a role in breast tumor initiation than in invasive progression. A role for exon 9 mutations in the progression of a subset of DCIS cannot be excluded."}, {"pubmed": 20557351, "text": "Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations."}, {"pubmed": 20569675, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20569675, "text": "reports the low frequency of PIK3CA and B-RAF mutations in astrocytomas, despite the presence of activated ERK and AKT proteins."}, {"pubmed": 20571907, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20571907, "text": "PIK3CA mutations may have a role in KRAS and BRAF wild type colorectal cancer"}, {"pubmed": 20593314, "text": "Oncogenic mutations of PI3Kalpha result in a constitutively activated enzyme that triggers downstream pathways that increase tumor aggressiveness and survival (Review)"}, {"pubmed": 20602615, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20616362, "text": "PIK3CA HRMA assay was evaluated by performing repeatability, sensitivity, and comparison with DNA sequencing studies and was further validated in 129 formalin-fixed paraffin-embedded breast tissue samples: 99 tumors, 20 noncancerous, and 10 fibroadenomas"}, {"pubmed": 20619739, "text": "if KRAS is not mutated, assessing BRAF, NRAS, and PIK3CA exon 20 mutations (in that order) gives additional information about the efficacy of cetuximab plus chemotherapy in metastatic colorectal cancer."}, {"pubmed": 20622004, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20622004, "text": "PIK3CA rs7651265 GG genotype was associated strongly with colon and rectal cancer."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20629536, "text": "mediates activation of TGF-beta2 promoter response elements leading to high cytokine expression in cancer cells"}, {"pubmed": 20652941, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20691427, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20699365, "text": "Genetic ablation of the mutant PIK3CA allele in MEK inhibitor-resistant cells restores MEK pathway sensitivity, re-expression of mutant PIK3CA reinstates resistance, highlighting the importance of this mutation in resistance to therapy in cancers."}, {"pubmed": 20703095, "text": "Data show that DLBS1425 significantly reduced phosphoinositide-3 (PI3)-kinase/protein kinase B (AKT) signalling by reducing PI3K transcript level and subsequent reduction in AKT phosphorylation."}, {"pubmed": 20713702, "text": "Data show that the mutations weaken an inhibitory interaction between p85alpha and p110alpha."}, {"pubmed": 20718712, "text": "Sodium butyrate increased PTEN expression, promoted the expression of MUC2 and induced the differentiation of gastric cancer cells through the PTEN/PI3K signalling pathway."}, {"pubmed": 20736745, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20813562, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20813562, "text": "study supports that mutations in the PIK3CA gene make at least a minor contribution to OSCC tumorigenesis"}, {"pubmed": 20813970, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20813970, "text": "PIK3CA mutation is associated with poor trastuzumab response in HER2-positive metastatic breast cancer."}, {"pubmed": 20824703, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20826237, "text": "The levels of total Akt and phosphorylated Akt (active Akt) are increased in E6-AP overexpressing prostate gland and LNCaP cells suggesting that E6-AP regulates the PI3K-Akt signaling pathway."}, {"pubmed": 20827662, "text": "STC1 induction by thyroid hormone depends on both TRbeta and PI3K activation."}, {"pubmed": 20857497, "text": "Findings suggest that there is p70S6K-mediated, cross-inhibitory regulation between the MEK/ERK and PI3K/mTOR pathways, in which each contribute to the maintenance of the self-renewal and tumorigenic capacity of glioblastoma glioblastoma stem-like cells"}, {"pubmed": 20860430, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20881644, "text": "Mutations in PIK3CA is associated with squamous cell carcinomas of the lung."}, {"pubmed": 20881644, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20937558, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20940279, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20940279, "text": "PIK3CA mutants overall showed a significantly longer time to first recurrence than wild type cases"}, {"pubmed": 20953381, "text": "the p110alpha and beta isoforms of class IA PI3K are both required for the proinflammatory response to flagellin via TLR5"}, {"pubmed": 20954287, "text": "Up-regulation of PIK3CA may promote the metastasis of gastric cancer through aberrant activation of PI3K/Akt."}, {"pubmed": 20959404, "text": "cIAP2 upregulated by E6 via EGFR/PI3K/AKT cascades may contribute to cisplatin resistance, revealing that the EGFR or PI3K inhibitor combined with cisplatin may improve the chemotherapeutic efficacy in HPV-infected lung cancer."}, {"pubmed": 21035469, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21042767, "text": "the PI3K/AKT signaling pathway is aberrantly active and plays a critical role for the cell cycle progression in human pleural mesothelioma cells."}, {"pubmed": 21048031, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 21051183, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21051183, "text": "findings indicate that somatic mutations in KRAS and PIK3CA but not BRAF oncogenes are closely associated with the development of cholangiocarcinoma in Chinese population"}, {"pubmed": 21062993, "text": "Combined inhibition of PI3K and mTOR, which activates autophagy without activating Akt, cooperated with inhibition of autophagy to cause glioma cells to undergo apoptosis."}, {"pubmed": 21071597, "text": "Although the mechanism of load-induced mTORC1 activation remains to be determined, it is clear that it does not require classical growth factor signaling."}, {"pubmed": 21072204, "text": "Data show that of primary tumors 64% were mutant for FGFR3, 11% for RAS, 24% for PIK3CA, and 26% for p53."}, {"pubmed": 21072204, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21092549, "text": "Expressions of Akt1, Akt2 and PI3K were decreased in ovarian epithelial cancer cells transduced with PTEN."}, {"pubmed": 21093899, "text": "Common genetic variation in PTEN, PIK3CA, AKT1, MLH1, or MSH2 was not statistically significantly associated with endometrial cancer."}, {"pubmed": 21103049, "text": "Data show that among 181 CRC patients, stratified by microsatellite instability status, DNA sequence changes were identified in KRAS (32%), BRAF (16%), PIK3CA (4%), PTEN (14%) and TP53 (51%)."}, {"pubmed": 21113138, "text": "PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors."}, {"pubmed": 21113787, "text": "Activation of the PI3K/AKT in addition to MAPK/ERK signaling pathways may underlie biological aggressiveness in pilocytic astrocytoma (PA). Specifically, it may mediate the increased proliferative activity observed in histologically anaplastic PA."}, {"pubmed": 21123564, "text": "In hyperglycemic leptin-deficient Lep(ob/ob) transgenic mice, leptin acutely and potently improves glucose metabolism, before any change of body fat mass, via a mechanism involving the p110alpha and -beta isoforms of phosphatidylinositol-3-kinase (PI3K)."}, {"pubmed": 21127054, "text": "down-regulation of PI3K-C2alpha may be a feature of type 2 diabetes."}, {"pubmed": 21168197, "text": "Mutations in PIK3CA, KRAS and NRAS were exclusive to tumors of uterine origin and age-adjusted Cox proportional hazards modeling associated advanced age, stage and TP53 mutations with decreased survival in the uterine subset."}, {"pubmed": 21169263, "text": "PIL3Ca mutations may not only be a prognostic factor, but may also be predictive of preoperative radiation benefit."}, {"pubmed": 21179398, "text": "Data support the idea that PI3Kalpha plays an important role in the metastatic process and suggest a more informed strategy for selecting drugs worthy of further development for clinical application."}, {"pubmed": 21185392, "text": "Results suggest that low magnitude stretch can induce cPLA(2) phosphorylation through the MEK/ERK and PI3K-Akt pathways, independently."}, {"pubmed": 21191416, "text": "Expression of matrix metalloproteinase-13 is controlled by IL-13 via PI3K/Akt3 and PKC-delta in normal human dermal fibroblasts."}, {"pubmed": 21209852, "text": "the PI3K/PAK1/ERK signaling pathway has a role in LPA-stimulated breast cancer cell migration"}, {"pubmed": 21209903, "text": "PIK3CA mutation and the Wnt pathway have roles in ERalpha-positive breast cancer"}, {"pubmed": 21225506, "text": "EGFR, PI3Kp110 and PTEN expression is a common feature of neuroblastoma"}, {"pubmed": 21228233, "text": "Here, the authors show that VP11/12 is required for virus-induced activation of PI3K-Akt signaling in herpes simplex virus 1-infected Jurkat T cells and primary fibroblasts."}, {"pubmed": 21252315, "text": "study identified one PIK3CA missense mutation in pancreatic neuroendocrine tumors"}, {"pubmed": 21255011, "text": "Data show that the effects of PI3K-Akt signalling on IL-10 responses were mediated at least in part by GSK3."}, {"pubmed": 21258250, "text": "PIK3CA mutations are associated with drug resistance in non-small cell lung cancer."}, {"pubmed": 21266528, "text": "analysis of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas"}, {"pubmed": 21290341, "text": "PI3K/AKT/mTOR signalling pathway activation is a common event in high-risk neuroblastoma."}, {"pubmed": 21300060, "text": "Data suggest that the PI3K/Akt pathway is involved in apoptotic function in PKHD1-silenced cells, and PI3K/Akt inhibition correlates with upregulation of NF-kappaB activity."}, {"pubmed": 21303542, "text": "The presence of activating mutations in PIK3CA specifically in gallbladder cancer has clinical implications in both the diagnosis of this cancer type, as well as the potential utility of targeted therapies such as PI3 kinase inhibitors."}, {"pubmed": 21310649, "text": "The importance of PIK3K/PAK in neoplasm transformation and progression, their disregulation detected in oral squamous cell carcer may provide early diagnosis and aid in the design of new therapies."}, {"pubmed": 21332555, "text": "PIK3CA mutations were rare in colorectal laterally-spreading tumors."}, {"pubmed": 21345071, "text": "Report novel hotspot PIK3CA mutation in Iranian breast cancer patients."}, {"pubmed": 21355052, "text": "PI3K-activating hormones inhibit ROMK by enhancing its endocytosis via a mechanism that involves phosphorylation of WNK1 by Akt1 and SGK1."}, {"pubmed": 21357506, "text": "Phosphatidylinositol 3'-kinase signaling pathway is essential for Rac1-induced hypoxia-inducible factor-1(alpha) and vascular endothelial growth factor expression in hypoxia."}, {"pubmed": 21358673, "text": "demonstrate here that breast cancer cells harbouring PIK3CA mutations are selectively sensitive to mTOR allosteric and kinase inhibitors. However, cells with PTEN loss of function are not sensitive to these drugs"}, {"pubmed": 21367892, "text": "Thus, sendai virus infection-mediated apoptosis is temporally regulated by the prevention of XIAP degradation by PI3K."}, {"pubmed": 21372221, "text": "Studies suggest that dual PI3K and mTOR inhibition using NVP-BEZ235 may be an effective novel therapeutic approach in patients with ovarian cancer."}, {"pubmed": 21377268, "text": "Our data demonstrate that PIK3CA is a mediator of collagen I-induced down-regulation of E-cadherin."}, {"pubmed": 21406404, "text": "Results show the mechanism by which EZH2 regulates BRCA1 expression and genomic stability mediated by the PI3K/Akt-1 pathway."}, {"pubmed": 21407159, "text": "Overexpression of PIK3CA was confirmed in biopsy washout specimens and in postoperative tissues of papillary thyroid carcinoma, in comparison to macroscopically unchanged thyroid tissue"}, {"pubmed": 21408138, "text": "Allele-specific qPCR assays for the most frequent activating mutations in EGFR, KRAS, BRAF and PIK3CA in tumor-positive fine needle cytological aspirates were compared against histological material of primary tumors."}, {"pubmed": 21412012, "text": "Single nucleotide polymorphisms in PI3K gene is not associated with colorectal cancer."}, {"pubmed": 21419810, "text": "Data suggest that glioma cell survival occurs through a PI(3)-kinase/PDK1/PKC-iota/BAD mediated pathway."}, {"pubmed": 21424126, "text": "data indicated that colorectal cancers with KRAS and PIK3CA bi-mutations are more likely to develop into liver metastasis"}, {"pubmed": 21440011, "text": "Studies indicate that FoxOs have emerged as an important effector arm of PI3K/Akt signaling by driving multiple apoptotic gene expression."}, {"pubmed": 21442372, "text": "Data suggest that the PI3K/Akt signal transduction pathway is involved in the regulation and release of pro-inflammatory cytokines such as TNF-alpha and plays an important role in the development and progression of ulcerative colitis."}, {"pubmed": 21454528, "text": "CCL5 signaling induces GLI2 through a PI3K-AKT-IkappaBalpha-p65 pathway and requires GLI2 transcriptional activity to modulate IL-6 expression and Ig secretion in vitro and in vivo"}, {"pubmed": 21468554, "text": "These results suggest that ERalpha induces the down-regulation of PTEN through PI3K activation in breast cancer cells."}, {"pubmed": 21469098, "text": "controls inflammatory cytokine production in human neutrophils"}, {"pubmed": 21474066, "text": "Based on a comparative molecular analysis, we show that activated PIK3CA/AKT is a weaker inducer of cell senescence than is activated RAS."}, {"pubmed": 21480388, "text": "Data show that the Ras/PI3K/Akt pathway can account for Fyn over-expression in cancers."}, {"pubmed": 21482133, "text": "A detachment-induced and PI3K/Akt-mediated resistance to apoptotic effects of TRAIL, is demonstrated."}, {"pubmed": 21482677, "text": "The PIK3CA H1047R oncogene targets a multipotent progenitor cell and, furthermore, show that this model recapitulates features of human breast tumors with PIK3CA H1047R."}, {"pubmed": 21490305, "text": "PIK3CA mutations were detected in 19 (40%) of primary tumors and 21 (42%) of metastases"}, {"pubmed": 21499215, "text": "Data show that hepatocyte growth factor inhibits anoikis of pancreatic carcinoma cells through phosphatidylinositol 3-kinase pathway in which activation of Akt may be involved."}, {"pubmed": 21501368, "text": "Moreover, sustained PI3K/Akt signalling in Aspergillus fumigatus infected cells is an important determinant to resist apoptosis."}, {"pubmed": 21507233, "text": "PIK3CA amplification was frequently found in NSCLC"}, {"pubmed": 21531001, "text": "PIK3CA somatic mutations occurred in 39 (19.9%) of 196 endometrial carcinomas.  No PIK3CA mutations were found in endometrial hyperplasias. PIK3CA amplification was observed in 24 (12.2%) carcinomas and in 2 (10%) hyperplasias."}, {"pubmed": 21538027, "text": "Inhibition of PI3K reduced rhTRAIL sensitivity independently of the cell line preference for either DR4- or DR5-mediated apoptosis signaling."}, {"pubmed": 21557211, "text": "Findings show that the oncogenic PI3K/Akt signalling pathway participates in maintaining cells in a type II phenotype by excluding CD95 from lipid rafts."}, {"pubmed": 21558396, "text": "Prediction of CH5132799 response on the basis of PIK3CA mutations could enable patient stratification in clinical settings."}, {"pubmed": 21594665, "text": "PIK3CA activating mutations and and PTEN loss is associated with less efficacy of trastuzumab therapy in metastatic breast cancer"}, {"pubmed": 21595858, "text": "These studies validate the Kit L575P-activated model of melanoma and establish the PI3K pathway as a dominant signaling pathway downstream of Kit in melanoma."}, {"pubmed": 21617917, "text": "Demonstrate the presence of PIK3CA and AKT1(E17K) mutations from pre-invasive to invasive to metastatic breast cancer tissue."}, {"pubmed": 21620836, "text": "Data show that PI3K dependent phosphorylation of Fbw7 stimulates its ability to ubiquitinate and degrade its substrates."}, {"pubmed": 21620963, "text": "Retinal pigment epithelial disruption induced by high glucose plus IL-1beta is prevented by erythropoietin through the downstream signaling of JAK2 and PI3K/AKT pathways."}, {"pubmed": 21622527, "text": "Tannerella forsythia epithelial cell entry is dependent on host PI3K signalling, purified BspA protein causes activation of this lipid kinase, and also requires the cooperation of host Rac1 GTPase."}, {"pubmed": 21646525, "text": "Results identify unique sites of PTEN and Akt regulation by means of S-nitrosylation, resulting in an \"on-off\" pattern of control of Akt/PI3K signaling."}, {"pubmed": 21660567, "text": "patients with Non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue that are positive for both PIK3CA and FOXP1 had a worse overall and progression-free survival"}, {"pubmed": 21663621, "text": "The present data indicate that activation of the PI3-kinase/PKB/AKT pathway through PIK3CA regulates various transformed phenotypes as well as growth and differentiation of HPV-immortalized cells"}, {"pubmed": 21667306, "text": "Investigated PIK3CA mutation in Chinese hepatocellular carcinoma patients.Exons 9 and 20 mutations of PIK3CA gene were detected.Two point mutations in exon 9 were found in only one patient (1/90; 1.11%), no mutation was found in exon 20 in any cases."}, {"pubmed": 21673026, "text": "Studies indicate that PI3K can phosphorylate and convert phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate (PIP3) that leads to activation of AKT."}, {"pubmed": 21676217, "text": "PIK3CA mutations occur more often in elderly HER2-positive breast cancer patients. Most mutations were at H1947R & E542K. PI3K pathway activation resulting from PIK3CA mutations may lead to drug resistance to lapatinib & trastuzumab."}, {"pubmed": 21682666, "text": "Data suggest that PI3K and PKC are along the same pathway that branches into two separate ones involving each either p38MAP kinase or MEK/ERK."}, {"pubmed": 21708979, "text": "PI3K signaling via p110alpha regulates invadopodia-mediated invasion of breast cancer cells."}, {"pubmed": 21711108, "text": "Beclin1/PI3K-mediated autophagy prevents hypoxia-induced apoptosis in EAhy926 cell line"}, {"pubmed": 21713404, "text": "TGF-beta1 undergo a switch into mesenchymal cells and PI3K/Akt and MAPK/Erk1/2 signaling pathways serve to regulate TGF-beta1-induced epithelial-to-mesenchymal transition of A549 cells."}, {"pubmed": 21725367, "text": "Results indicate that stimulation of the early metastatic steps of motility and invasion by ErbB3 requires activation of the PI3-kinase pathway by the ErbB3 receptor."}, {"pubmed": 21735444, "text": "These findings provide evidence that mutations of the PIK3CA gene occur in the putative precursor lesions of ovarian clear cell adenocarcinoma"}, {"pubmed": 21768115, "text": "Glycosaminoglycans and glucose prevent apoptosis in 4-methylumbelliferone-treated human aortic smooth muscle cells in a process mediated by Toll-like receptor 4, CD44, and PI3K but not by ERK1/2"}, {"pubmed": 21769475, "text": "These findings indicate that the expression of IL-15 up-regulated by IL-6 is associated with MAPKs-ERK1/2 and PI3K-AKT signaling pathways in HaCaT cells."}, {"pubmed": 21788516, "text": "Cells transformed by the p110alpha-H1047R mutant of PI3K show increased tyrosine phosphorylation of Stat3."}, {"pubmed": 21789382, "text": "results show that hotspot mutations in the PI3K, JAK2, FLT3 and NPM1 genes are not common in myelodysplastic syndrome patients."}, {"pubmed": 21822287, "text": "Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms."}, {"pubmed": 21824802, "text": "data confirm that PIK3CA is important to oral squamous cell carcinoma (OSCC) tumorigenesis and can contribute to oncogene activation of the PIK3CA/AKT pathway in OSCC"}, {"pubmed": 21829508, "text": "PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers."}, {"pubmed": 21830111, "text": "PIK3CA mutation in exon 20 is a negative prognostic factor in stage III colon cancer patients. Moreover, this negative effect is not present in stage I and II patients."}, {"pubmed": 21861134, "text": "Down-regulation of JAK1 by RNA interference inhibits growth of the lung cancer cell line A549 and interferes with the PI3K/mTOR pathway"}, {"pubmed": 21872252, "text": "CREG plays a critical role in protecting the vascular endothelium from apoptosis, and the protective effort of CREG against ECs apoptosis is through the activation of the VEGF/PI3K/AKT signaling pathway"}, {"pubmed": 21887250, "text": "FGF2 and EGF affect the motor neuron fate decision in human fetal neural stem cells differently through a fine tuning of the PI3K/AKT/GSK3beta pathway."}, {"pubmed": 21893189, "text": "The OHCI induces mitochondrial oxidative stress, leading to DNA double-strand breaks and elicitation of a phosphoinositol 3-kinase-mediated cellular response in peripheral blood lymphocytes."}, {"pubmed": 21899695, "text": "Accumulation of viral RNA in cells infected with influenza A or B viruses results in PI3K activation."}, {"pubmed": 21906875, "text": "Results demonstrate a PIK3CA mutation simultaneously occuring with a 15-up deletion in KIT exon 11 in gastrointestinal stromal tumors."}, {"pubmed": 21932420, "text": "PIK3CA mutations were uncommonly, but exclusively, seen in tubulovillous adenomas (4/124, 3.2%) and 1/4 (25.0%) tubulovillous adenomas with a focus of cancer"}, {"pubmed": 21937609, "text": "PI3 kinase-alpha/gamma-mediated signaling downstream of VEGFR2 activation regulated Akt-dependent survival signals, but it was not required to activate endothelial nitric oxide synthase or to elicit NO production in glomerular endothelial cells."}, {"pubmed": 21945955, "text": "Mutations in PIK3CA were found in 3 of 11 Intraductal tubulopapillary pancreatic neoplasms but not in intraductal papillary pancreatic mucinous neoplasms"}, {"pubmed": 21949775, "text": "These findings, representing the first genomewide search for variants influencing human protein phosphorylation, provide useful information about the PI3K/AKT/mTOR pathway."}, {"pubmed": 21970855, "text": "FASN inhibition not only abrogates lipogenesis, which is indispensable for cancer growth, but also downregulates oncogenic PI3K signaling."}, {"pubmed": 21990951, "text": "Data show that siRNA mediated targeting of PIK3CA may specifically knockdown the expression of PIK3CA in gastric cancer cells, providing a potential implication for therapy of gastric cancer."}, {"pubmed": 21991326, "text": "Survival, proliferation, leptin production, OB-R isoforms (OB-Ra and OB-Rb), phosphoinositide 3-kinase (PI3k) and BCL-2 expression have been tested after 24h, 48h and 72h of treatment with alpha-linolenic acid."}, {"pubmed": 21994334, "text": "Findings suggest that large HBsAg (LHBs) promotes tumorigenesis of hepatoma cells by triggering a PKCalpha/Raf1 to Src/PI3K/Akt signaling pathway, revealing novel insights into the underlying mechanisms of HBV-associated hepatocarcinogenesis."}, {"pubmed": 21997360, "text": "A frequent PIK3CA mutation appears in a series of rosette-forming glioneuronal tumors."}, {"pubmed": 22006429, "text": "multiple mutations were identified in phosphoinositide-3-kinase (PI3K), catalytic, alpha polypeptide (PIK3CA) (H1047R, E-->lysine at codon 545 [E545K], and H-->proline at codon 701 [H701P]) that were not observed previously in osteosarcoma"}, {"pubmed": 22020193, "text": "activating mutation of PIK3CA, loss of PTEN, or IGF1R expression have a role in round cell transformation"}, {"pubmed": 22026810, "text": "The overall prevalence of PIK3CA mutations was 23% (7/31) for both tumor types (22% in glioblastoma multiform, and 25% in anaplastic astrocytoma)."}, {"pubmed": 22033276, "text": "Common germline variation in PIK3CA does not have a strong influence on the risk of breast cancer"}, {"pubmed": 22037177, "text": "the activation of PI3K and MEK pathways is not the only mechanism of EGFR-resistance"}, {"pubmed": 22039088, "text": "PIK3CA exon 20 mutations may be a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer. [Review and meta-analysis]"}, {"pubmed": 22045127, "text": "Addition of short (6 to 16 amino acids) peptide sequences to the N-terminus of p110alpha induces a gain of function includeds signaling, oncogenic transformation and stimulation of cell growth."}, {"pubmed": 22064833, "text": "PIK3R1, like PIK3CA, is a potential therapeutic target in Glioblastoma multiforme and that it also influences tumor cell growth and motility"}, {"pubmed": 22072736, "text": "In endometriotic stromal cells, overactivation of the phosphatidylinositol 3-kinase/AKT signaling pathway contributes to the reduced expression of the decidua-specific gene, IGFBP1, potentially through reduced levels of nuclear FOXO1."}, {"pubmed": 22095222, "text": "combination of low CEN7 copy number, PTEN loss, and PI3KCA gain may be useful for identifying NSCLC patients unlikely to benefit from treatment with EGFR (TKIs), specifically in wild-type EGFR cases"}, {"pubmed": 22105580, "text": "proliferation of human IVD cells is regulated by exogenous and autocrine growth factors mainly via the MEK/ERK and PI-3K/Akt pathways."}, {"pubmed": 22107784, "text": "The prognostic impact of Akt (Akt1) phosphorylated at threonine308 and serine473, Akt2, Akt3, PI3K and PTEN, alone and in coexpression with ER and PgR in non-gastrointestinal stromal tumor soft tissue sarcomas."}, {"pubmed": 22120431, "text": "PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma."}, {"pubmed": 22135231, "text": "Data indicate that PIK3CA mutations occur in lung adenocarcinomas, usually concurrently with EGFR, KRAS, and anaplastic lymphoma kinase (ALK)."}, {"pubmed": 22146375, "text": "BDNF promotes EGF-induced proliferation and migration of neural stem/progenitor cells through the PI3K/Akt pathway."}, {"pubmed": 22146979, "text": "PIK3CA rs6443624 and rs9838411 variants either somewhat or significantly decreased risk of endometrial cancer in a dominant model."}, {"pubmed": 22157930, "text": "Loss of ARID1A protein expression occurs as a very early event in ovarian clear-cell carcinoma development and frequently coexists (not mutually exclusive) with PIK3CA mutations."}, {"pubmed": 22172323, "text": "Breast cnacer patients with PIK3CA mutations or increased PI3K pathway activity had a significantly poorer survival despite adequate treatment with adjuvant chemotherapy and trastuzumab."}, {"pubmed": 22185283, "text": "Data suggest that wild-type PTEN gene transfection might increase drug sensitivity or reverse drug resistance via inhibiting the PI3K/Akt pathway and regulating downstream molecules of the cell signaling transduction pathway in K562/ADM cells."}, {"pubmed": 22188534, "text": "Mutations in ras PIK3CA are present in benign lichenoid keratosis."}, {"pubmed": 22188813, "text": "Data indicate that NVP-BKM120 inhibits all four class I PI3K isoforms in biochemical assays."}, {"pubmed": 22190283, "text": "Gene mutations of PIK3CA are not associated with the postoperative prognosis of patients with hepatocellular carcinoma."}, {"pubmed": 22208359, "text": "Results show a novel anti-inflammatory role for the PI3K/Akt signaling pathway in microglia, and show that Ad-IRF3 suppressed proinflammatory genes and enhanced anti-inflammatory genes."}, {"pubmed": 22209294, "text": "PIK3CA mutation status was analyzed by sequencing in 94 tumors. phosphatidylinositol 3'-kinase pathway alteration might have a favorable prognostic impact on endometrial cancers in Chinese women."}, {"pubmed": 22212451, "text": "conclude that exocrine pancreatic expression of phosphatidylinositol 3-kinase p85alpha subunit is attenuated by aging"}, {"pubmed": 22214007, "text": "Although PIK3CA mutation has been found in 10-18% of colorectal cancer patients, the results are still inconclusve if it affects the efficacy of cetuximab or panitumumab.[review]"}, {"pubmed": 22227580, "text": "Results describe how phosphatidylinositol 3-kinase and protein kinase D1 cooperate to regulate the insulin-like growth factor signaling pathway."}, {"pubmed": 22258409, "text": "Mutational activation of both BRAF and PIK3CA genes does contribute to hepatocellular tumorigenesis at somatic level in Southern Italian population."}, {"pubmed": 22271473, "text": "Patients with PIK3CA mutations treated with PI3K/AKT/mTOR inhibitors demonstrated a higher response rate than patients without mutations."}, {"pubmed": 22285706, "text": "loss of PTEN expression (by immunohistochemistry) and PIK3CA mutation is likely to be predictive of a lack of benefit to anti-EGFR therapy in metastatic colorectal cancer"}, {"pubmed": 22285928, "text": "UCA1 regulated cell cycle through CREB via PI3K-AKT dependent pathway in bladder cancer."}, {"pubmed": 22287190, "text": "PIK3CA mutation is associated with colorectal serrated adenocarcinoma."}, {"pubmed": 22301279, "text": "data suggest that lamin A/C proteins are positively involved in malignant behavior of PC cells through the PI3K/AKT/PTEN pathway. Lamin A/C may represent a new oncogenic factor and a novel therapeutic target for PC"}, {"pubmed": 22302350, "text": "These findings strengthen the evidence for involvement of the Notch, Hedgehog, NF-KB, and PIK3CA pathways in breast cancer development, and point to novel processes that likely are involved."}, {"pubmed": 22315990, "text": "PIK3CA mutations confer constitutive activation of PI3K, which initiates intracellular kinase signaling cascades that promote cell proliferation and survival."}, {"pubmed": 22325221, "text": "PIK3CA mutations may play an important role in the carcinogenesis and development of breast cancer."}, {"pubmed": 22330809, "text": "PIK3CA mutation was associated with significantly longer metastasis-free survival in breast cancer patients."}, {"pubmed": 22336203, "text": "PIK3CA mutations at exon 9 or 20 may have different impact on the prognosis in endometrial carcinoma."}, {"pubmed": 22336586, "text": "PI3K/mTOR inhibitors can enhance 5-FU cytotoxicity in vitro and in vivo, especially in PIK3CA mutant tumor cells."}, {"pubmed": 22340730, "text": "Studies suggest that the effects of PHLPP1 deletion on prostate carcinogenesis may be explained by the strong dependence of prostate cancer on phosphoinositide 3-kinase (PI3K)/Akt signalling."}, {"pubmed": 22351695, "text": "Data indicate that the mechanisms of action of ON 01910.Na invloved PI3K/AKT inhibition and induction of oxidative stress response."}, {"pubmed": 22355357, "text": "High p110alpha is associated with non-small cell lung cancer."}, {"pubmed": 22357840, "text": "coexistence of PIK3CA (the PI3K p110alpha subunit) exon 9 and 20 mutations, but not PIK3CA mutation in either exon 9 or 20 alone, is associated with poor prognosis of colorectal cancer patients"}, {"pubmed": 22363436, "text": "The relationship between expression and genetic alterations of the components of the PI3K/AKT pathway in non-small cell lung cancer, was investigated."}, {"pubmed": 22363598, "text": "Merkel cell carcinoma samples were analyzed for activating PIK3CA and AKT1 mutations."}, {"pubmed": 22383975, "text": "analysis of FGFR2 point mutations in 466 endometrioid endometrial tumors and their relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations"}, {"pubmed": 22417847, "text": "we have analyzed the prevalence of somatic mutations in the FGFR3, PIK3CA, AKT1, KRAS, HRAS, and BRAF genes in bladder cancers"}, {"pubmed": 22430133, "text": "The PIK3CA mutation rate was lower in adenocarcinomas compared to other forms of lung cancers"}, {"pubmed": 22430209, "text": "Our findings indicate that the effects of mutant PIK3CA are both cell type- and mutation-specific."}, {"pubmed": 22460814, "text": "PIK3CA mutations were identified in 13/24 columnar cell lesions (54%) and 3/8 invasive carcinomas (37%)."}, {"pubmed": 22463491, "text": "Data indicate a functional link between the Notch1 and PI3K/Akt pathways in clear cell renal cell carcinoma (CCRCC)."}, {"pubmed": 22471665, "text": "This review outlines the interaction of the PI3K pathway with other signaling cascades, highlights mechanisms involved in hyperactivation, discusses current therapeutics in cancer-related clinical trials that target this pathway."}, {"pubmed": 22488590, "text": "The PI3K/AKT pathway can be an important signaling pathway for the survival of BRCA1-defective breast cancer cells."}, {"pubmed": 22495819, "text": "Both osteopontin-c and osteopontin-b splic-ing isoforms promote distinct aspects of PCa progression by inducing PI3K signaling."}, {"pubmed": 22498935, "text": "A PIK3CA mutation was observed in 16 (17%) specimens in patients with endometrial cancer."}, {"pubmed": 22522453, "text": "In summary, the PI3K/PKCiota regulates the alternative splicing of Bcl-x pre-mRNA with implications in the cell survival of NSCLC cells."}, {"pubmed": 22522847, "text": "Aberrant DLC1 methylation and PIK3CA mutat-ions may have important roles in extra-mammary Paget's disease pathogenesis."}, {"pubmed": 22552288, "text": "findings describe a PI3K-driven, NF-kappaB-dependent transcriptional profile that may play a critical role in promoting a microenvironment amenable to tumor progression"}, {"pubmed": 22556157, "text": "In human airway smooth muscle cells, regulation of CD38 expression occurs by specific class I PI3K isoforms."}, {"pubmed": 22556379, "text": "Although there is an association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer, there is no clear evidence that this is driven specifically by PIK3CA mutations."}, {"pubmed": 22575839, "text": "We further identify the activation of the PI3K/AKT signal pathway by T3 as an underlying mechanism for the enhanced conversion to cell pluripotency in this model."}, {"pubmed": 22579930, "text": "KRAS, BRAF, and PIK3CA mutations in colorectal cancer have sustained prevalence rate in the Taiwanese population."}, {"pubmed": 22586484, "text": "In the present study, we did not find any significant correlations between KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression and various clinicopathological features in Chinese patients with colorectal cancer."}, {"pubmed": 22619175, "text": "Data suggest that phosphoinositide-3-kinase/Akt and mammalian target of rapamycin (mTOR) pathway signaling differentially regulate phospho-Mst1-Thr-120/Thr-183."}, {"pubmed": 22623730, "text": "Our findings implicate amplifications of 3q26 focused on PIK3CA and 8q24 focused on MYC in chronic lymphocytic leukemia."}, {"pubmed": 22635024, "text": "Single nucleotide polymorphism in PIK3CA is associated with synchronous endometrial and ovarian cancer."}, {"pubmed": 22640628, "text": "Breast cancer patients with tumors harboring a PIK3CA mutation have a better clinical outcome than those with a wild-type PIK3CA gene."}, {"pubmed": 22648906, "text": "Angiosarcoma (AS) is characterized by a complex pattern of alterations of the TP53 and PIK3CA/AKT/mTOR pathways that does not depend on MYC amplification status."}, {"pubmed": 22649008, "text": "In conclusion, SPRY2 is an important tumour suppressor in prostate cancer since its loss drives the PI3K/AKT pathway via functional interaction with the ErbB system."}, {"pubmed": 22658544, "text": "CLOVES syndrome is caused by postzygotic activating mutations in PIK3CA"}, {"pubmed": 22662165, "text": "Our data highlights a new functional synergism between oncogenic EGFR and PIK3CA with WNT/beta-catenin conferring high tolerance to oxidative stress generated by nutrient deprivation."}, {"pubmed": 22675430, "text": "KRAS and PIK3CA mutations frequently coexist in patients with colorectal cancer, and are associated with clinical characteristics and outcome."}, {"pubmed": 22675553, "text": "The interaction between HGF and c-Met increases OPN expression in human osteoblasts via the PI3K, Akt, c-Src, c-Jun, and AP-1 signaling pathway."}, {"pubmed": 22683270, "text": "several Rho family small GTPases activate PI3K by an indirect cooperative positive feedback that required a combination of Rac, CDC42, and RhoG small GTPase activities"}, {"pubmed": 22689060, "text": "PIK3CA H1074R mutation and PTEN loss differentially regulate LIM-kinase1 and slingshot-1L."}, {"pubmed": 22704443, "text": "Cyclic hydrodynamic pressure stimulating the roliferation of human bladder smooth muscle cells cultured in scaffolds. The signal transduction mechanism for this process is involved with the PI3K/SGK1 and not the PI3K/AKT signaling pathway."}, {"pubmed": 22705003, "text": "PIK3CA mutations were significantly associated with a favorable overall survival of patients with ovarian clear cell carcinoma"}, {"pubmed": 22705004, "text": "Mucinous breast carcinomas lack PIK3CA mutations."}, {"pubmed": 22723903, "text": "Using high throughput mutation screening platform, we identified that PIK3CA mutations were the most frequently observed target for gastric adenocarcinoma."}, {"pubmed": 22729222, "text": "Sequencing of PIK3CA in ten individuals with fibroadipose hyperplasia syndromes identified either the p.His1047Leu alteration or a second cancer-associated alteration, p.His1047Arg, in nine cases."}, {"pubmed": 22729223, "text": "Exome sequencing and mass spectrometry analysis in paired brain-blood samples from individuals with hemimegalencephaly (20 cases) identified de novo somatic mutations in 30% of affected individuals in the PIK3CA, AKT3 and MTOR genes."}, {"pubmed": 22729224, "text": "identified mutations in AKT3, PIK3R2 and PIK3CA in 11 unrelated families with megalencephaly-capillary malformation and megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndromes"}, {"pubmed": 22736407, "text": "A high copy number of MET or PIK3CA was found to be associated with poorer prognostic features and triple receptor-negative disease"}, {"pubmed": 22737248, "text": "analysis of multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor"}, {"pubmed": 22744290, "text": "this study evaluated whether activating mutations of PI3KCA or complete loss of PTEN is associated with response to anti-human Her2 treatment in breast cancer"}, {"pubmed": 22768164, "text": "Epithelial CEACAMs associate in cis with other membrane receptor(s) via their extracellular domains to trigger bacterial uptake in a PI3K-dependent manner."}, {"pubmed": 22768179, "text": "These data support a strong biological-link between NFkB and the PI3-kinase/AKT pathway in the modulation of anti-apoptotic effects in primary effusion lymphoma cells."}, {"pubmed": 22779686, "text": "study demonstrated that the somatic mutations of PIK3CA and JAK2 occurred in a small fraction of sarcomas and that these mutations may not play a principal role in the development of sarcomas"}, {"pubmed": 22782554, "text": "This study demonstrates the presence of somatic mutations and amplifications of the PIK3CA gene in a second series of pituitary adenomas, corroborating the previously described involvement of the PI3K/Akt signaling pathway in this tumorigenic process."}, {"pubmed": 22798500, "text": "In CRC patients treated with cetuximab, activating mutation signatures for PIK3CA (49 genes) were developed."}, {"pubmed": 22807617, "text": "PIK3CA-targeted short hairpin RNAs can block the phosphoinositide 3-kinase-Akt signaling pathway and inhibit cell growth, increase apoptosis, and induce cell cycle arrest in PIK3CA-mutant colon cancer SW948 cells"}, {"pubmed": 22840496, "text": "Data provide information for developing new therapeutics targeting PI3K/Akt/mTOR signaling pathway in autoimmune diseases like psoriasis and rheumatoid arthritis."}, {"pubmed": 22842715, "text": "Electroacupuncture profoundly activated PI3K/Akt signaling in ischemic cerebral tissues."}, {"pubmed": 22851869, "text": "PI3K expression and PIK3CA mutations are related to colorectal cancer metastases"}, {"pubmed": 22863784, "text": "LOX-1 up-regulation induced by AGE-BSA was a receptor mediated through RAGE and is via the PI3K/PDK1/mTORC2 pathway"}, {"pubmed": 22870241, "text": "High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations."}, {"pubmed": 22875023, "text": "Data suggest that targeting Hedgehog (Hh) pathway alone or in combination with PI3K/AKT pathway could be a novel therapeutic option in treating endocrine-resistant breast cancer."}, {"pubmed": 22880054, "text": "The Epstein-Barr virus protein LMP1, which lacks the canonical ITAM required for Syk activation, can nevertheless activate Syk, and the Src kinase Fyn, resulting in downstream c-Cbl and PI3K/Akt activation."}, {"pubmed": 22897848, "text": "Deregulated c-MYC and PI3K activity cooperate in Burkitt lymphoma pathogenesis."}, {"pubmed": 22897902, "text": "These results demonstrated that hepatitis B virus X protein could upregulate LASP-1 through PI3-K pathway to promote the proliferation and migration of hepatoma cells."}, {"pubmed": 22905202, "text": "Grape proanthocyanidin inhibit pancreatic cancer cell growth in vitro and in vivo through induction of apoptosis and by targeting the PI3K/Akt pathway"}, {"pubmed": 22912864, "text": "Data indicate that mutation frequency in malanoma patients was found witih BRAF(V600) in 51%, NRAS in 19%, PI3K pathway in 41% and PTEN in 22%."}, {"pubmed": 22923510, "text": "Molecular genetic aberrations involving the p53, cyclin E-FBXW7, and PI3K pathways represent major mechanisms in the development of uterine serous carcinoma."}, {"pubmed": 22928013, "text": "Class IA phosphatidylinositol 3-kinase p110alpha is required for vacuole maturation"}, {"pubmed": 22931052, "text": "heterogeneity in frequencies of KRAS/PIK3CA somatic mutations is consistent with already-reported discrepancies in distribution of germline mutations for other malignancies within Sardinian population."}, {"pubmed": 22936809, "text": "Data indicate that resveratrol suppressed IL-1beta-induced activation of NF-kappaB and PI3K in a dose- and time-dependent manner."}, {"pubmed": 22938585, "text": "Data indicate that KRAS, BRAF, PIK3CA, and AKT1 mutations can be rapidly and accurately detected for cancer diagnosis."}, {"pubmed": 22940133, "text": "these results demonstrate that miR-124 functions as a growth-suppressive miRNA and plays an important role in inhibiting the tumorigenesis through targeting PIK3CA."}, {"pubmed": 22949056, "text": "results suggest that PIK3CA gene mutations may play a key role in tumourigenesis and aggressiveness of bronchopulmonary neuroendocrine tumours"}, {"pubmed": 22949682, "text": "diverse PIK3CA mutations stimulate lipid kinase activity by facilitating allosteric motions required for catalysis on membranes"}, {"pubmed": 22955107, "text": "The subgroup of ovarian clear cell carcinomas harboring activated PIK3CA seems to have better prognosis possibly due to more indolent biological property compared to tumors without PIK3CA activation."}, {"pubmed": 22964641, "text": "Results indicate that CIB1 is uniquely positioned to regulate PI3K/AKT and MEK/ERK signaling and that simultaneous disruption of these pathways synergistically induces a nuclear GAPDH-dependent cell death."}, {"pubmed": 22982396, "text": "the Ras-PI3K signaling pathway targets specific epigenetic modifications in tumor cells"}, {"pubmed": 22988297, "text": "PI3K has a crucial role in regulating Brn-2 and Pax3 expression and neoplasm invasiveness, and it is a key determinant of melanoma subpopulation diversity."}, {"pubmed": 22994622, "text": "Data indicate that copy number amplification of the PIK3CA gene is associated with poor prognosis in head and neck squamous cell carcinoma (HNSCC) patients without lymph node metastasis."}, {"pubmed": 22994717, "text": "LY294002 prevented phosphorylation of protein kinase B (PKB/Akt) by inhibition of PI3K phosphorylation activity."}, {"pubmed": 22997091, "text": "Investigated PIK3CA mutations in ILBC with special reference to late stage tumor progression. PIK3CA mutations were detected in 32/88 (36%) specimens."}, {"pubmed": 22998445, "text": "PI3K is a mediator of stretch-induced COX-2 expression in urothelial cells."}, {"pubmed": 23013731, "text": "PIK3CA mutation is associated with early-stage low-grade endometrial cancers."}, {"pubmed": 23021375, "text": "EGFR and downstream genetic alterations in KRAS/BRAF and PI3K/AKT pathways have roles in colorectal cancer and treatment [review]"}, {"pubmed": 23028762, "text": "PIK3CA mutations lead to a shift towards a highly glycolytic phenotype."}, {"pubmed": 23051731, "text": "p110alpha was activated at mitosis entry and regulated early mitotic events, such as PIP(3) generation, prometaphase progression, and spindle orientation."}, {"pubmed": 23066026, "text": "Src family kinases, PI3 kinase and protein kinase C synergize to mediate Gq-dependent platelet activation"}, {"pubmed": 23066039, "text": "PIK3CA H1047R mutation was the only independent factor predicting response to PI3K/AKT/mTOR inhibitors in patients with advanced cancers"}, {"pubmed": 23071680, "text": "Data indicate that resistance to UVB induced apoptosis in the alpha6 integrin(high+)/CD44(+) cells involved increased expression of TAp63 and was overcome by PI-3 kinase inhibition."}, {"pubmed": 23082158, "text": "PI3K/Akt signaling is utilized by alphaIIb-mediated outside-in signaling to activate platelets."}, {"pubmed": 23085752, "text": "either mutant PIK3CA expression or PTEN loss, but not mutant AKT1 E17K, cause disrupted epithelial architecture."}, {"pubmed": 23092874, "text": "activation of the PI3K-AKT pathway through loss of PTEN or PIK3CA mutation was frequently observed in trastuzumab refractory breast cancer."}, {"pubmed": 23094721, "text": "Use of aspirin after diagnosis was associated with longer survival among patients with mutated-PIK3CA colorectal cancer. Suggests that the PIK3CA mutation in colorectal cancer may serve as a predictive molecular biomarker for adjuvant aspirin therapy."}, {"pubmed": 23100325, "text": "identified somatic gain-of-function mutations in PIK3CA in the affected nerve that caused macrodactylous overgrowth"}, {"pubmed": 23107319, "text": "PI3K/AKT/mTOR signalling components appear to be differentially implicated in urothelial tumorigenesis and, with the exception of p85aPI3K, are unrelated to the PIK3CA or AKT1 mutational status."}, {"pubmed": 23110163, "text": "Data indicate that cells grown in three-dimensional (3D) gels showed reduced proliferation and migration as well as reduced PI3K pathway activation when compared to cells grown in 2D."}, {"pubmed": 23115297, "text": "In the present study, the authors provide evidence that the West Nile virus capsid protein blocks apoptosis through a phosphatidylinositol (PI) 3-kinase-dependent pathway."}, {"pubmed": 23125007, "text": "One hundred and ten patients (51%) were identified who were potentially nonresponders to anti-EGFR therapy:  7/209 (3.3%) had mutations in PIK3CA exon 20."}, {"pubmed": 23136191, "text": "PIK3CA amplification was detected in thirty-seven percent of lung squamous tumors and five percent of lung adenocarcinomas."}, {"pubmed": 23136247, "text": "Molecular characterization of single CTCs demonstrated considerable intra- and interpatient heterogeneity of EGFR expression and genetic alterations in EGFR, KRAS, and PIK3CA"}, {"pubmed": 23172887, "text": "Targeting the phosphoinositide 3-kinase p110-alpha isoform impairs cell proliferation, survival, and tumor growth in small cell lung cancer."}, {"pubmed": 23182717, "text": "Data show that a photodynamic therapy (PDT) dose-dependent upregulation of CRP gene, as well as of PTX3 and ficolin 1 genes in lung tumor A549 cells, and indicate critical role played by PI3K/Akt/AP-1 pathway."}, {"pubmed": 23184205, "text": "Our finding that PIK3CA exon 20 mutations were associated with more aggressive breast cancer and poor outcomes, regardless of the treatment regimen, has important clinical implications."}, {"pubmed": 23185308, "text": "A dramatically lower prevalence of the heterozygous genotype G/T at rs17849071 of PIK3CA was found in patients with follicular thyroid cancer."}, {"pubmed": 23192871, "text": "In conclusion, authors have found that the varicella-zoster virus ORF12 protein activates the PI3K/Akt pathway to regulate cell cycle progression."}, {"pubmed": 23219661, "text": "in primary endometrial carcinoma, mutations in PIK3CA, TP53, PTEN and FBXW7 correlate with high tumor grade, endometrial cancer type and lymph node status; PIK3CA H1047R mutations serve as prognostic markers for relapse-free survival in endometrial cancer patients"}, {"pubmed": 23224067, "text": "Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomas."}, {"pubmed": 23233531, "text": "miR-148b controls malignancy by coordinating a novel pathway involving over 130 genes and, in particular, it directly targets players of the integrin signaling, such as ITGA5, ROCK1, PIK3CA/p110alpha, and NRAS, as well as CSF1"}, {"pubmed": 23237847, "text": "Findings indicate driver mutations in AKT1, and extend the number and type of mutations that activate the PI3-kinase pathway in human breast cancers."}, {"pubmed": 23243017, "text": "Findings suggest that inhibiton of Bcl-2, Bcl-xL and PI3K, and release of Bim from Bcl-2/Bcl-xL and GSK3alpha/beta culminating in Bax/Bak activation and apoptosis."}, {"pubmed": 23246288, "text": "8 of 91 (8.8%) unrelated CS individuals without germline PTEN mutations carried 10 germline PIK3CA mutations"}, {"pubmed": 23248156, "text": "PIK3CA mutations in diverse cancers were not associated with clinical characteristics, but were correlated with MAPK mutations. PIK3CA mutations, especially, H1047R, were associated with attaining a PR/CR to PI3K/AKT/mTOR pathway inhibitors."}, {"pubmed": 23261389, "text": "Linoleic acid induces opening of connexin26 hemichannels through a PI3K/Akt/Ca(2+)-dependent pathway"}, {"pubmed": 23266353, "text": "In cervical cancer patients treated with CRT, tumor PIK3CA mutation status was associated with overall survival in FIGO stage IB/II cervix cancers."}, {"pubmed": 23271282, "text": "Coincided with the activation of the PI3K/AKT pathway."}, {"pubmed": 23275335, "text": "Selective inhibition of phosphoinositide 3-kinase p110alpha preserves lymphocyte function"}, {"pubmed": 23292187, "text": "Data indicate protein secretion pathways activated by monosodium urate (MSU) in macrophages, and reveal a novel role for cathepsin B and Src, Pyk2, PI3 kinases in the activation of unconventional protein secretion."}, {"pubmed": 23300780, "text": "FGFR2, KRAS and PIK3CA are frequently mutated in primary and metastatic endometrial lesions."}, {"pubmed": 23301057, "text": "PIK3CA has a role in response to everolimus and letrozole in estrogen receptor positive breast cancer"}, {"pubmed": 23314198, "text": "No correlation was observed between PIK3CA exon 9 and 20 mutations and age at breast cancer diagnosis, histological type, hormone receptor and HER2 status."}, {"pubmed": 23318440, "text": "Data indicate that phosphatidylinositol 3'-kinase (PI3K) alpha and beta p110 isoforms of PI3K are broadly expressed in myeloma."}, {"pubmed": 23335533, "text": "PIK3CA amplifications in large cell and squamous cell carcinomas were significantly higher compared with adenocarcinomas."}, {"pubmed": 23341541, "text": "High PIK3CA/PIK3CD ratio identified a subset of primary mantle cell lymphomas resistant to GS-1101 and this ratio increased significantly with relapse."}, {"pubmed": 23345407, "text": "Results indicate a key role of class I PI3K in IL-2R endocytosis that creates a link with IL-2 signalling."}, {"pubmed": 23352210, "text": "The rate of PIK3CA mutations in this series of micropapillary carcinomas is similar to invasive ductal carcinomas; however, there may be an enrichment of AKT1 mutations."}, {"pubmed": 23374602, "text": "only 5 tumours with exon 20 PIK3CA mutations were detected. Only PIK3CA mutations occasionally coexisted with other gene mutations in colorectal cancer."}, {"pubmed": 23383294, "text": "PI3K abrogation interferes with key T cell activation processes through both differential expression and alternative splicing, which together actively contribute to T cell suppression."}, {"pubmed": 23386617, "text": "14-3-3 negatively regulates the RGC downstream of the PI3-kinase/Akt signaling pathway"}, {"pubmed": 23392229, "text": "PIK3CA mutations are associated with lung cancer."}, {"pubmed": 23401445, "text": "PIK3CA-mutant lung cancers are dependent on this driver oncogene, whereas in other patient cases, the mutation may modulate the effect of another oncogenic process."}, {"pubmed": 23409016, "text": "down regulation of fibroblast growth factor receptor 3 (FGFR3) and PI3K/Akt signaling mechanisms leading to inhibition of cell proliferation and induction of molecular mechanisms of apopto"}, {"pubmed": 23417417, "text": "Studies suggest that adipokines, AMPK, PI3K and the PPAR signaling pathways could be targets of therapeutic strategies for the ovarian cancers and reproductive pathologies."}, {"pubmed": 23418602, "text": "Results indicate that the induction of MCP-2/CCL8 by mycobacteria is dependent on the activation of TLR2/PI3K/Akt signaling pathway."}, {"pubmed": 23429328, "text": "The correlation between T stage of gastric cancer and the higher expression of CD40, VEGF, AKT, and PI3K, along with lower S100 expression in DC, may provide insights into future targets for more effective immunotherapy for cancer."}, {"pubmed": 23435830, "text": "PIK3CA mutation is a promising predictive biomarker for poor survival in mCRC patients treated with anti-EGFR mAbs, particularly in KRAS wild-type patients."}, {"pubmed": 23453624, "text": "cell-autonomous phosphoinositide 3-kinase and 3-phosphoinositide-dependent protein kinase 1 are key effectors of oncogenic Kras in the pancreas, mediating cell plasticity, acinar-to-ductal metaplasia, and pancreatic ductal adenocarcinoma formation"}, {"pubmed": 23475955, "text": "these data suggest the efficacy of agents that target the MAPK and PI3K pathways can be improved by combination with a Bcl-2 family inhibitor."}, {"pubmed": 23523798, "text": "PI3K is involved in CKII inhibition-mediated cellular senescence in HCT116 cells."}, {"pubmed": 23532889, "text": "PIK3CA mutations in esophageal squamous cell carcinoma are associated with longer survival."}, {"pubmed": 23538402, "text": "High phospho-stathmin(S38) is associated with PI3K pathway alterations: amplification of the 3q26 region and increased PIK3CA copy number."}, {"pubmed": 23546602, "text": "Data suggest that 17 beta-estradiol enhances the the glucose uptake, activates PI3K/Akt signaling pathway, leading to translocation of glucose transporter 4 to the plasma membrane in an ERalpha-dependent manner."}, {"pubmed": 23548132, "text": "About one fourth of mCRC cases wild-type for KRAS codons 12 and 13 present other mutations either in KRAS, BRAF, or PIK3CA, many of which may explain the lack of response to anti-EGFR therapy observed in a significant proportion of these patients."}, {"pubmed": 23549875, "text": "Data indicate that concurrent BRAF and PI3K/mTOR blockade results in induction of apoptosis."}, {"pubmed": 23563091, "text": "APG dramatically reduced Nrf2 expression at both the messenger RNA and protein levels through downregulation of PI3K/Akt pathway."}, {"pubmed": 23564819, "text": "PIK3CA mutations are not associated with tyrosine kinase inhibitors treatment efficacy in non-small cell lung cancer."}, {"pubmed": 23568272, "text": "p110alpha acts as a negative regulator of beta cell exocytosis and insulin secretion, while p110beta is a positive regulator of insulin secretion through a mechanism separate from its catalytic activity"}, {"pubmed": 23580570, "text": "Data show that somatic cell knockin of both KRAS G12V and oncogenic PIK3CA mutations in human breast epithelial cells results in cooperative activation of the phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) pathways."}, {"pubmed": 23583669, "text": "mutational analysis of TP53 (exons 4-9) and CTNNB1 (exon 3) as well as PIK3CA (exon 9) genes in hepatocellular carcinoma from Southern Italy"}, {"pubmed": 23588386, "text": "PI3K signaling contributed to tumor growth and vasculogenic mimicry of gallbladder carcinomas."}, {"pubmed": 23592373, "text": "PIK3CA mutation status was also not associated with treatment outcome after first-line tamoxifen"}, {"pubmed": 23597702, "text": "the review provides a complete picture of the PIK3CA oncogene and its deregulation in oral cancer (Review)"}, {"pubmed": 23612454, "text": "These results confirm that the outcome of HER2-positive patients treated with trastuzumab is significantly worse in patients with PIK3CA-mutated compared with wild-type tumours."}, {"pubmed": 23615713, "text": "Results show that stromal cell-derived factor-1 (SDF-1) enhanced ovarian cancer cell invasion through alphavbeta6 integrin-mediated urokinase-type plasminogen activator (uPA) expression via the p38 MAPK and PI3 K/Akt pathway."}, {"pubmed": 23624506, "text": "Data indicate that the PI3K/Akt pathway plays an important role in the regulation of telomerase reverse transcriptase (hTERT) activity in response to histone deacetylases (HDACs) inhibitor."}, {"pubmed": 23625205, "text": "Results indicate that ADAM17 is upregulated by hypoxia and contributes to hypoxia-induced cisplatin resistance via EGFR/PI3K/Akt pathway."}, {"pubmed": 23626817, "text": "the PI3K/AKT/mTOR signaling pathway, which was overactivated in APA and IHA compared with normal zona glomerulosa, may mediate aldosterone hypersecretion and participate in the development of PA."}, {"pubmed": 23633456, "text": "PIK3CA exon 20 and PTEN mutations associated with features of colon cancer tumorigenesis"}, {"pubmed": 23640046, "text": "our results suggest that CAPE suppresses phosphoinositide 3-kinase/AKT/XIAP pathway leading to apoptosis in melanoma tumor cells in vitro and in vivo"}, {"pubmed": 23643389, "text": "Disruption of the IRS1-p110alpha E545K interaction destabilizes the p110alpha protein, reduces AKT phosphorylation, and slows xenograft tumor growth of a cancer cell line expressing p110alpha E545K."}, {"pubmed": 23660947, "text": "Aberrations in PIK3CA and PTEN did not add significant prognostic information on colorectal carcinoma patients."}, {"pubmed": 23680019, "text": "These results reveal a previously unknown, essential role of PI3K in the life cycle of human astrovirus type 1."}, {"pubmed": 23684925, "text": "Report a synthetic lethal interaction between PI3K/mTOR and MEK inhibitors in rhabdomyosarcoma."}, {"pubmed": 23695676, "text": "Mitotic Plk1 activity is regulated not only by Plk1-Thr210 phosphorylation, but also by Plk1 binding to 14-3-3gamma following Plk1-Ser99 phosphorylation downstream of the PI3K-Akt signalling pathway."}, {"pubmed": 23702729, "text": "Loss of ARID1A expression, PI3K-Akt pathway alterations, TP53 status and microsatellite instability are involved in endometrial cancer."}, {"pubmed": 23708425, "text": "Effectively inhibited the PI3K signaling pathway."}, {"pubmed": 23709421, "text": "no specific relationship between mutation in the exon of PIK3CA and clinical characteristics of the hepatocellular carcinoma in korean patients"}, {"pubmed": 23721513, "text": "Data indicate that NVP-BKM120 inhibited pan-class I phosphatidyl-inositol-3-kinase and decreased cell proliferation and increased apoptotic cell death in diffuse large B-cell lymphoma (DLBCL)."}, {"pubmed": 23725225, "text": "A downregulation of FASN effectively inhibits the activity of \"HER2-PI3K/Akt axis\" and alters the malignant phenotype in colorectal cancer cells."}, {"pubmed": 23728071, "text": "We also examined 61 of our cases for the presence of PIK3CA, AKT1, PTEN and K-RAS mutations."}, {"pubmed": 23728594, "text": "PIK3CA-mutated colorectal cancer appears to have a distinct epidemiologic profile that is of clinical significance."}, {"pubmed": 23734265, "text": "Data indicate that the activation of MAPK and PI3K pathways resulted in TGF-beta1 signaling by down-regulating Nm23-H1 expression and up-regulating the expression of TbetaRI and TbetaRII, favoring further activation of multiple signaling pathways."}, {"pubmed": 23739063, "text": "PIK3CA mutations were associated with a better outcome, however this effect disappeared after 3 years. There were no statistically significant associations with trastuzumab benefit."}, {"pubmed": 23743572, "text": "The PI3K/Akt inhibitor LY294002 can enhance chemosensitivity of human gastric cancer to VCR."}, {"pubmed": 23785428, "text": "PIK3CA mutation also contributes to significantly decreased survival for patients with wild-type BRAF tumors."}, {"pubmed": 23787421, "text": "4 of 41 HPV-negative tumors (10%) demonstrated PIK3CA hot spot mutations, 3 at codon 1047 and 1 at codon 542. Of 46 HPV-positive tumors, 13 (28%) demonstrated activating PIK3CA mutations, including 7 at codon 542, 5 at codon 545, and 1 at codon 1047."}, {"pubmed": 23800951, "text": "These results suggest that the phosphatidylinositol 3-kinase/Akt signaling pathway plays an important role in beta1 integrin-mediated internalization of Staphylococcus aureus by alveolar epithelial cells."}, {"pubmed": 23812937, "text": "Activation of the PI3K/Akt pathway with expression of survivin identified a subgroup of acute myeloid leukemia patients with an excellent outcome."}, {"pubmed": 23813545, "text": "PIK3CA mutation and copy number gain were detected in 3 (4.9%) and 8 (13.1%), respectively, of 61 gastric cancer samples while PTEN loss was detected in 24 (39%) of the tumours. Two tumours had both PTEN loss and PIK3CA copy number gain."}, {"pubmed": 23821376, "text": "This study investigated the impact of KRAS, NRAS, BRAF, PI3KCA and TP53 status on outcome of elderly metastatic colorectal cancer patients"}, {"pubmed": 23826249, "text": "Study developed a cancer stem cell model from a colorectal cancer patient-derived xenograft tumor and identified a PIK3CA (H1047R) mutation in the CSC population as a predictive biomarker to guide targeted therapy."}, {"pubmed": 23826284, "text": "Single-nucleotide polymorphism in PIK3CA gene is associated with Insulin Resistance."}, {"pubmed": 23832540, "text": "Data indicate that increased activation of PI3K/AKT signaling was observed in the cholangiocarcinoma (CCA) tissues, and suggest that inhibition of PI3K and mTOR activity by the inhibitor NVP-BEZ235 has anti-cancer activity against CCA."}, {"pubmed": 23851329, "text": "PIK3CA mutations and/or PTEN loss were identified in the wide morphologic spectrum of salivary duct carcinomas."}, {"pubmed": 23852799, "text": "frequent PIK3CA mutations in patients with high-risk HNSCC confined predominantly to the oropharyngeal and sinonasal subsites; for the first time, mutation in AKT1 has been identified in HNSCC"}, {"pubmed": 23867512, "text": "we discuss the preclinical and clinical experience with the rapalogues in RCC, potential mechanisms of resistance to the rapalogues, and the progress in the clinical development of novel agents directed against the phosphatidylinositol 3-kinase/Akt/mTOR"}, {"pubmed": 23867821, "text": "This study shows that PI3K inhibitors only transiently inhibit AKT which limits their antitumor activities."}, {"pubmed": 23884447, "text": "Among 30 breast tumors, 10(33%) had BCSCs with AKT1, HRAS, or PIK3CA mutations. 3 mutations were detected in PIK3CA.Tumors in which BCSCs have defects in PI3K/Akt signaling are significantly more likely to manifest nodal metastases."}, {"pubmed": 23886157, "text": "Increase in the expression of PI3K was associated with colorectal carcinoma."}, {"pubmed": 23887305, "text": "our findings suggest that loss of CDKN2A and, to a lesser extent, KRAS and PIK3CA somatic mutations have a role in the progression of a benign to an atypical proliferative Brenner tumor"}, {"pubmed": 23888070, "text": "AKT1 E17K is a bona fide oncogene in a human luminal breast cancer context. Distinct PI3K pathway mutations confer differential sensitivity to drugs targeting the pathway at different points and by distinct mechanisms."}, {"pubmed": 23891538, "text": "Results suggest that IFN-gamma-mediated IL-27 protein but not IL-27p28 gene expression is positively regulated by the C-Jun N-terminal kinases (JNK), mitogen-activated protein kinases (MAPKs) and the phosphoinositide 3-kinase (PI3K)."}, {"pubmed": 23891627, "text": "Uterine serous carcinoma cell lines with oncogenic PIK3CA mutations were significantly more sensitive to GDC-0980 exposure."}, {"pubmed": 23903756, "text": "In PIK3CA-mutant cancer cell lines with persistent mTORC1 signaling, the addition of the allosteric mTORC1 inhibitor RAD001 to the cells along with BYL719 resulted in reversal of resistance in vitro and in vivo."}, {"pubmed": 23936502, "text": "Oncogenic mutations of p110alpha isoform of PI 3-kinase upregulate its protein kinase activity."}, {"pubmed": 23971979, "text": "PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer."}, {"pubmed": 23981382, "text": "Data indicate that inflammatory cytokine-induced increases in chronic lymphocytic leukemia (CLL) cell adhesion to stromal cells are correlated with ZAP-70 expression and blocked by PI3K inhibitor."}, {"pubmed": 23982433, "text": "PIK3CA mutations are significantly associated with lower grade and hormone receptor positivity in Arab breast cancer patients."}, {"pubmed": 23990352, "text": "PI3K p85alpha-depletion results in activated expression of apoptosis-associated genes."}, {"pubmed": 23996432, "text": "Multivariate analyses revealed that PTEN expression (HR, 0.48; p = 0.02) and absence of PI3K expression (HR, 0.2; p = 0.001) were independent prognostic factors for increased PFS"}, {"pubmed": 24001613, "text": "Data indicate that PYK2 N-terminal domain interacting receptor 1 (Nir1) could induce epithelial-mesenchymal transition by stabilising Snail via the PI3K/Akt/GSK3beta/Snail signalling pathway through binding to CCL18."}, {"pubmed": 24006859, "text": "mutations in KRAS codon 61, KRAS codon 146, BRAF, NRAS, or PIK3CA detected in Asian patients were not predictive of clinical benefits from cetuximab treatment."}, {"pubmed": 24011769, "text": "PIK3CA gene mutations have been shown to predict a better otcome in ER/HER2 negative breast cancer, treated with endocrine therapy."}, {"pubmed": 24011934, "text": "Data indicate that dual targeted inhibitors of PI3K/mTOR in combination with inhibitors of RAS/ERK signalling as a potentially effective approach to treating ovarian cancer."}, {"pubmed": 24062397, "text": "PIK3CA mutation does not predict benefit from rofecoxib therapy, but it does predict reduced colorectal carcinoma recurrence in regular users of low-dose aspirin after diagnosis."}, {"pubmed": 24069951, "text": "suggesting that the changes in AKT/BCL2 signaling molecules might mediate growth and anti-apoptosis processes at least in part, thus increasing the survival potential of Congenital Giant Nevi melanocytes and maintaining their integrity"}, {"pubmed": 24077110, "text": "Some mutations in the gene encoding for the catalytic subunit of phosphatidyl-inositol-3-kinase, the PIK3CA gene, plays an important role, especially in the resistance to targeted therapies."}, {"pubmed": 24099783, "text": "Heavy metals in cigarette smoke induce PI3K expression in epithelial cells and tumor cells."}, {"pubmed": 24105357, "text": "Induced apoptosis mainly via the PI3K/AKT pathway."}, {"pubmed": 24117074, "text": "Its signal plays a crucial role in tumor genesis and tumor progression by promoting cell proliferation and inhibiting apoptosis."}, {"pubmed": 24122451, "text": "Phosphoinositide 3-kinase (PI3K) is required for PSGL-1-induced beta1 integrin clustering which ultimately regulates beta1 integrin-mediated Jurkat cell adhesion to fibronectin."}, {"pubmed": 24122611, "text": "PIK3CA gene mutations were found in 13 (16%), of 28 patients with squamous cell anal cancer"}, {"pubmed": 24175777, "text": "Results show PI3KCA mutations present in 34% of human breast cancer patients and significantly higher PIK3CA expression in breast cancer tissues in comparison with control tissues."}, {"pubmed": 24175786, "text": "In a Chinese cohort, rs7646409 genotype distributions between the osteosarcoma and control groups was significantly different (P = 0.032). Taking genotype TT as a reference, the risk of osteosarcoma increased three fold in patients with genotype CC."}, {"pubmed": 24186142, "text": "The frequently discordant genotypes of usual ductal hyperplasia/columnar cell change and concurrent carcinoma support a role for PIK3CA-activating point mutations in breast epithelial proliferation, perhaps more so than transformation."}, {"pubmed": 24193002, "text": "A screen of a cohort of radial scars for a large panel of activating point mutations, revealing PIK3CA mutations in over 60% of specimens."}, {"pubmed": 24218517, "text": "In chemotherapy-refractory colorectal cancer, neither PIK3CA mutation status nor PTEN expression were prognostic, nor were they predictive of benefit from cetuximab"}, {"pubmed": 24229379, "text": "PIK3CA mutations and PIK3R1 underexpression show opposite effects on patient outcome and could become useful prognostic and predictive factors in breast cancer."}, {"pubmed": 24231454, "text": "Overall tumor PIK3CA mutation status is not associated with stage III colon cancer prognosis. PIK3CA mutation does not appear to serve as a predictive tumor molecular biomarker for response to irinotecan-based adjuvant chemotherapy."}, {"pubmed": 24233241, "text": "PI3KCA mutation was associated with the absence of Her2/neu amplification/overexpression and a low level of MIB1/Ki-67 labelling"}, {"pubmed": 24241346, "text": "PIK3CA gene hypomethylation plays a key role in the tumorigenesis and development of esophageal cancer in Chinese patients, while the mutations of PIK3CA gene have little effect on the development of esophageal cancer"}, {"pubmed": 24244431, "text": "Knockdown of RPS7 resulted in increased expression of P85alpha, P110alpha, and AKT2."}, {"pubmed": 24249715, "text": "This allows the usage of p110alpha-specific PI3K inhibitors and thus may spare patients the toxicities of pan-PI3K inhibition to allow maximal dosage and efficacy."}, {"pubmed": 24262879, "text": "PIK3CA exon 9 or exon 20 missense mutations were more commonly observed in cases that were deficient for mismatch repair protein expression (p=0.0058) and showed loss of ARID1A expression"}, {"pubmed": 24263107, "text": "Data iindicate that he combination therapy of mTOR inhibitor RAD001 and PI3K (phosphatidylinositol 3-kinase) inhibitor LY294002 decreased the cell growth in vitro and progression of liver metastasis in vivo."}, {"pubmed": 24276243, "text": "Findings show that PPP1R1B-STARD3 fusion transcript has a key role in subsets of gastric cancers through the activation of PI3K/AKT signaling."}, {"pubmed": 24299208, "text": "Our study demonstrates relatively low frequency of PIK3CA mutations and amplifications in ovarian clear cell carcinoma."}, {"pubmed": 24314632, "text": "Dengue virus 2 subgenomic RNA induces apoptosis through the Bcl-2-mediated PI3k/Akt signaling pathway."}, {"pubmed": 24320611, "text": "The Pik3ca(H1047R) mutation promotes the development of highly aggressive and invasive adenocarcinomas in intestine."}, {"pubmed": 24323026, "text": "Data indicate that responses were noted in patients with HER2-amplified breast cancer resistant to trastuzumab, HER2-mutant non-small-cell lung cancer, and tumor types without identified mutations in the HER-PI3K-mTOR pathway."}, {"pubmed": 24323028, "text": "Data indicate that seven genes showed statistical enrichment for mutation: TP53, RB1, PTEN, NFE2L2, KEAP1, MLL2, and PIK3CA."}, {"pubmed": 24328409, "text": "Low expression of miR-1 and high expression of PIK3CA are closely related to the invasion, progression and metastasis of non-small-cell lung cancer.There is a negative correlation between the expression of miR-1 and PIK3CA in non-small-cell lung cancer."}, {"pubmed": 24341335, "text": "PIK3CA mutations/amplification, HRAS mutation, or PTEN loss that likely lead to PI3K pathway activation were identified in 34 of 75 cases (45%) and did not correlate with disease specific survival."}, {"pubmed": 24347284, "text": "PIK3CA gene alteration in non-muscle invasive bladder tumors predicts reduced recurrence."}, {"pubmed": 24347489, "text": "blocking PI3K/Akt signaling pathway by LY294002 or Akt siRNA could remarkably inhibit the PAK1 activation and cell invasion has to"}, {"pubmed": 24360885, "text": "patients with PIK3CA-mutated tumors showed trend towards favorable overall survival (P = .085) but not disease-free survival (P = .238), suggesting that PIK3CA gene status may be favorable predictive marker in esophageal squamous cell carcinoma patients"}, {"pubmed": 24364210, "text": "This paper presents an overview of PIK3CA mutations in the path PI3K/PTEN/Akt of the most common cancers."}, {"pubmed": 24370118, "text": "PIK3CA mutations are associated with non--small-cell lung cancer."}, {"pubmed": 24374682, "text": "Affected tissue from individuals with facial infiltrating lipomatosis contains PIK3CA mutations that have previously been reported in cancers and in affected tissue from other nonheritable, overgrowth disorders."}, {"pubmed": 24425104, "text": "AFP can promote the proliferation of hepatoma cells via activation of PI3K/Akt signaling pathway."}, {"pubmed": 24428908, "text": "Data indicate that PI3K signaling pathway was critical for the anti-myeloma activity of BENC-511."}, {"pubmed": 24440701, "text": "Data indicate that siRNA-mediated silencing of PIK3CA blocked the inhibitory effect of miR-375 on Colorectal cancer (CRC) cell growth."}, {"pubmed": 24440976, "text": "PIK3CA mutations showed a trend toward an association with an increased risk of death compared to absence of those mutations in African American colorectal cancer patients."}, {"pubmed": 24450638, "text": "Te structure and function of the p110alpha enzyme and two of its most common oncogenic mutations. [Review]"}, {"pubmed": 24451154, "text": "These results suggest that the combination of PI3K inhibition with dual HER2 blockade is necessary to circumvent the resistance to HER2 inhibitors conferred by PIK3CA mutation and also provides benefit to HER2+ tumors with wild-type PIK3CA tumors."}, {"pubmed": 24453288, "text": "this is the first reported case to our knowledge of a patient with both a possible germline EGFR T790M mutation and a somatic PIK3CA mutation."}, {"pubmed": 24467828, "text": "PIK3CA mutations do not have clinical validity to predict intrinsic resistance to adjuvant tamoxifen and may therefore be unsuitable as companion diagnostic for PI3K/AKT/mTOR inhibitors in ERalpha- positive, postmenopausal, early breast cancer patients."}, {"pubmed": 24468202, "text": "mutations may confer resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in lung adenocarcinoma patients with mutated EGFR"}, {"pubmed": 24469048, "text": "molecular or pharmacologic inhibition of the Lyn-PI3K/AKT pathway, markedly increased the sensitivity of the otherwise chemoresistant Cbl mutant-JMML cells to chemotherapeutic agents currently used in the treatment of JMML patients"}, {"pubmed": 24471188, "text": "PIK3CA mutation was found to be a frequent genetic change in all breast cancer subtypes but occurred with the highest rate in HR(+)/HER2(-) tumors"}, {"pubmed": 24486107, "text": "miR-1 may play an important role in the pathogenesis of NSCLC by regulating PIK3CA through the PI3K/Akt pathway."}, {"pubmed": 24505629, "text": "frequent PIK3CA amplification and promoter methylation of RASSF1A and PAX6 genes in gastric cancers"}, {"pubmed": 24507683, "text": "Studied the expression of phosphatidylinositol 3 kinase (PI3-K), protein kinase B (PKB) and glycogen synthase kinase 3 beta (GSK-3 beta) in skeletal muscle tissue of gestational diabetes mellitus patients."}, {"pubmed": 24511546, "text": "Studied the PIK3CA gene expression status and hotspot mutations in six cases of SDC by immunohistochemistry and genomic DNA sequencing."}, {"pubmed": 24518503, "text": "Data indicate that oncogenic activation of the phosphoinositide 3-kinase (PI3K) pathway involving phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) gene mutations can contribute to the progression of mucin-producing neoplasms"}, {"pubmed": 24533074, "text": "PIK3CA mutations frequently coexist with EGFR/KRAS mutations and may have a role in survival and prognosis"}, {"pubmed": 24569712, "text": "Data show the expression of N-myc downstream-regulated gene 2 (NDRG2) is frequently downregulated in adult T-cell leukaemia-lymphoma, resulting in enhanced phosphorylation of PTEN and activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway."}, {"pubmed": 24595049, "text": "These results reveal betaig-h3 enhances the metastasis potentials of human osteosarcoma cells via integrin alpha2beta1-mediated PI3K/AKT signal pathways."}, {"pubmed": 24599934, "text": "PIK3CA mutations are more common in HPV(+) OPSCC and are associated with activation of mTOR, but not AKT. These data suggest that inhibitors for mTOR may have activity against HPV(+) PIK3CA mutant oropharyngeal cancers."}, {"pubmed": 24603487, "text": "Data suggest that the expression of ATP-binding cassette sub-family G member 2 (ABCG2) and the side population may be regulated by phosphatase and tensin homologue deleted on chromosome -10 (PTEN) through the PI3K/Akt pathway."}, {"pubmed": 24615084, "text": "NGF regulates the expression of VEGF through the PI3K/mTOR signaling pathway in human HaCaT keratinocytes."}, {"pubmed": 24619078, "text": "Our data indicate that activation of the PI3K/AKT pathway evidenced on the protein level might be a valuable prognostic marker to stratify patients for their risk of tumour recurrence."}, {"pubmed": 24630930, "text": "Inhibition of PI3K (and mTOR) leads to an increase in catalase expression in MCF-7 breast cancer cells."}, {"pubmed": 24641407, "text": "PIK3CA mutations play a critical role in the genesis of rhabdomyosarcoma"}, {"pubmed": 24642661, "text": "PIK3CA gene was found to be mutated in 11 (22%) squamous cell anal carcinoma cases."}, {"pubmed": 24651445, "text": "The present experiments demonstrated a critical role for the GPRC6A-ERK1/2 and PI3K/Akt signaling pathway in arginine-mediated fibroblast survival."}, {"pubmed": 24662006, "text": "In this review, we discuss the emerging evidence for a functional relationship between the IGF-I/PI3K/AKT/mTOR pathway and ASDs, as well as a possible role of this signaling pathway in the diagnosis and treatment of ASDs. [review]"}, {"pubmed": 24666267, "text": "Mutations in PIK3CA predict resistance to anti-EGFR therapies."}, {"pubmed": 24673525, "text": "Among the 42 patients who were seropositive for hepatitis B, 17 (40.5%) had HBx mutations and 4 (9.52%) had mutations in PIK3CA."}, {"pubmed": 24687028, "text": "Increased PTGS2 expression or the presence of mutated PIK3CA did not predict benefit from aspirin in colon cancer."}, {"pubmed": 24691006, "text": "the outcome of 68 patients with advanced colorectal cancer and RAS, BRAF and PI3KCA status according to ALK gene status, is reported."}, {"pubmed": 24699302, "text": "We examined the response of 80 samples of primary cells from acute myeloid leukemia patients to selective inhibitors of the phosphatidylinositol 3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) axis."}, {"pubmed": 24713430, "text": "Data indicate PI3K/Akt signaling as an essential pathway regulating the distribution of nucleolin."}, {"pubmed": 24718026, "text": "Consistent expression of the PI3K catalytic isoform PI3K p110alpha was detected in a panel of glioblastoma patient samples. Inhibition of PI3K p110alpha activity impaired the anchorage-dependent growth of glioblastoma cells and induced tumor regression in vivo."}, {"pubmed": 24726064, "text": "Protein expression of PI3K, Akt and survivin were significantly associated with the development, progression and metastasis of gastric cancer and may have value as diagnostic and prognostic markers in gastric cancer."}, {"pubmed": 24735980, "text": "Aberrant activation of the PI3K/Akt/mTOR axis acts in parallel to RCAN1 in phosphorylating tau, in DS and DS/AD."}, {"pubmed": 24736592, "text": "Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease"}, {"pubmed": 24762137, "text": "PI3K-dependent binding of FOXO to the HBP1 promoter is part of a pathway that controls cell proliferation."}, {"pubmed": 24766330, "text": "PIK3CA isoform is of paramount importance for constitutive Akt activity in multiple myeloma , and - in contrast to inhibition of other class I isoforms - only the blockade of PIK3CA was sufficient to induce cell death in a sizeable subgroup of MM samples."}, {"pubmed": 24769208, "text": "TEIF is a downstream effector in EGF/PI3K/Akt signaling."}, {"pubmed": 24770869, "text": "Data demonstrate that the BRAF(V600E) cooperates with either PIK3CA(H1074R) or with silencing of the tumor-suppressor PTEN, to promote development of anaplastic thyroid carcinoma."}, {"pubmed": 24774510, "text": "This study indicated that mutations of KRAS, PIK3CA and NRAS were rare in advanced gastric cancer."}, {"pubmed": 24782652, "text": "We have identified no significant relationship between PIK3CA amplification, race (p= 0.630) and histological type (p=0. 731) in breast carcinoma, but correlation of PIK3CA amplification and age showed a significant relationship (p=0. 003) between them"}, {"pubmed": 24784415, "text": "These data indicate that HIV-1 might also promote PI3K signalling to balance processing of its transcripts by regulating phosphorylation of splicing regulatory proteins."}, {"pubmed": 24788832, "text": "E4-ORF1 interacts with Dlg1 and PI3K to assemble a ternary complex where E4-ORF1 hijacks the Dlg1 oncogenic function to relocate cytoplasmic PI3K to the membrane for constitutive activation."}, {"pubmed": 24806753, "text": "FAM3A plays crucial roles in the regulation of glucose and lipid metabolism in the liver, where it activates the PI3K-Akt signaling pathway by way of a Ca(2+) /CaM-dependent mechanism"}, {"pubmed": 24818793, "text": "Our results indicate that, besides HIF-1alpha, several other pathways, including PI3K/Akt, may be involved in the response to hypoxia of immature and, more specifically, of mature DC to sustain their trafficking and functions within hypoxic microenvironments."}, {"pubmed": 24821574, "text": "Dual MAPK and PI3K/Akt inhibition was detected."}, {"pubmed": 24838432, "text": "The expression of PIK3CA and survivin had a significant correlation with pathological grade and lymph node metastasis in the primary adenosquamous lung carcinoma patients."}, {"pubmed": 24861917, "text": "Chinese colorectal cancer patients with either KRAS or PIK3CA mutations are more susceptible to distant metastasis."}, {"pubmed": 24866151, "text": "We identified differential therapeutic vulnerabilities that emerge upon the loss of both PTEN and p53, and observed that combined inhibition of PARP and PI3K provides increased efficacy in hormone-insensitive advanced prostate cancer."}, {"pubmed": 24878609, "text": "MCP-1 was shown to have a role in activation of the ER1 by phosphorylating Ser167 via the PI3K/Akt/mTORC1 signaling pathway"}, {"pubmed": 24887566, "text": "Further experiments demonstrated that phosphatidylinositide 3-kinases/protein kinase B/mammalian target of rapamycin/p70S6 kinase (PI3K/AKT/mTOR/p70S6K) and extracellular regulated protein kinases (ERK)."}, {"pubmed": 24903376, "text": "Data indicate that upregulation of TRPM cation channel TRPM8 promoted epithelial-mesenchymal transition of breast cancer cells via activating c-akt protein/glycogen synthase kinase 3 beta (GSK-3beta) pathway."}, {"pubmed": 24903382, "text": "Data indicate that Src kinase participates in the regulation of apoptosis through Src/PI-3 K/Akt signaling pathway in Hep-2 cell line."}, {"pubmed": 24908061, "text": "PIK3CA single nucleotide polymorphism rs17849071 GT+GG genotype was inversely associated with P53 protein accumulation in breast cancer samples."}, {"pubmed": 24908601, "text": "PIK3CA mutations were observed in 11 of 79 cases (13.92%), including a rare mutation, Q546 P, that had not previously been reported in OSCC."}, {"pubmed": 24909280, "text": "Data indicate that combined PI3K inhibitor LY294002 and mitogen activated protein kinase kinase (MEK) inhibitor AZD6244 showed synergistic effect on inhibition of SKOV3/DDP cell growth by inducing apoptosis and blocking cell cycle."}, {"pubmed": 24910434, "text": "Findings implicate APOBEC3B activity as a key driver of PIK3CA mutagenesis and HPV-induced transformation."}, {"pubmed": 24918944, "text": "sequencing analysis revealed missense mutations in PIK3CA, and TP53 genes in the breast cancer samples of various histologic types"}, {"pubmed": 24920352, "text": "Shorter GT dinucleotide repeat in the intron 1 of PIK3CA gene is associated with increased risk of breast cancer in Iranian women."}, {"pubmed": 24930890, "text": "the transcriptional activity of nuclear beta-Catenin depends on PI3K activity and both factors synergize for full WNT signaling activity and are associated with distant metastasis in colon cancer"}, {"pubmed": 24936148, "text": "our results demonstrate that activation of the PI3K/Akt/mTOR/p70S6K signaling pathway is involved in S100A4-induced viability, migration, upregulation of VEGF and downregulation of E-cadherin in CRC cells."}, {"pubmed": 24952635, "text": "Results show that thioridazine regulates endothelial cell function and subsequent angiogenesis by inhibiting VEGFR-2/PI3K/mTOR signal transduction."}, {"pubmed": 24957098, "text": "Data indicate that malic enzyme 2 knockdown impacts phosphatidylinositol 3-kinases/proto-oncogene protein akt (PI3K/AKT) signaling."}, {"pubmed": 24958106, "text": "Results show that cell stimulation promotes p110alpha and p110beta association, demonstrating oligomerization of PI3K catalytic subunits within cells."}, {"pubmed": 24964744, "text": "Data indicate that combination of epidermal growth factor (EGFR) inhibitors with either the phosphatidylinositol 3-kinases inhibitor ZSTK474 or the mTOR serine-threonine kinases inhibitor sirolimus showed increased activity."}, {"pubmed": 24967401, "text": "Knockdown of AKT3 and/or PI3KCA genes in T98G cells led to a significant reduction in cell viability, the accumulation of subG1-phase cells and, a reduced fraction of cells in the S and G2/M phases."}, {"pubmed": 24980293, "text": "High expression of PI3K is associated with sinonasal and laryngeal small-cell neuroendocrine carcinoma."}, {"pubmed": 24981670, "text": "PIK3CA mutations are associated with classical markers of good prognosis and signatures of PI3K pathway activity. The presence of a PIK3CA mutation does not preclude a response to neoadjuvant anastrozole treatment."}, {"pubmed": 25002028, "text": "The combination of PI3K and CDK 4/6 inhibitors overcomes intrinsic and adaptive resistance leading to tumor regressions in PIK3CA mutant xenografts."}, {"pubmed": 25009009, "text": "Different targeted therapies may be necessary for Triple-negative breast cancer that involves activation of PIK3CA and AKT1 ."}, {"pubmed": 25013125, "text": "In tDNA, 50 mutations (36 EGFR, 5 ERBB2, 4 KRAS, 3 BRAF, and 2 PIK3CA) were identified, of which 26 were detected in cfDNA. These data demonstrate the feasibility and potential utility of mutation screening in the detection of a range of tumor biomarkers"}, {"pubmed": 25027743, "text": "PIK3CA mutations are associated with good response to docetaxel plus epirubicin neoadjuvant chemotherapy in breast cancer."}, {"pubmed": 25044986, "text": "We detected a mosaic disease-causing mutation in PIK3CA by sequencing of DNA extracted from cultured amniotic cells."}, {"pubmed": 25051360, "text": "Studies indicate the importance of the EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3 pathway in breast cancer."}, {"pubmed": 25054828, "text": "PIK3CA mutations were not correlated with clinicopathological characteristics.  However in the esophageal squamous cell carcinoma patients with family cancer history, PIK3CA mutations were independently correlated with worse overall survival."}, {"pubmed": 25056500, "text": "PTEN was neither a significant prognostic nor predictive factor. PIK3CA mutations were an adverse prognostic factor for survival but not predictive for lapatinib benefit."}, {"pubmed": 25068972, "text": "we have found that the PI3Ka/b isoforms and AKT are involved in the downstream mechanisms leading to actin polymerization, ATP secretion and aggregation of human platelets stimulated by 2-AG."}, {"pubmed": 25073438, "text": "KRAS, BRAF, and PIK3CA mutations were evaluated in 204 colorectal carcinoma samples; the frequency of KRAS, BRAF, and PIK3CA mutations was 23.5, 9.8, and 5.9 %, respectively."}, {"pubmed": 25078343, "text": "A significant percentage of Uterine malignant mesodermal mixed tumors, Uterine clear cell carcinomas, and Uterine serous carcinomas have mutations in PIK3CA."}, {"pubmed": 25090459, "text": "The presented data subclassified colorectal cancers (CRCs) based on their activated signaling pathways and identify a role for c-MET and IGF1R-driven PI3K signaling in CRCs, which is superior to KRAS mutational tests alone."}, {"pubmed": 25099740, "text": "The presence of PIK3CA and RAS mutations and other alterations affecting the mTOR pathway activity in HNSCC could be exploited to predict the potential resistance to cetuximab"}, {"pubmed": 25103565, "text": "PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors."}, {"pubmed": 25104442, "text": "PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer."}, {"pubmed": 25108739, "text": "Germline SNPs in the PI3 K-AKT-mTOR pathway were associated with breast cancer."}, {"pubmed": 25120209, "text": "It is anticipated that through an improved understanding of the biology of the PI3K/Akt pathway in prostate cancer, relevant biomarkers and rationale combination therapies will optimize targeting of this pathway"}, {"pubmed": 25120743, "text": "other mutation was in exon 19 of the phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA) gene, resulting in a G-A substitution at position 1624 (E542K)"}, {"pubmed": 25122428, "text": "The PI3K/AKT/mTOR pathway is distinguishable in SCLC genomic alterations. Therefore, a sequencing-based comprehensive analysis could stratify SCLC patients by potential therapeutic targets."}, {"pubmed": 25146530, "text": "Studies indicate that the PI3K/PTEN/Akt/mTOR pathway is in the pathogenesis of malignancies and development of resistance to anticancer therapies, and inhibitors are a promising therapeutic option."}, {"pubmed": 25150293, "text": "These results provide a rationale for targeting mutant RAS or PI3K/AKT/mTOR signaling in the subset of Erdheim Chester disease patients with NRAS or PIK3CA mutations."}, {"pubmed": 25172557, "text": "E2-induced Nrf2 activation was completely suppressed by the PI3K inhibitors."}, {"pubmed": 25176561, "text": "PIK3CA mutations were significantly related to ER/PR expression."}, {"pubmed": 25186604, "text": "Studies indicate that phosphatidylinositol 3-kinase (PI3K) pathway involved in glioblastoma (GBM) pathogenesis, and PI3K pathway inhibitors can help optimize GBM vaccine immunotherapy."}, {"pubmed": 25192370, "text": "PIK3CA mutations are associated with better outcomes in primary estrogen receptor positive disease and have been reported to be associated with resistance to human epidermal growth factor receptor 2 and endocrine therapies."}, {"pubmed": 25194337, "text": "Data show that IL-27 on IFN-gamma mediated autophagy perpetuates by simultaneous induction of kinases mTOR via JAK/PI3 K/Akt cascade and increment in myeloid cell leukemia sequence 1 (Mcl-1) level through PI3 K pathway."}, {"pubmed": 25194338, "text": "Data indicarte that Helicobacter pylori infection promotes protein synthesis through phosphatidylinositol 3 kinase/mTOR serine-threonine kinases(PI3K/Mtor)."}, {"pubmed": 25197873, "text": "KRAS (41%) and PIK3CA (8%) mutations in Colorectal cancer in patient-derived xenograft models closely paralleled patient tumors (35 to 51% KRAS, 12 to 21% PIK3CA)."}, {"pubmed": 25199759, "text": "HER2-positive breast carcinomas with a PIK3CA mutation are less likely to achieve a pCR after neoadjuvant anthracycline-taxane-based chemotherapy plus anti-HER2 treatment, even if a dual anti-HER2 treatment is given."}, {"pubmed": 25215588, "text": "In this review we present a state of art review on various classes of small molecule inhibitors selectively involving PI3K/Akt/mTOR pathway and their clinical potential in this disease."}, {"pubmed": 25220666, "text": "Mutations in the TP53 gene and to lesser extent in the PIK3CA gene seem more frequent in cervical adenocarcinoma than in squamous cell carcinoma and CIN3"}, {"pubmed": 25247763, "text": "Aberrant activation of PI3K pathway leads to increased phosphorylation of a surprisingly wide variety of kinases and downstream signalling networks."}, {"pubmed": 25257463, "text": "Impaired EPCs proliferation could be reversed by BBR via the PI3K/AKT/eNOS signaling pathway."}, {"pubmed": 25257839, "text": "RI represents an important predictor of progression in patients with CRC and suppresses proliferation and metastasis in CRC cells through inhibiting PI3K/AkT pathway."}, {"pubmed": 25280563, "text": "High PI3K is associated with hepatocellular carcinoma."}, {"pubmed": 25310235, "text": "The phosphoinositide 3-kinase/Akt signaling pathway was activated in cells overexpressing Sox2."}, {"pubmed": 25318886, "text": "Data indicate that quercetin induces apoptosis via phosphatidylinositol 3-kinase PI3k/Akt pathways, suggesting quercetin has potential to be used as an anti-tumor agent against human cervix cancer."}, {"pubmed": 25326806, "text": "These results suggest that the combination of a selective MEK inhibitor and a PI3K/mTOR inhibitor was effective in CRC harboring with KRAS and PIK3CA mutations."}, {"pubmed": 25337237, "text": "Report PIK3CA mutation status in colorectal neoplasms and neuroendocrine differentiation in primary/metastatic colorectal neoplasms."}, {"pubmed": 25340423, "text": "Studied the structure and dynamics of the PIK3CA wild-type and H1047R oncogenic mutant."}, {"pubmed": 25367220, "text": "HER3 knock down decreases cell proliferation preferentially in PIK3CA kinase domain mutation (H1047R) cells."}, {"pubmed": 25384882, "text": "Classification by PIK3CA and SOX2 protein expression is useful for predicting the prognosis of Asian patients with lung SQCC with stage I."}, {"pubmed": 25387153, "text": "Studies indicate that phosphatidylinositol 3-kinases (PI3Ks) and phosphatidylinositol 3-kinase-related protein kinases (PIKKs) are two related families of kinases and share very similar kinase domains."}, {"pubmed": 25398847, "text": "PIK3CA hotspot mutations are present at a relatively high frequency in CTCs and their presence is associated with worse survival in patients with breast cancer with metastasis."}, {"pubmed": 25422220, "text": "PIK3CA gene mutation is a good indication of breast cancer development in early diagnosis of cancer."}, {"pubmed": 25431257, "text": "MALAT1 might suppress the tumor growth and metastasis via PI3K/AKT signaling pathway."}, {"pubmed": 25458846, "text": "Breast cancers harboring oncogenic PIK3CA activate SGK3 signaling while suppressing Akt, indicative of oncogenic functions for both INPP4B and SGK3 in these tumors."}, {"pubmed": 25466966, "text": "certain Akt/mTOR/4E-BP1 pathway signals could be novel therapeutic targets for Merkel cell carcinomas regardless of Merkel cell polyomavirus infection status"}, {"pubmed": 25467032, "text": "Patients with HER2-amplified tumors were more likely to present PIK3CA mutations compared to patients with triple negative tumors."}, {"pubmed": 25471734, "text": "Data show that the combination of PI3 kinase inhibitors with ErbB receptors HER2/HER3 targeting antibodies may constitute a promising therapeutic strategy for prostate cancer."}, {"pubmed": 25473901, "text": "Data indicate that phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutations have no negative impact on survival after surgery or systemic therapy. However"}, {"pubmed": 25483439, "text": "Tim-3 triggers growth factor type responses in acute myeloid leukaemia cells by activating a phosphatidylinositol-3 kinase (PI-3K)/mammalian target of rapamycin (mTOR) pathway."}, {"pubmed": 25483727, "text": "Combination therapy of PI3Kis with IGF1R inhibitors for treating IGF1R-positive human cancers."}, {"pubmed": 25491172, "text": "Study sequenced a large clinical series of patients with metastatic colorectal cancer (mCRC) for RAS and PIK3CA mutations. RAS alterations occurred in 48% of mCRC cases, with mutations within KRAS exon 2 in 43%, KRAS exons 3 and 4 in 3%, and NRAS in 2% of cases. PIK3CA mutations occurred in about 10% of mCRC and were significantly associated with concurrent RAS mutation."}, {"pubmed": 25491778, "text": "While P7170 inhibits PI3K and mTOR in ER+/HER2- human breast cancer cells and tumors ex vivo, in vivo data indicate that the primary mechanism of P7170 anti-tumor action is inhibition of mTOR and cell proliferation"}, {"pubmed": 25497009, "text": "Data indicate that pretreatment of BEZ235 can confer the radiation-inducing phosphoinositide 3-kinase/mammalian target of rapamycin/AKT signaling pathway, and further inhibit the cell viability."}, {"pubmed": 25498454, "text": "Data indicate that ibrutinib significantly reduced PI3K-Akt activity in cardiac cells."}, {"pubmed": 25501707, "text": "AKT3, PI3KCA, and VEGFR2 silencing reduces the invasiveness of glioblastoma multiforme T98G cells."}, {"pubmed": 25501831, "text": "Drugs interfering with expression and activity of XIAP re-sensitize mutant PIK3CA colorectal cancer cells to TRAIL-induced cell death."}, {"pubmed": 25538040, "text": "self-renewal versus differentiation of human ESCs (hESCs) in response to Wnt signaling is predominantly determined by a two-layer regulatory circuit involving beta-catenin, E-cadherin, PI3K/Akt, and Slug in a time-dependent manner."}, {"pubmed": 25539732, "text": "The purpose of the study was to investigate the heterogeneity of PIK3CA mutational status within single circulating Tumor Cells isolated from individual metastatic breast cancer patients."}, {"pubmed": 25542038, "text": "Combined analysis of PIK3CA mutation and PTEN expression may serve as critical indicators to identify patients unlikely to respond to trastuzumab."}, {"pubmed": 25550888, "text": "The expression of both PIK3CA and PIK3CB is increased and related to the development and progress of colorectal carcinoma and multidrug resistance"}, {"pubmed": 25601471, "text": "we will summarize the current knowledge about the role of PAM ( PI3K/AKT/mTOR) signaling in medulloblastoma and discuss the strategies that are currently being evaluated with targeted agents against this pathway."}, {"pubmed": 25624177, "text": "High tumor PI3K signaling was correlated with adverse survival outcome in patients with rectal cancer."}, {"pubmed": 25627962, "text": "suggests that PIK3CA mutations account for a small fraction of PI3K pathway activation and have a limited impact in interfering with the BRAF/NRAS-driven growth in melanoma"}, {"pubmed": 25639555, "text": "our results unveil a functional cross-talk between YB-1, DeltaNp63alpha and the PI3K/AKT pathway critically governing survival of squamous carcinoma cells."}, {"pubmed": 25641861, "text": "PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer"}, {"pubmed": 25679319, "text": "The present study emphasizes that the treatment for breast cancer should include molecular analysis of relevant driver mutations with priority to PIK3CA gene while taking clinical decisions in breast cancer patients."}, {"pubmed": 25681199, "text": "Somatic PIK3CA mutations are the most common cause of isolated LMs and disorders in which LM is a component feature."}, {"pubmed": 25689095, "text": "PIK3CA amplifications and mutations in Non-small cell lung cancer have been reported in 37% and 9%, respectively. Both are poor prognostic factors in Squamous Cell Carcinoma."}, {"pubmed": 25695693, "text": "PIK3CA, SMAD4, and TP53 are most often involved in clonal divergence, providing potential targets that may help guide the clinical management of tumor progression or metastases."}, {"pubmed": 25701229, "text": "Lastly, 17.5% of hepatocellular carcinoma paradoxically had diffuse loss of the oncoprotein p110alpha compared with strong expression in background cirrhotic liver"}, {"pubmed": 25701704, "text": "The PIK3CA hotspot mutations E542K, E545K, and H1047R were found to be significantly more prevalent in PIK3CA-mutant MSS (21/58, 36%) compared to PIK3CA-mutant MSI-H EECs (5/37, 13.5%; p=0.019)."}, {"pubmed": 25710724, "text": "Data show that licochalcone A (LicoA) suppresses solar UV-induced cyclooxygenase (COX-2) expression by acting as a potent inhibitor of enzymes PI3K, MEK1, and B-Raf."}, {"pubmed": 25722288, "text": "findings identify PI3K/AKT pathway mutations as an important cause of epileptogenic brain malformations and establish megalencephaly, hemimegalencephaly, and focal cortical dysplasia as part of a single pathogenic spectrum."}, {"pubmed": 25724520, "text": "Mutations in the PI3K pathway seem therefore to be an important parameter to predict absence of response to cetuximab."}, {"pubmed": 25736040, "text": "Circulating tumor DNA containing PIK3CA mutations is highly predictive of shorter recurrence-free survival and overall survival in primary breast cancer patients."}, {"pubmed": 25742472, "text": "Neither all RAS gene mutation status nor PIK3CA mutation status was prognostic for PFS or OS."}, {"pubmed": 25753288, "text": "Overexpression of STAT1 or of a constitutively active PI3Kalpha mutant failed to induce basal IDO production"}, {"pubmed": 25757539, "text": "PI3K is activated after imatinib secondary resistance in gastrointestinal stromal tumors."}, {"pubmed": 25771729, "text": "PIK3CA and AKT2 mutations occurred at low frequency in gastric cancer."}, {"pubmed": 25773678, "text": "Somatic mutations and copy number amplification of PIK3CA were associated with response to CCRT in patients with cervical squamous cell carcinoma."}, {"pubmed": 25815786, "text": "The frequency of mutations in either KRAS or PIK3CA were significantly higher in patients without lymph node metastasis than those with."}, {"pubmed": 25816324, "text": "PIK3CA mutation is associated with breast cancer."}, {"pubmed": 25826091, "text": "Study demonstrates the oncogenic cooperation between PI3K and Yap pathways along liver carcinogenesis. The PIK3CA/Yap mouse represents an important preclinical liver tumor model."}, {"pubmed": 25834816, "text": "These findings provide evidence that a miR-520a binding site polymorphism rs141178472 in the PIK3CA 3'-UTR may play a role in the etiology of colorectal cancer"}, {"pubmed": 25835181, "text": "This result suggests polymorphic GT repeat of PIK3CA gene may be a potential predictive marker of colorectal cancer risk in Iranian population"}, {"pubmed": 25839328, "text": "PIK3CA hotspot mutations (c.1624G>A [p.Glu542Lys] and c.1633G>A [p.Glu545Lys]) were enriched in APOBEC-signature esophageal squamous cell carcinoma."}, {"pubmed": 25850957, "text": "in a high number of HNSCC tumours, PI3K/Akt signalling is activated by different molecules or by the combination of these molecules."}, {"pubmed": 25851630, "text": "PIK3CA mutations often affect a limited fraction of transformed metastatic colorectal cancer cells."}, {"pubmed": 25852062, "text": "Data indicate that high-grade serous ovarian carcinoma (HGSC) cell lines with high GRB2 associated binding protein 2 (GAB2) expression are more responsive to phosphatidylinositol 3-kinases (PI3K) inhibitor PF-04691502."}, {"pubmed": 25855885, "text": "The PIK3CA mutations within our engineered cell model did not lead to enhanced oncogene-dependent cell death when treated with direct inhibition of the PI3K enzyme yet did show increased sensitivity compared with control with dual PI3K/mTOR inhibition."}, {"pubmed": 25858893, "text": "Despite the rare prevalence of the 5 most common PIK3CA mutations in Langerhans cell histiocytosis, this report highlights that the PI3K-AKT pathway could be implied in the pathogenesis of Langerhans cell histiocytosis."}, {"pubmed": 25886136, "text": "Among 264 patients, mutations in KRAS exon 2, KRAS exons 3 or 4, NRAS, BRAF and PIK3CA were detected in 34.1%, 3.8%, 4.2%, 5.4% and 6.4%, respectively. Thus, a total of 12.1% of patients without KRAS exon 2 mutations had other RAS mutations"}, {"pubmed": 25896413, "text": "MiR-10b directly targets the 3'-UTRs of ZEB1 and PIK3CA."}, {"pubmed": 25909227, "text": "Data show that microRNA miR-21 plays an oncogenic role in diffuse large B-cell lymphoma (DLBCL) by modulating the PI3-Kinase/AKT protein/mTOR protein/forkhead box O1 protein (FOXO1) pathway at multiple levels resulting in strong prognostic implication."}, {"pubmed": 25915427, "text": "Data show that microRNA miR-451 target tuberous sclerosis 1 (TSC1) gene and activates the PI3-kinase/Akt protein/mTOR protein signaling in multiple myeloma (MM) Side population (SP) cells."}, {"pubmed": 25953087, "text": "Proteins induced by PIK3CA mutations correlated with EGFR signaling and reduced relapse-free survival in basal-like breast cancer."}, {"pubmed": 25962440, "text": "PI3KCA gene polymorphism is associated with poor drug response in metastatic renal cell carcinoma."}, {"pubmed": 25962638, "text": "treatment with butein significantly increased reactive oxygen species (ROS) generation and reduced the phosphorylation of PI3K, AKT and mTOR expression, which contributes to the inhibition of the tumor growth of cervical cancer"}, {"pubmed": 25994739, "text": "The prevalence of PIK3CA mutation status in colorectal cancer does not differ according to race/ethnicity, but may vary according to other relevant clinicopathologic and etiologic factors"}, {"pubmed": 26019684, "text": "PIK3CA amplification may be an early and important event in colorectal carcinogenesis and may drive the development of left-side tubular adenomas independently with KRAS mutation."}, {"pubmed": 26033401, "text": "KRAS and PIK3CA genotype may be considered as negative predictive markers and should carry out the analysis expeditiously."}, {"pubmed": 26036761, "text": "our results demonstrate that miR-375 functions as a growth-suppressive miRNA and plays an important role in inhibiting the tumorigenesis through targeting PIK3CA in osteosarcoma."}, {"pubmed": 26040420, "text": "Data show that PI3 kinase is an attractive therapeutic target in malignancies induced by proto-oncogene protein c-Kit mutations."}, {"pubmed": 26053643, "text": "The aim of the present study was to obtain the first data for the phosphatidylinositol-4,5-bisphosphate 3-kinase (PIK3CA) mutation frequency among nonsmall-cell lung cancer (NSCLC) patients in Turkey."}, {"pubmed": 26054797, "text": "This is the first study identifying the PIK3CA mutation specifically in sporadic cribriform-morular variant of papillary thyroid carcinoma"}, {"pubmed": 26058752, "text": "we also explored the downstream molecules of miR-19a/PIK3CA signaling. We found that Notch signaling was induced by upregulation of miR-19a, and inactivation of Notch signaling attenuated the cell proliferation, migration and invasion promoted by miR-19a"}, {"pubmed": 26067136, "text": "observations during clinical tumor genotyping suggest that when other pro-oncogenic pathways are mutated along with PIK3CA, then, PIK3CA inhibition alone may not be effective and combination therapy may be warranted"}, {"pubmed": 26070568, "text": "Loss of PIPKIgamma or its focal adhesion-targeting variant, PIPKIgammai2, impaired PI3K/Akt activation upon stimulation with growth factors or extracellular matrix proteins in different tumor cells."}, {"pubmed": 26107192, "text": "PIK3CA Mutation and Amplification is not associated with Clinicopathological Characteristics of Gastric Cancer."}, {"pubmed": 26119563, "text": "ata show that activation of EphB2 receptor kinase arrests tau protein hyperphosphorylation through phosphatidylinositol 3-kinase (PI3K)/Akt protein-mediated glycogen synthase kinase-3beta (GSK-3beta) inhibition."}, {"pubmed": 26122737, "text": "Analysis of interdomain interactions of wild-type and mutants at the p110alpha-p85alpha interface with molecular dynamics simulations suggest that tumor-associated mutations weaken interactions between p110alpha and p85alpha by disrupting key stabilizing interactions."}, {"pubmed": 26124336, "text": "It also inhibited extrinsic pathway protein caspase 8, growth-related protein PI3K and further activated PTEN in combination with cisplatin."}, {"pubmed": 26138514, "text": "Mutations of PIK3CA occur in approximately 20% of urothelial carcinoma ,and often include gain-of-function mutations that involve the helical and kinase domain."}, {"pubmed": 26138515, "text": "Genomic amplifications through copy gain of the PI3KCA have been frequently found in Follicular thyroid carcinoma (in 24% of tumors) and Anaplastic thyroid carcinoma (in 42% of tumors)."}, {"pubmed": 26149216, "text": "Data show that immunoglobulin-like transcript 4 (ILT4) increases the expression of the co-inhibitory molecule B7-H3 through PI3K/AKT/mTOR signalling."}, {"pubmed": 26173098, "text": "we also observed frequent PIK3CA mutations in Tiawanese oral squamous cell carcinoma patients."}, {"pubmed": 26174078, "text": "HSP60 overexpression increases the protein levels of the p110alpha subunit of phosphoinositide 3-kinase and c-Myc"}, {"pubmed": 26191320, "text": "Case Report: enlarging cystic lymphangioma of the mediastinum might harbor a neoplastic nature related to the recently discovered PIK3CA mutation."}, {"pubmed": 26192087, "text": "Studied how rapamycin affects CCN2 expression and migration of lung fibroblasts in vitro; PI3K and inhibitors were used to determine rapamycin's mechanism of action."}, {"pubmed": 26213461, "text": "the current study illustrated that downregulation of miR203 and overexpression of PIK3CA were novel potential prognosis predictors of gastric cancer patients"}, {"pubmed": 26247526, "text": "Found no association between PIK3CA mutational status and other clinical/biological parameters in breast cancer treated with adjuvant trastuzumab."}, {"pubmed": 26266975, "text": "there is a key effect of PIK3CA(H1047R) on mammary cell fate in the pre-neoplastic mammary gland and the cell of origin of PIK3CA(H1047R) tumours dictates their malignancy, thus revealing a mechanism underlying tumour heterogeneity and aggressiveness"}, {"pubmed": 26266985, "text": "oncogenic Pik3ca(H1047R) activates a multipotent genetic program in normally lineage-restricted populations at the early stage of tumour initiation, setting the stage for future intratumoural heterogeneity"}, {"pubmed": 26267517, "text": "Studied the global phosphotyrosine proteome of isogenic knock-in cell lines containing two hotspot mutations in PIK3CA (E545K and H1047R); 824 unique phosphopeptides were identified."}, {"pubmed": 26267533, "text": "Findings indicate inositol polyphosphate 5-phosphatase PIPP (INPP5J) as a suppressor of oncogenic phosphoinositide 3-kinase (PI3K)/AKT signaling in breast cancer."}, {"pubmed": 26271341, "text": "PIK3CA Mutations are associated with Head and Neck Squamous Cell Carcinoma."}, {"pubmed": 26276776, "text": "Distinct beta-catenin and PIK3CA mutation are linked in endometriosis-associated ovarian endometrioid and clear cell carcinomas"}, {"pubmed": 26281684, "text": "It plays a role in cell survival, cell differentiation and cell proliferation in neoplasms."}, {"pubmed": 26296968, "text": "Data show that leukemia inhibitory factor (LIF) signaling promote chemoresistance in cholangiocarcinoma by up-regulating myeloid cell factor-1 (Mcl-1) via phosphatidylinositol 3-kinase (PI3K)/c-akt protein (AKT)-dependent pathway."}, {"pubmed": 26301495, "text": "assessed the clinical impact of changes in the frequency and topology of PIK3CA mutation and HER2 (ERBB2) amplification within HER2-positive breast cancer during neoadjuvant the"}, {"pubmed": 26325104, "text": "Results show that oncogenic PIK3CA mutations in HER2/neu overexpressing uterine serous carcinoma cells are common and may constitute a major mechanism of resistance to trastuzumab."}, {"pubmed": 26333383, "text": "Data show that dual epidermal growth factor receptor 2 HER2/phosphatidylinositol 3-kinase PIK3CA blockade may be a drug therapy for uterine serous carcinoma (USC) with HER2 gene amplification and mutated wild-type PIK3CA resistant to chemotherapy."}, {"pubmed": 26334097, "text": "analysis of ARID1A, CDH1, cMET and PIK3CA expression and target-related microRNA expression in gastric cancer"}, {"pubmed": 26334752, "text": "A concurrent PIK3CA mutation is a poor prognostic factor in patients with advanced EGFR-mutant or KRAS-mutant lung adenocarcinomas."}, {"pubmed": 26339434, "text": "Case Report: undifferentiated pleomorphic sarcoma with two missense mutations - KRAS mutation (35G > A, G12D) and PIK3CA mutation (1636C > A, Q546K."}, {"pubmed": 26340871, "text": "Somatic mutations in PIK3CA have roles in PIK3CA-related somatic overgrowth spectrum"}, {"pubmed": 26351730, "text": "We describe the case of a patient in whom we were able to confirm a causative PIK3CA mutation."}, {"pubmed": 26353837, "text": "the presence of PIK3CA major mutations of cell-free DNA could be a discriminatory predictor of survival in early-stage triple negative breast cancer"}, {"pubmed": 26356562, "text": "Data show that rapamycin-insensitive companion of mTOR protein (RICTOR) plays a central role in phosphatidylinositol 3-kinase (PI3K)/proto-oncogene protein c-akt (AKT) pathway in melanocytes and its deregulation could be involved in melanoma development."}, {"pubmed": 26358014, "text": "patients with mutant PIK3CA had distinct characteristics in age, menopausal status, and histological subtype and have better treatment outcome and less distant metastasis after surgery-based multimodal therapy."}, {"pubmed": 26390688, "text": "Overexpression of PI3K-p110alpha is associated with progression of uterine cervical neoplasia, and the expression of pAkt and DJ-1 is positively correlated with PI3K-p110alpha expression in this process."}, {"pubmed": 26390889, "text": "Down-regulation of PIK3 is associated with osteoporosis."}, {"pubmed": 26393468, "text": "29b lowers postoperative IOP and sustains the function of filtering bleb. It inhibits the proliferation of fibroblasts and reduces collagen deposition by repressing the PI3K/Akt/Sp1 pathway in rabbits subjected to GFS."}, {"pubmed": 26447856, "text": "Data show that apoptotic cell death by esculetin was associated with inhibition of the EGFR/PI3K/Akt signaling pathway and the decreased expression of nucleophosmin (NPM)."}, {"pubmed": 26452060, "text": "no prognostic significance of specific PIK3CA mutations in breast cancer treated with adjuvant chemotherapy"}, {"pubmed": 26453385, "text": "We have observed a 4% oncogenic mutation frequency of the PIK3CA gene, which plays a minor role in the development of OSCC in an Indian population."}, {"pubmed": 26459773, "text": "Data show that RNA silencing of CCN family member 1 protein (CCN1) inhibits umbilical vein endothelial cell (HUVEC) proliferation under hypoxic conditions by inhibiting phosphoinositide 3-kinase (PI3K)/AKT protein signaling."}, {"pubmed": 26460589, "text": "Results indicate that resveratrol could increase the anti-proliferative activity of bestatin through downregulating P-gp expression via suppressing the PI3K/Akt/mTOR signaling pathway."}, {"pubmed": 26462835, "text": "Data show that synergistic apoptotic effect of the combination treatment is correlated with the block of the PI3K/Akt signal pathway in breast cancer cells."}, {"pubmed": 26482612, "text": "Data show that microRNA miR-221 targets PTEN protein, leading to activation of the PI3K/Akt pathway."}, {"pubmed": 26497122, "text": "Somatic mutations affecting PI3K pathway genes were found to be highly prevalent in infiltrating epitheliosis, suggesting that these lesions may be neoplastic rather than hyperplastic."}, {"pubmed": 26498688, "text": "Data show that low-level phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) mutations were detectable in the serum indicating the utility of cell free DNA (cfDNA) as a DNA source to detect mutations in metastatic biliary cancers."}, {"pubmed": 26499488, "text": "Data show that puquitinib mesylate (XC-302) induced autophagy in nasopharyngeal cancer cells CNE-2 by promoting cell autophagy and inhibits the phosphatidylinositol 3-Kinase (PI3K)/AKT protein/TOR serine-threonine kinases (mTOR) signaling pathway."}, {"pubmed": 26499886, "text": "Data suggest that the overexpression of microRNA miR16 inhibits the proliferation, invasion and metastasis of hepatocellular carcinoma cells associated with the"}, {"pubmed": 26500061, "text": "Results indicate that p110alpha primarily mediates PI3K/AKT signaling in HER2+ PTEN deficient breast tumors whereas p110beta conditionally mediates HER2/PI3K signaling in the absence of p110alpha."}, {"pubmed": 26503204, "text": "PIK3CA mutation is associated with response to therapy in Breast Cancer."}, {"pubmed": 26506516, "text": "Data show that the combination of a phosphatidylinositol 3-Kinase (PI3K)/mTOR protein inhibitor with an androgen receptor {AR) inhibitor results in a synergistic anti-tumor response in non-castration-resistant prostate cancer (CRPC) and CRPC models."}, {"pubmed": 26515594, "text": "Data indicate the role of tropomyosin-related kinase-B (TrkB) in activation of the interleukin-6/Janus kinase 2/STAT3 transcription factor and PI3 kinase/c-AKT proto-oncogene protein pathway in breast cancer."}, {"pubmed": 26528858, "text": "Mutations in PIK3CA gene are associated with esophageal squamous cell carcinoma."}, {"pubmed": 26540293, "text": "PIK3CA mutations and PI3K/AKT pathway activation are common events in TNBC."}, {"pubmed": 26543351, "text": "High PI3K p110alpha expression contributes to MET inhibitor resistance in gastric carcinoma xenografts."}, {"pubmed": 26549032, "text": "Cytokines IL-2/7/9 stimulation activates PI3K/Akt pathways downstream of Ras in RasGRP1 T-cell acute lymphoblastic leukemia (T-ALL)."}, {"pubmed": 26559013, "text": "miR-490-5p functions as a tumour suppressor in renal carcinoma by targeting PIK3CA"}, {"pubmed": 26568302, "text": "Findings indicate that Epstein-Barr virus(EBV)-encoded latent membrane protein 1 (LMP1), PI3K/AKT, miR-21 and PTEN constitute a positive feedback loop and have a key role in LMP1-induced cancer stem cells (CSCs) in nasopharyngeal carcinoma (NPC)."}, {"pubmed": 26581613, "text": "Increased Expression of Phosphatidylinositol 3-Kinase p110alpha and Gene Amplification of PIK3CA is associated with Nasopharyngeal Carcinoma."}, {"pubmed": 26600545, "text": "PIK3CA mutations were observed in 32% (8) of the 25 breast cancer tissues examined, Sequencing of exon 2 of KRAS suggested that 20% (5) of the 25 samples harbored a mutation and 16% (4) of BRAF harbored a mutation."}, {"pubmed": 26617776, "text": "miR-203 represses NF-kappaB signaling via targeting TAK1 and PI3KCA and miR-203 overexpression may contribute to the COPD initiation."}, {"pubmed": 26637981, "text": "Somatic activating PIK3CA mutations cause venous malformation."}, {"pubmed": 26640141, "text": "Inducible expression of mutant PIK3CA resulted in a robust activation of phosphatidylinositol-3-kinase (PI3K)/AKT signaling but attenuation of Her2/Her3 signaling, and this can be reversed by deinduction of PIK3CAH1047R expression."}, {"pubmed": 26643470, "text": "These results indicate an association between PIK3CA gene polymorphism on the rs7621329(C/T) site and the risk of schizophrenia."}, {"pubmed": 26650777, "text": "As depicted in Figure 3, APC (25%) followed by KRAS (20%), TP53 (14%), and PIK3CA (11%) were the most frequently mutated genes."}, {"pubmed": 26670666, "text": "Findings of frequent mutations in CDKN2A, NOTCH1, PIK3CA, and EGFR (all in excess of 20%) point to potential therapeutic avenues. Trials of targeted therapies directed toward these mutations should be explored."}, {"pubmed": 26680641, "text": "Study shows that high EGFR protein expression and exon 9 PIK3CA activating mutations are independent prognostic factors in triple negative breast cancers."}, {"pubmed": 26687646, "text": "High PI3K expression is associated with prostate cancer."}, {"pubmed": 26691448, "text": "These results revealed differences in the genetic profiles of KRAS, NRAS, PIK3CA and BRAF at mutation hotspots between Chinese CRC patients and those of Western countries."}, {"pubmed": 26701847, "text": "Patients with PIK3CA amplifications were more likely to have diffuse-type and poorly differentiated gastric cancers and were more likely to experience peritoneal recurrence compared with those without PIK3CA amplifications."}, {"pubmed": 26712086, "text": "PIK3CA Mutation is associated with Colorectal Cancer."}, {"pubmed": 26718898, "text": "It was suggested that somatic point mutations in BRAF, CDKN2A and PI3KCA do not participate in the oncogenesis of Medullary thyroid carcinoma"}, {"pubmed": 26722541, "text": "none of the nine tested SNPs of PIK3CA was associated with susceptibility to oral squamous cell carcinoma in the studied population."}, {"pubmed": 26730736, "text": "Data show that 14-3-3beta protein augmented the expression of matrix metalloproteinasea MMP2 and MMP9 through PI3 kinase/Akt protein/NF-kappaappa B pathway, thereby enhancing the invasiveness of hepatocellular carcinoma (HCC) cells."}, {"pubmed": 26733612, "text": "Continuous and metronomic PI3K inhibition elicits robust anticancer effects in ER(+), PIK3CA-mutant breast cancer."}, {"pubmed": 26747178, "text": "PIK3CA and PIK3CB significantly increase multidrug resistance of CRC cells in vivo."}, {"pubmed": 26792725, "text": "effects. Further studies indicated that PRKCI knockdown-mediated autophagy was associated with the inactivation of phosphatidylinositol 3-kinase alpha/AKT-mammalian target of rapamycin (PIK3CA/AKT-MTOR) signaling."}, {"pubmed": 26796526, "text": "we reported the rare occurrence of PIK3CA mutations in imatinib-naive gastrointestinal stromal tumors"}, {"pubmed": 26797271, "text": "Therefore, we identified a tumorigenic role of Id-1 in OS and suggested a potential therapeutic target for OS patients."}, {"pubmed": 26797279, "text": "Based on the collective findings, we suggest that vIRF2 acts as an activator in PI3K/Akt pathway."}, {"pubmed": 26820797, "text": "KRAS and PIK3CA mutations can influence the response of DLD1 colorectal cancer cell lines to MEK and PI3K inhibitors, but that the effect is dependent on the experimental model used to assess drug sensitivity."}, {"pubmed": 26823766, "text": "Suggest that copy number loss of Variation_91720 in PIK3CA predicts risk of esophageal squamous cell carcinoma."}, {"pubmed": 26823876, "text": "PIK3CA rs17849071 and rs17849079 polymorphisms may increase the risk of hepatocellular carcinoma."}, {"pubmed": 26826201, "text": "This work identifies PI3K signaling as an important target for precision medicine trials in meningioma patients"}, {"pubmed": 26827608, "text": "Though Wortmannin was found to nullify the effect of H1047R over the PIK3CA, further studies are required for designing a better compound."}, {"pubmed": 26829882, "text": "Activation of the NF-kappaB-JNK pathway is independent of the PIK3CA-Rac1-JNK pathway involved in the bFGF-regulated human fibroblast cell migration and wound healing."}, {"pubmed": 26832731, "text": "PIK3CA and MET may play an important role in oncogenesis of certain specific subtypes of head and neck cancer"}, {"pubmed": 26848623, "text": "Results indicate that eIF4B integrates the signals from Pim and PI3K/Akt/mTOR pathways in Abl-expressing leukemic cells."}, {"pubmed": 26851524, "text": "Here we report a Hungarian girl with macrodactyly and syndactyly. Genetic screening at hotspots in the PIK3CA gene identified a mosaic mutation (c.1624G > A, p.Glu542Lys) in the affected tissue, but not in the peripheral blood"}, {"pubmed": 26853422, "text": "Results suggest, a potential role for PIK3CA, VEGFR2, RET and FGFR2 as therapeutic targets in EGFR non-mutated NSCLC that requires further clinical validation."}, {"pubmed": 26876212, "text": "our results offer significant insight into how PIK3CA overexpression drives squamous cell carcinoma (HNSCC) invasion and metastasis, providing a rationale for targeting PI3K/PDK1 and TGFb signaling in advanced HNSCC patients with PIK3CA amplification"}, {"pubmed": 26884879, "text": "Combined detection of p110alpha and p110beta is helpful to determine the neoplastic potential of colorectal villous adenoma and serrated adenoma."}, {"pubmed": 26889984, "text": "PIK3CA gene plays a crucial role in carcinogenesis in general and head and neck squamous cell carcinoma in particular."}, {"pubmed": 26902608, "text": "The siRNA-induced AKT3 and PI3KCA mRNA knockdown."}, {"pubmed": 26918351, "text": "Data suggest that class I phosphatidylinositol 3-kinase (PI3K) inhibitor ZSTK474 induced autophagy might contribute to the antitumor activity."}, {"pubmed": 26921096, "text": "PIK3CA gene mutations are associated with breast cancer"}, {"pubmed": 26927447, "text": "PI3KCA mutations were extremely rare in pancreatic cancer, suggesting that they play a limited role in PC development.[review]"}, {"pubmed": 26945423, "text": "No relation was found between PIK3CA expression and clinical features of ovarian clear cell carcinoma. PIK3CA expression had no impact on survival."}, {"pubmed": 26947331, "text": "Fulvestrant plus palbociclib was associated with significant and consistent improvement in progression-free survival compared with fulvestrant plus placebo, irrespective of the degree of endocrine resistance, hormone-receptor expression level, and PIK3CA mutational status. The combination could be considered as a therapeutic option for patients with HER2-negative breast cancer"}, {"pubmed": 26947513, "text": "investigated mutations in exons 9 and 20 of the PI3K gene in gallbladder cancer (GBC) ; results show the PI3K gene to be mutated in approximately 17% of GBC"}, {"pubmed": 26956874, "text": "Pharmacophore model suggested the mechanism of the inhibition of PI3Kalpha and mTOR by the compounds were mostly the same, which was supported by the docking study showing similar docking modes. The analysis also suggested the importance of the flat plane shape of the ligands, the space surrounding the ligands in the binding pocket, and the slight difference in the shape of the binding sites between PI3Kalpha and mTOR."}, {"pubmed": 26971883, "text": "Data underscore the importance of phosphatidylinositol 3-kinase (PI3K) signalling in myeloid cells in the context of chronic inflammatory diseases."}, {"pubmed": 26980034, "text": "PIK3CA was overexpressed in Epstein Barr virus-associated gastric adenocarcinoma and was associated with a less aggressive phenotype and better prognosis."}, {"pubmed": 26995633, "text": "PIK3CA mutations detected at high frequencies in breast cancer and mostly associated with better or insignificant outcomes in estrogen receptor-positive (ER+) early stage breast cancer and tend to be with worse prognosis in ER- disease."}, {"pubmed": 26997442, "text": "Low incidence of PIK3CA mutations in adenocarcinomas of the ampulla of Vater suggest no major role in tumorigenesis."}, {"pubmed": 27001433, "text": "PIK3CA plays a key role in promoting the proliferation and motility of esophageal squamous carcinoma cells."}, {"pubmed": 27007084, "text": "PIK3CA mutations are associated with metastatic lung adenocarcinomas."}, {"pubmed": 27016421, "text": "Data indicate that PIK3CA copy number gain was an independent poor prognostic factor for disease-free survival (DFS)."}, {"pubmed": 27020207, "text": "A low prevalence of PIK3CA mutation exists in the distal extrahepatic bile duct (EBD) carcinoma of Korean patients, indicating that mutation screening may not be useful in determining prognosis or in formulating a treatment response to targeted inhibition in Korea."}, {"pubmed": 27020460, "text": "Data show that the elevated activities of PI3Ks, AKt and GSK-3beta were effectively suppressed by exogenous carbon monoxide (CO), leading to the improvement of platelet function."}, {"pubmed": 27030594, "text": "activating PIK3CA mutations gives rise to sporadic venous malformations in mice, which closely resemble the histology of the human disease."}, {"pubmed": 27030595, "text": "These data demonstrate a causal relationship between activating Pik3ca mutations and the genesis of vascular malformations."}, {"pubmed": 27037860, "text": "The authors present three clinically challenging cases with congenital mosaic tissue overgrowth caused by a heterozygous missense mutation in PIK3CA in the affected tissue."}, {"pubmed": 27048245, "text": "Our study demonstrates that the IGF1R/p110b/AKT/mTOR axis confers resistance to BYL719 in PIK3CA mutant breast cancers"}, {"pubmed": 27059323, "text": "Mutations of PIK3CA were found in our cohort in 21 cases (28 %), 10 (13 %) in exon 9 and 11(15 %) in exon 20. Mutation frequency of AKT1 and PTEN genes was 4 and 3 %, respectively"}, {"pubmed": 27070496, "text": "A recursively partitioned mixture model of all 3 somatic alteration burden measures resulted in classes of tumors whose epigenetic and genetic burden profile were associated with the PAM50 subtype and mutations in TP53, PIK3CA, and CDH1"}, {"pubmed": 27101199, "text": "Data indicate that EPHA3 is involved in regulating the multidrug resistance (MDR) of small cell lung cancer (SCLC) via PI3K/BMX/STAT3 signaling and may be a therapeutic target in SCLC."}, {"pubmed": 27108388, "text": "The results suggest PIK3CA H1047R mutant cells have a selective advantage in breast, contribute to breast cancer susceptibility, and drive tumor progression during breast carcinogenesis, even when present as only a subpopulation of tumor cells."}, {"pubmed": 27120806, "text": "Concomitant inhibition of PIM kinase and p110alpha activities inhibits glioma stem cell function and survival."}, {"pubmed": 27127129, "text": "PIK3CA gene mutations were sought in 145 tissue samples from central nervous system metastases of NSCLC using 3 PCR techniques.  One E542K and two H1047R substitutions were found in male patients."}, {"pubmed": 27167340, "text": "Data show that long noncoding RNA RMEL3 is required for MAPK and PI3K signaling, and its knockdown decrease BRAFV600E melanoma cell survival and proliferation."}, {"pubmed": 27167344, "text": "Results indicate that des-gamma-carboxy prothrombin (DCP) antagonizes the inhibitory effects of Sorafenib on hepatocellular carcinoma (HCC) through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways."}, {"pubmed": 27176780, "text": "PI3K isoforms p110a, p110b and p110g were selectively inhibited and effects on proliferation and migration assessed. Inhibition increased transcription of cancer stem cell genes in both models, suggesting de-differentiation in response to blockade of the PI3K/AKT/mTOR signalling axis."}, {"pubmed": 27177864, "text": "Overall PIK3CA mutant/HER2+ tumours had significantly lower pCR rates compared with wild-type tumours, however mainly confined to the HR+/PIK3CA mutant population. No definite conclusions can be drawn regarding survival"}, {"pubmed": 27184479, "text": "Like the mammary intraductal papillomas, activating mutations in PIK3CA or AKT1 are present in most hidradenoma papilliferums."}, {"pubmed": 27189717, "text": "Single TOR serine-threonine kinases (mTOR) and dual phosphatidylinositol 3-kinases (PI3K)/mTOR inhibitors promote Treg cells immunosuppressive activity."}, {"pubmed": 27191687, "text": "we report a fourth patient with asymmetric overgrowth due to a somatic PIK3CA mutation who had nephroblastomatosis or Wilms tumor. Similar to two of three reported patients with a somatic PIK3CA mutation and renal tumors, he shared a PIK3CA mutation affecting codon 1047, presented at birth with asymmetric overgrowth, and had fibroadipose overgrowth."}, {"pubmed": 27197157, "text": "PIK3CA gene mutation is associated with breast Cancers."}, {"pubmed": 27219019, "text": "Study identified PIK3CA mutation as an independent prognostic factor in patients who underwent APR for ASCC recurrence."}, {"pubmed": 27220763, "text": "that the spindle cell type of Mmtaplastic breast carcinoma with myoepithelial features exhibits a higher frequency of PIK3CA mutation than other types of metaplastic or basal-like breast cancer"}, {"pubmed": 27255162, "text": "Identify mutually exclusive activating hotspot mutations in FGFR1 and related PI-3K/RAS signaling genes in malignant phyllodes tumors which are implicated in tumor pathogenesis and/or progression."}, {"pubmed": 27268661, "text": "Mutations in PIK3CA Sensitize Breast Cancer Cells to Physiologic Levels of Aspirin."}, {"pubmed": 27282497, "text": "to our knowledge, this is the largest study to evaluate the PIK3CA mutation in Indian breast cancer patients. The frequency and distribution pattern of PIK3CA mutations is similar to global reports"}, {"pubmed": 27283966, "text": "While TP53 mutation and MYC amplification were synergistic in promoting tumor progression, PIK3CA mutation was found to have alleviated the oncogenic effect of either the TP53 mutation or MYC amplification, and was associated with a significant reduction in mitotic activity in TP53 mutated and/or MYC amplified breast cancer"}, {"pubmed": 27301639, "text": "We revealed that activation of the PI3K/Akt pathway was the main cause of impaired autophagy in ELK3 KD. Our results suggest that targeting ELK3 may be a potential approach to overcome doxorubicin resistance in breast cancer therapeutics."}, {"pubmed": 27307077, "text": "Data indicated next-generation sequencing (NGS) for the identification of somatic variation in the phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA)-related overgrowth spectrum (PROS) among 14 patients submitted for clinical testing."}, {"pubmed": 27308891, "text": "MARCH2 has a role in regulating autophagy by promoting CFTR ubiquitination and degradation and PIK3CA-AKT-MTOR signaling"}, {"pubmed": 27317099, "text": "Study shows that PIK3CA is required for the proliferation, migration, invasion and clone formation of gallbladder carcinoma (GBC) cells in vitro and that the E545K mutation of PIK3CA promotes GBC progression through its enhanced binding to EGFR."}, {"pubmed": 27321283, "text": "The data establish oncogenic PIK3CA mutations as a cause of glutamine dependency in colorectal cancer and suggest that targeting glutamine metabolism may be an effective approach to treat patients harboring PIK3CA mutations."}, {"pubmed": 27329843, "text": "AQP9 overexpression decreased the protein levels of phosphatidylinositol-3-kinase (PI3K), leading to reduced phosphorylation of Akt, and subsequently the protein levels of forkhead box protein O1 (FOXO1) were increased."}, {"pubmed": 27336598, "text": "This meta-analysis proved that detecting PIK3CA gene mutation by cfDNA has high diagnostic accuracy in breast cancer, especially for metastatic breast cancer. It may serve as a reliable non-invasive assay for detecting and monitoring PIK3CA mutation status in order to deliver personalized and precise treatment."}, {"pubmed": 27339899, "text": "NEDD4L negatively regulates PIK3CA protein levels via ubiquitination and is required for the maintenance of PI3K-AKT signaling pathway."}, {"pubmed": 27348297, "text": "PIK3CA mutation is associated with endometrial carcinoma progression and abdominopelvic metastasis."}, {"pubmed": 27369359, "text": "TP53 and PIK3CA mutations appear to have diverse effects on the outcome of early breast cancer patients, according to whether these genes are co-mutated or not, and for TP53 according to tumor-infiltrating lymphocyte density and ER/PgR-status"}, {"pubmed": 27379604, "text": "PIK3CA mutation is associated with salivary duct carcinoma."}, {"pubmed": 27387578, "text": "Mutations in PIK3CA, AKT1, and PTEN also were less frequently found in cancers with mutations in the DNA guardian, TP53. This observation might seem counterintuitive because increased genome instability might facilitate development and selection of advantageous mutations."}, {"pubmed": 27388016, "text": "Results showed that mutations in PIK3CA exons 9 and 20 were observed in 25 of the 208 (12 %) gastric cancer patients but found that no correlation with prognosis."}, {"pubmed": 27388585, "text": "PIK3CA, PTEN, and AKT1 mutations occurred more frequently in the presence of hormone receptor overexpression (androgen, progesterone, or estrogen receptor). PIK3CA mutations were also more common in the HER2-positive than in the HER2-negative group; the opposite pattern was seen for PTEN mutation or PTEN loss"}, {"pubmed": 27426307, "text": "Combined inhibition of PI3K and PARP effectively synergized to block the growth of three wild-type PIK3CA ovarian cancer cell lines and explants of a primary ovarian tumor specimen."}, {"pubmed": 27426476, "text": "CLOVES syndrome is an overgrowth syndrome caused by mosaic activating mutation in phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) gene."}, {"pubmed": 27436848, "text": "Our findings suggest that PIK3CA mutation has the neutral prognostic effects on colorectal cancers (CRC) OS and progression-free survival. Evidence was accumulating for the establishment of CRC survival between PIK3CA mutations and patient-specific clinical or molecular profiles."}, {"pubmed": 27441415, "text": "Our data indicate that, similar to other benign proliferative lesions occurring in the breast parenchyma, activating PIK3CA mutations are very common in nipple adenomas"}, {"pubmed": 27448972, "text": "Combined treatment with gamma-irradiation (gammaIR) and a dual PI3K/mTOR inhibitor causes loss of stemness and of FoxO1/3 proteins in p53-proficient glioblastoma multiforme stem cells (GBM-SCs)."}, {"pubmed": 27449034, "text": "Data show that zinc finger protein 143 (ZNF143) promotes epithelial-mesenchymal transition (EMT) through regulating PI3K/AKT pathway in gastric cancer (GC) cells."}, {"pubmed": 27455559, "text": "The FGFR3, PIK3CA, TERT mutations, along with aberrant DNA methylation patterns, can serve as reliable genetic markers for the diagnosis of urinary bladder cancer. (Review)"}, {"pubmed": 27465249, "text": "Mutant PIK3CA is a potent oncogenic driver in many urothelial carcinoma cell lines"}, {"pubmed": 27489350, "text": "Cervical cancer patients whose tumours are positive for the PIK3CA-E545K mutation may benefit from PI3K inhibitor therapy in concert with standard cisplatin and radiation therapy."}, {"pubmed": 27489353, "text": "HPV16 E6-E7 promotes cancer stem-like cells phenotype in esophageal squamous cell carcinoma cells through the activation of PI3K/Akt signaling pathway"}, {"pubmed": 27491860, "text": "relevant genomic aberrations such as mutations in the hotspot regions of exon 9 and 20 of the PIK3CA gene can be detected in single circulating tumor cells and might provide insights into mechanisms of resistance to HER2-targeted therapies."}, {"pubmed": 27491861, "text": "the expression of 3 miRs and 9 mRNAs associate with the PIK3CA status. Expression of LRG1 is independent of luminal (A or B) subtype, decreased after neo-adjuvant aromatase inhibitor treatment."}, {"pubmed": 27494839, "text": "the majority of cells within the tumor appears to express predominantly TAp63 isoform. While DeltaNp63 exerts its effects by regulating a PI3K/CD44v6 pathway."}, {"pubmed": 27502552, "text": "Case Report: sildenafil could be an alternative treatment option for lymphatic malformations in patients with syndromes belonging to the PIK3CA-related overgrowth spectrum."}, {"pubmed": 27507059, "text": "A dual PI3K and mTOR inhibitor, BEZ235 with the HDAC inhibitor Trichostatin A (TSA) significantly increased anti-tumor activities compared with BEZ235 and TSA alone, suggesting a combination treatment for non-small-cell lung cancer (NSCLC)."}, {"pubmed": 27520487, "text": "In the very high-risk Bladder Cancer patients , several genes had a higher frequency of mutations than reported in the The Cancer Genome Atlas database, including PIK3CA . Mutation associations with receipt of neoadjuvant chemotherapy, nodal involvement, metastatic disease development, and survival were analyzed."}, {"pubmed": 27525871, "text": "PTEN and PIK3CA were shown to be upregulated by 89 and 76% (western blot), respectively, in the pemetrexed-resistant cell line compared with control cells."}, {"pubmed": 27554588, "text": "Study found that PIK3CA mutation occurred in approximately 2.8% of patients with lung adenocarci- noma in a cohort of Chinese patients."}, {"pubmed": 27572308, "text": "Findings indicate that PTEN and its downstream PI3K/AKT signaling targets were modulated by JQ1 compound."}, {"pubmed": 27573562, "text": "The primary end point was progression-free survival (PFS) in the intention-to-treat (ITT) population and patients with PIK3CA-mutated tumours.In patients with PIK3CA-mutated tumours, the median PFS was 7.3 months for pictilisib (n = 32) versus 5.8 months with placebo (n = 30) (HR, 1.06; 95% CI 0.52-2.12; P = 0.88)"}, {"pubmed": 27581627, "text": "E545K missense mutation of PIK3CA is associated with loss of protein stability and development of breast cancer."}, {"pubmed": 27602501, "text": "Results indicate that specific inhibition of PI3K p110alpha could provide an alternative therapeutic approach for colorectal cancer (CRC) patients, particularly those harboring KRAS mutations."}, {"pubmed": 27614430, "text": "Bis(acetylacetonato)-oxidovanadium(IV) and sodium metavanadate induced the activation of both PI3K/AKT and MAPK/ERK signaling pathways dose- and time-dependently."}, {"pubmed": 27621407, "text": "Studies suggest to maximize therapeutic benefit, drug combinations and schedules for Inhibition of the PI3K/AKT/mTOR Pathway must be explored to identify those with the highest efficacy and lowest toxicity overlap."}, {"pubmed": 27626181, "text": "Expression of LINC00520 is regulated by oncogenic Src, PIK3CA and STAT3, and may contribute to the molecular etiology of breast cancer."}, {"pubmed": 27626684, "text": "Platelet-derived growth factor (PDGF) activates the PI3K/Akt/mTOR pathway, and suppresses apoptosis."}, {"pubmed": 27629725, "text": "Data show that the incidence of phosphatidylinositol 3-kinase catalytic 110-KD alpha (PIK3CA) mutation is low in small cell lung cancer (SCLC) and the pseudogene-positive alteration of A1634C is prone to occur in exon 9 of PIK3CA mutations in cancers."}, {"pubmed": 27634934, "text": "PI3K signaling enhanced SOX2 translation, which in turn induced the expression of genes regulating the stemness characteristics of cancer stem cells ."}, {"pubmed": 27672108, "text": "Sixteen of 20 patients treated at the MTD had reduced (18)FDG-PET uptake; 7 (33%) had a reduction >25%. One patient achieved a complete response (CR; endometrial carcinoma exhibiting both PIK3CA and PTEN mutations and complete PTEN loss) and two had a partial response (PR; both metastatic breast cancer)."}, {"pubmed": 27686608, "text": "High expression of PI3K is associated with glioma."}, {"pubmed": 27713121, "text": "miR-130a could alleviatehuman coronary artery endothelial cells (HCAECs) injury and inflammatory responses by down-regulating PTEN and activating PI3K/Akt/eNOS signaling pathway."}, {"pubmed": 27734950, "text": "PIK3CA mutation may not be associated with primary resistance to EGFR TKI among lung adenocarcinoma patients"}, {"pubmed": 27737711, "text": "No significant impact on prognosis was observed for mutated KRAS, NRAS, and PIK3CA genes or combined RAS mutations"}, {"pubmed": 27742746, "text": "PIK3CA and AKT1 are frequently mutated in Hidradenoma papilliferum (HP) tumours (29% and 14%, respectively). PIK3CA/AKT1 pathway alterations in HP further support the hypothesis that HP is the vulvar (anogenital mammary-like gland) analogue of breast intraductal papilloma."}, {"pubmed": 27750372, "text": "Gains of PIK3CA is associated with hypopharyngeal squamous cell carcinoma."}, {"pubmed": 27765909, "text": "Report outcome of PIK3CA/mTOR/MEK co-targeted inhibition strategy in the treatment of non-small cell lung carcinomas."}, {"pubmed": 27792260, "text": "Mutations in PIK3CA gene is associated with breast cancer."}, {"pubmed": 27800646, "text": "Our study did not demonstrate a significant survival advantage from aspirin use in stage 2 PIK3CA mutated colon cancer (CC). The 'real-world' nature of our cohort and the subsequent uncontrolled differences in age and fitness in aspirin users are likely to have contributed to this result. In the PIK3CA mutated group, there was a trend towards improved recurrence-free survival of CC."}, {"pubmed": 27834349, "text": "This study, for the first time segregates atypical verruciform lesions by virtue of a unique genotype (PIK3CA mutant/TP53 wild type) illustrating an example of progression to a TP53-mutated keratinizing carcinoma."}, {"pubmed": 27835884, "text": "these results suggest that PIK3CA mutation may be a new predictive biomarker for celecoxib efficacy treatment in breast cancer"}, {"pubmed": 27852700, "text": "We find that both primary and recurrent Squamous cell carcinoma of the anal canal (ASCC) tumors harbor mutations in genes, such as PIK3CA and FBXW7, that are also mutated in other HPV-associated cancers. Overall mutational burden was not significantly different in pre- versus post-CRT tumors, and several examples of shared clonal driver mutations were identified"}, {"pubmed": 27863385, "text": "Gli1 promotes colorectal cancer cells metastasis in a Foxm1-dependent manner by activating EMT and PI3K-AKT signaling."}, {"pubmed": 27863403, "text": "Report targeted analysis of KRAS, BRAF and PIK3CA mutations in circulating tumor cells captured by a label-free platform and compare to expression in primary tumor tissue and metastases."}, {"pubmed": 27864574, "text": "PI3K catalytic-alpha(PIK3CA) mutations assessed from circulating tumor DNA represent the first potentially viable serum biomarker for the selection of ET combinations, and new data demonstrate the feasibility of this minimally invasive technique as an alternative to traditional tissue analysis"}, {"pubmed": 27901576, "text": "Study shows that PIK3CA mutation occurs approximately in 45% of breast cancer patients, and are frequent in exon 20 in comparison with exon 9 of the gene. Also, PIK3CA mutations were found significantly associated with low-grade tumors."}, {"pubmed": 27903677, "text": "Because apoptosis and tumor regression occurred early but not late in the treatment course, and proliferative arrest was maintained throughout treatment, p110a/b inhibitors may be considered short-term cytotoxic agents and long-term cytostatic agents"}, {"pubmed": 27913435, "text": "Functional studies demonstrated that IDH2 and PIK3CA hotspot mutations are likely drivers of solid papillary carcinoma with reverse polarity"}, {"pubmed": 27918554, "text": "Data show that acid sensing ion channel 1a (ASIC1a) mediated calcium influx, which resulted in the activation of PI3K/AKT signaling and increased drug resistance, suggesting that ASIC1a/Ca(2+)/PI3K/AKT signaling represents a pathway that regulates drug resistance, thus offering a potential target for chemotherapy of hepatocellular carcinoma (HCC)."}, {"pubmed": 27919038, "text": "FBS. Following stimulation of RTKs (receptor tyrosine kinases), microinjected PI3Kalpha was recruited to the PM, but oncogenic forms of PI3Kalpha were not recruited to the PM to a greater extent and did not reside at the PM longer than the wild-type PI3Kalpha. Instead, the E545K mutant specifically bound activated Cdc42"}, {"pubmed": 27933776, "text": "Findings show that calmodulin (CaM) stimulates phosphoinositide-3-kinase (PI3K) lipid kinase activity by binding MARCKS and displacing it from phosphatidylinositol 4,5-bisphosphate (PIP2) headgroups, thereby releasing free PIP2 that recruits active PI3K to the membrane and serves as the substrate for the generation of phosphatidylinositol 3,4,5-trisphosphate (PIP3)."}, {"pubmed": 27959444, "text": "High PI3K expression is associated with liver cancer."}, {"pubmed": 27974663, "text": "PIK3CA mutations have a role in breast tumor response to targeting mTOR-mediated MCL-1 translation"}, {"pubmed": 28024928, "text": "the most frequent genomic abnormality in patients with primary pulmonary neuroendocrine carcinoma in China"}, {"pubmed": 28025078, "text": "Report KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer may depend on tumor histology."}, {"pubmed": 28029147, "text": "Somatic PIK3CA variants in breast cancers associate with rs252913 and rs331499 SNPs in the locus 5q11.2 locus."}, {"pubmed": 28031425, "text": "The combination of SAR256212 and SAR245408 resulted in stable disease as the best response. Side effects seen in combination were similar to the profiles of each individual drug. Patient outcome was the same regardless of tumor PI3KCA mutation status"}, {"pubmed": 28036259, "text": "Cytoplasmic retention of FOXO3a may represent a potential biomarker for response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cervical cancer cells."}, {"pubmed": 28060766, "text": "Report a functional interaction between EZH2- and PIK3CA-dependent signaling pathways in non-muscle invasive bladder cancer cells."}, {"pubmed": 28062544, "text": "Despite a significant prevalence of BRAF mutation, more than 70% of hobnail variant of papillary thyroid carcinomas (HPTCs) in our series showed concurrent mutations of other genes such as TP53, PIK3CA, CTNNB1 and hTERT, in contrast to classic PTC."}, {"pubmed": 28068934, "text": "PIK3CA mutations are associated with esophageal squamous cell carcinoma."}, {"pubmed": 28069289, "text": "Increased levels of FGFR3 and PIK3CA mutated DNA in urine and plasma are indicative of later progression and metastasis in bladder cancer."}, {"pubmed": 28087713, "text": "The expression of ribosomal and proteasomal components was significantly up-regulated in primary human colorectal tumors harboring PI3K pathway activation"}, {"pubmed": 28095868, "text": "PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression."}, {"pubmed": 28098872, "text": "Upregulation of PI3K is associated with thyroid cancer."}, {"pubmed": 28098897, "text": "Upregulation of PI3K is associated with ovarian cancer."}, {"pubmed": 28132399, "text": "MicroRNA miR-155-5p promoted proliferation, invasion and migration, but inhibited apoptosis in hepatocellular carcinoma (HCC) by directly targeting the 3'-UTR of PTEN through the PI3K/Akt pathway."}, {"pubmed": 28165066, "text": "High expression of PI3KCA is associated with drug resistance and proliferation of breast cancer."}, {"pubmed": 28167203, "text": "We identified a de novo phosphatidylinositol-4,5- bisphosphate 3-kinase catalytic subunit alpha gene (PIK3CA) mutation as a potential drug resistance mechanism."}, {"pubmed": 28178653, "text": "Derlin-1 is overexpressed in bladder cancer and promotes malignant phenotype through ERK/MMP-2/9 and PI3K/AKT signaling pathway."}, {"pubmed": 28181739, "text": "PIK3CA gene mutations were not found; however, a synonymous single nucleotide polymorphism (SNP) [rs17849079] was observed frequently [35/96 (36.4%)] in oral cancer samples."}, {"pubmed": 28183140, "text": "PIK3CA E545K/E542K mutations are associated with everolimus resistance in breast cancer."}, {"pubmed": 28188683, "text": "KRAS mutations and AKT activation are present in Wilms tumors (WT) and may represent novel therapeutic targets for this tumor."}, {"pubmed": 28188750, "text": "KRAS and PIK3CA genetic variants are associated with aggressive clinicopathological features in colorectal adenocarcinoma."}, {"pubmed": 28190247, "text": "Compared to single-gene-targeted cells and parental controls, cells with both a PIK3CA mutation and TP53 alteration had increased cancerous phenotypes including cell proliferation, soft agar colony formation, aberrant morphology in acinar formation assays, and genomic heterogeneity."}, {"pubmed": 28196852, "text": "Phosphatidylinositol-3-kinase signaling is regulated by INPP4B and PTEN in the triple-negative breast cancer cells."}, {"pubmed": 28206962, "text": "Data indicate that PI3K pathway mutation predicts longer time to local progression after radioembolization of colorectal liver metastases."}, {"pubmed": 28209106, "text": "Recurrent PIK3CA mutations associated with Epstein-Barr virus - infected Gastroesophageal junction tumor."}, {"pubmed": 28223411, "text": "abundance is stimulated, in part, through AKT- and nuclear factor kappaB (NF-kappaB)-dependent pathways and that presence of PTX3 is necessary for PI3K-induced stem cell-like traits."}, {"pubmed": 28233937, "text": "This study provides insights as to how mutationally activated PIK3CA acts in concert with MEK1/2 signaling to cooperatively regulate mTORC1/2 to sustain PIK3CA-mutated melanoma proliferation."}, {"pubmed": 28258248, "text": "Data show that cancer-associated fibroblasts (CAFs)-derived hepatocyte growth factor (HGF) or recombinant HGF activated c-Met/phosphoinositide 3-kinase (PI3K)/Akt and glucose-regulated protein 78 (GRP78) signalling pathways in ovarian cancer cells."}, {"pubmed": 28263743, "text": "Psgl-1 deficiency accelerates bleomycin-induced lung fibrosis and inflammation in mice through activating the PI3K/AKT axis."}, {"pubmed": 28269754, "text": "This study identified PIK3CA mutations in breast carcinoma patients of Western China that will enable a more rapid molecular diagnosis, and provide a stronger rationale evidence for development of precision therapeutic approaches as well as promising therapeutic targets for breast cancer treatment or patient management"}, {"pubmed": 28285689, "text": "Out of 171 EGFR mutated tumor-patient cases, 20 were sequenced using at least a limited comprehensive genomic profiling platform. 50% harbored concurrent TP53 mutation, 10% PIK3CA mutation, 5% PTEN mutation, among others."}, {"pubmed": 28291131, "text": "in series of benign and malignant neoplasms thought to be associated with anogenital mammary-like glands, PIK3CA mutation was detected in extramammary Paget disease, mammary-type invasive ductal carcinoma and tubulolobular carcinoma"}, {"pubmed": 28328134, "text": "Somatic PIK3CA mutations in seven patients with PIK3CA-related overgrowth spectrum have been reported."}, {"pubmed": 28331003, "text": "Preliminary data consistent with preclinical data indicate increased antitumor activity of taselisib in patients with PIK3CA-mutant tumors (in comparison with patients with tumors without known activating PIK3CA hotspot mutations) starting at the lowest dose tested of 3 mg, thereby supporting higher potency for taselisib against PIK3CA-mutant tumors."}, {"pubmed": 28339079, "text": "A combination of CAL-101, a p110delta-specific inhibitor, with bortezomib treatment of HT/EBV cells synergistically suppressed proliferation, reduced levels of drug resistance-related proteins, activated caspase cleavage and recovered expression of p110a/p110b."}, {"pubmed": 28355296, "text": "Tetraarsenic hexoxide (As4O6) induced G2/M arrest, apoptosis and autophagic cell death through PI3K/Akt and p38 MAPK pathways alteration in SW620 colon cancer cells."}, {"pubmed": 28360038, "text": "p110alpha subunit of PI3K and PKD mediate YAP activation in response to insulin and neurotensin in pancreatic cancer cells. Inhibitors of PI3K or PKD disrupt crosstalk between insulin receptor and GPCR signaling systems by blocking YAP/TEAD-regulated gene expression in pancreatic cancer cells"}, {"pubmed": 28379870, "text": "APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases."}, {"pubmed": 28381646, "text": "Data, including data from hydrogen/deuterium exchange mass spectrometry studies using full-length constructs for both catalytic/p110alpha and regulatory/p85alpha subunits of phosphoinositide 3-kinase isoform, suggest that the catalytic subunit exhibits binding sites for four inhibitor compounds studied, including a low-affinity binding site for CAL-101."}, {"pubmed": 28384037, "text": "PI3K protein was expressed in 81.3% (91/112) of all ESCC samples, whereas it was found in only 4.9% (5/56) of adjacent normal cells.PIK3CA gene mutations were highly correlated with age, tobacco use, and clinical stage (p<0.05), but not with gender, location, alcohol use, lymph node metastasis, or degree of differentiation. PI3K protein expression was not statistically correlated with PIK3CA gene mutations."}, {"pubmed": 28393905, "text": "phenotypic changes in metabolism following a single copy knock-in of mutant PIK3CA (H1047R) in the MCF10A cell line, an important cell model for studying oncogenic transformation in breast tissues, were examined."}, {"pubmed": 28396387, "text": "because PIK3CA mutant cells exhibit a profound reliance on glucose metabolism, malate-aspartate shuttle deregulation leads to a specific proliferative block due to the inability to maintain NAD(+)/NADH homeostasis. Together these observations define a precise metabolic vulnerability imposed by a recurrently mutated oncogene."}, {"pubmed": 28418888, "text": "High Expressions of PI3K is associated with metastasis of esophageal squamous cell carcinoma."}, {"pubmed": 28424201, "text": "Data suggest that the phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) mutations may potentially contribute to acquired cetuximab resistance in patients with metastatic colorectal cancer (mCRC)."}, {"pubmed": 28427202, "text": "there was no association between PIK3CA mutation and expression, or of other related genes, namely PIK3CB, PIK3CD, PIK3CG, and PTEN. Mutation of PIK3CA might alter calmodulin expression and other genetic pathways"}, {"pubmed": 28442534, "text": "Oncogenic beta-catenin and PI3K activities interact in the acquisition of multiple cancer-related phenotypes in organoids grown in Matrigel."}, {"pubmed": 28446642, "text": "In vivo single-agent mTORC inhibition inhibited growth of one PIK3CA-mutant cancer, but had little effect on any PIK3CA(WT) or a second PIK3CA-mutant model. In all models, the combination therapy showed greater growth delay than monotherapy. The uniform ability of PI3K and mTORC inhibition to suppress the growth of Head and neck squamous cell carcinomas (HNSCC) cells highlights the pathway's role in driving proliferation"}, {"pubmed": 28453696, "text": "PIK3CA mutant and -wildtype gastric tumor subclones are skilled to metastasize independently to different regional lymph nodes."}, {"pubmed": 28465643, "text": "Suggest that PIK3CA gene mutations could act as a prognostic biomarker in Northwest Chinese esophageal squamous cell carcinoma patients."}, {"pubmed": 28468801, "text": "we demonstrate that oncogenic p110alphaH1047R, K-RasG12V, H-RasG12V, and Her2 use a common Akt1-FOXO3a pathway in suppression of DeltaNp63alpha expression and, consequently, promote cell migration/invasion and tumor metastasis. Thus, DeltaNp63alpha may function as a critical integrator of oncogenic signals in cell motility and cancer metastasis."}, {"pubmed": 28476872, "text": "our data point to a targetable Axl-PI3 kinase-PD-L1 axis that is highly associated with radiation resistance"}, {"pubmed": 28490463, "text": "In this study of 71 patients with advanced solid tumors who had received prior treatments (86% of whom were PIK3CA mutated), 3 different dose schedules of TAK-117 were evaluated. The MTD of TAK-117 was established as 150 mg once daily and 900 mg for both intermittent (MWF/MTuW) schedules."}, {"pubmed": 28515318, "text": "Data suggest HRas activates both p110alpha and p110delta isoforms; membrane-resident HRas, not soluble HRas, increases membrane recruitment of both p110alpha and p110delta. (HRas = v-Ha-ras Harvey rat sarcoma viral oncogene homolog; p110alpha = class IA phosphoinositide 3-kinases, subunit p110alpha; p110delta = class IA phosphoinositide 3-kinases, subunit p110delta)"}, {"pubmed": 28532501, "text": "PIK3CA mutations can lead to resistance to MET inhibition, supporting future clinical evaluation of combinations of PI3K and MET inhibitors in common scenarios of malignant neoplasms featuring aberrant MET expression and PIK3CA mutations."}, {"pubmed": 28534983, "text": "PI3K overexpression is associated with colorectal cancer metastasis."}, {"pubmed": 28549032, "text": "Expression of Phosphoinositide 3-Kinase p110alpha and p110beta Subunits and PIK3CA Mutation in Patients With Advanced Gastric Carcinoma."}, {"pubmed": 28550907, "text": "This study revealed that (1) PIK3CA hotspot mutations occurred with low frequency in gastric cancer; (2) PIK3CA hotspot mutations were not directly associated with PI3K pathway activation; and (3) p-AKT (+) may be a biomarker for better outcomes for gastric cancer patients undergoing gastrectomy regardless of the PIK3CA mutation status."}, {"pubmed": 28551389, "text": "The lack of KRAS, NRAS, BRAF, and PIK3CA mutation in our study may suggest that a subset of eyelid sebaceous carcinomas is unlike that of eyelid sebaceous carcinomas of western countries."}, {"pubmed": 28566443, "text": "Mosaic mutations in PIK3CA or PIK3R2 which activate class 1A PI3K cause severe non-ketotic hypoglycaemia in a subset of patients, with the metabolic phenotype presumably related to the extent of mosaicism within the liver."}, {"pubmed": 28577738, "text": "Mosaic gain of function mutation in PIK3CA gene leads to abnormal AKT-mTOR pathway activation and is responsible of the clinical manifestations."}, {"pubmed": 28585132, "text": "The findings suggest that PIK3CA mutation has no significant effects on overall survival and on disease-free survival in esophageal squamous cell carcinoma patients. (Meta-analysis)"}, {"pubmed": 28586035, "text": "High expression of PI3K is associated with nasopharyngeal carcinoma."}, {"pubmed": 28630349, "text": "p85alpha plays a tumor-suppressive role in transformation; p110alpha-selective therapeutics may be effective in the treatment of breast cancer patients with PIK3R1 loss"}, {"pubmed": 28637905, "text": "Results show that head and neck squamous cell carcinoma tumors with low P120CTN and PI3K pathway mutations have higher levels of MMP1 compared to tumors with high P120CTN and no PI3K pathway mutations demonstrating that P120CTN downregulation and PIK3CA mutations promote MMP1-driven invasion."}, {"pubmed": 28665924, "text": "Case Reports: PIK3CA mutations are present in multiple tissues of facial infiltrating lipomatosis."}, {"pubmed": 28676499, "text": "Data suggest that Lys-776 (in the P-loop of PIK3CA) is critical for autophosphorylation in PIK3CA/PIK3R1 heterodimer; both His-936 and His-917 (in the activation and catalytic loops of PIK3CA) are important catalytically, but appear to have different functions; bisubstrate kinetic analysis of PIK3CA/PIK3R1 heterodimer indicates an ordered sequential mechanism."}, {"pubmed": 28685592, "text": "Knowing the mutation status of KRAS, BRAF or PIK3CA in stage II colorectal cancer can significantly improve the accuracy of prognoses."}, {"pubmed": 28692045, "text": "Data suggest a critical role for KDM3A in the PI3K/AP-1 oncogenic axis and propose a novel strategy for inhibition of KDM3A against liver tumor development under PI3K pathway activation."}, {"pubmed": 28726194, "text": "An increase in the frequency of PIK3CA gene mutations with disease progression (from 2.4 to 28.7% with tumor progression from I-IIa to III-IV stage; p=0.0001) and a trend towards its increase in the tumors with unfavorable prognostic characteristics (high histological grade, triple negative phenotype) were demonstrated."}, {"pubmed": 28750640, "text": "PIK3CA and/or ERBB family mutations were detected in 23 (31.1%) tumour samples tested, whereas PTEN expression was low in 31.1% of cases tested"}, {"pubmed": 28755461, "text": "Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas."}, {"pubmed": 28774796, "text": "High PI3K expression is associated with melanoma."}, {"pubmed": 28808038, "text": "The bladder cancer cell line TCCSUP, which harbors a PIK3CA E545K mutation, was sensitive to pictilisib compared to cell lines with wild-type PIK3CA Pictilisib exhibited stronger antitumor activity in bladder cancer patient-derived xenografts models with PI3KCA H1047R mutation or amplification than the control patient-derived xenografts model"}, {"pubmed": 28847905, "text": "RAS signaling through PI3K is necessary for normal lymphatic vasculature development and for RAS-induced transformation in vitro and in vivo, especially in lung cancer, where it is essential for tumor initiation and necessary for tumor maintenance. [review]"}, {"pubmed": 28849118, "text": "these results suggest that aspirin inhibited human uterine leiomyoma cell growth by regulating KRasp110alpha interaction. Aspirin which targeting on interaction between K-Ras and p110alpha may serve as a new therapeutic drug for uterine leiomyoma treatment."}, {"pubmed": 28850092, "text": "while telomere length did not correlate with the presence of a mutation in BRAF (V-raf murine sarcoma viral oncogene homolog B), PIK3CA (phosphatidylinositol 3-kinase catalytic subunit), or MSI status, it was significantly associated with the occurrence of a mutation in KRAS"}, {"pubmed": 28860563, "text": "While PIK3CA mutations generally had no impact on survival, and were not associated with clinicopathological variables, patients with exon 9 charge-changing mutations were associated with poor survival in endometrial primary tumors. PIK3CA mRNA levels were increased in metastases compared to the primary tumors, independent of PIK3CA mutation status, which rather associated with reduced PIK3CA mRNA expression."}, {"pubmed": 28867187, "text": "These data indicate that increased irisin levels may have protective roles in liver cancer cells through partial activation of the PI3K/AKT pathway, which may facilitate liver cancer progression and decrease the sensitivity to chemotherapy."}, {"pubmed": 28867195, "text": "These results indicated that dual targeting of PI3K and PERK pathways might improve clinical prognosis and enhance the treatment of ESCC patients."}, {"pubmed": 28867506, "text": "A mosaic gain-of-function mutation in PIK3CA was identified in a patient with gait disturbance, leg pain, isolated macrodactyly of the foot, and mild intellectual disability."}, {"pubmed": 28887744, "text": "results suggest that c-Jun, p38 MAPK, PIK3CA/Akt, and GSK3 signaling involved in the effect of miR-203 on the proliferation of hepatocellular carcinoma cells."}, {"pubmed": 28902361, "text": "Study showed for the first time that co-occuring oncogenic HER2 and mutant PIK3CA could induce replication stress in mammary epithelial cells and drives breast cancer progression."}, {"pubmed": 28945826, "text": "PIK3CA mutation was associated with treatment response in breast cancer."}, {"pubmed": 28947417, "text": "Combined PI3Kalpha and CDK4/6 inhibition significantly improved disease control in human xenograft models compared with either monotherapy."}, {"pubmed": 28958829, "text": "Targeting activating mutations in PIK3CA assay was used for screening tumor DNA from Metastatic Relapse in Advanced Bladder Cancer patients; at least one mutation was detected in 19 of the 60 patients."}, {"pubmed": 28993455, "text": "Ehrlichia chaffeensis infection activated the phosphatidylinositol 3-kinase (PI3K)-Akt-mTOR (mechanistic target of rapamycin) pathway, and activation was induced by three ehrlichial tandem repeat protein (TRP) effectors, with TRP120 inducing the strongest activation."}, {"pubmed": 29021135, "text": "Overexpression of KAT6A or TRIM24 promoted PIK3CA expression, AKT phosphorylation, and cell proliferation."}, {"pubmed": 29098623, "text": "Studies indicate the role of the insulin-like growth factor 1 (IGF1) - phosphoinositide 3-kinase (PI3K)-Akt signaling pathway in regulating exercise-induced physiological cardiac hypertrophy and cardiac protection [Review]."}, {"pubmed": 29110152, "text": "When considered together (43 cases), 1/25 cases (4%) with a PIK3CA mutation and/or low PTEN expression levels had a pathologic complete response (pCR)compared to 7/18 cases (39%) with wild-type PI3KCA and high PTEN expression levels (p = 0.006)."}, {"pubmed": 29133261, "text": "Together, dual inhibition of BRD4 and PI3K by SF2523 suppresses human prostate cancer cell growth in vitro and in vivo."}, {"pubmed": 29170395, "text": "The majority of PIK3CA H1047R mutations in the breast cancer cohort precede genome doubling."}, {"pubmed": 29191607, "text": "PIK3CA mutation is a distinctive genetic feature of NSCLC with COPD, regardless of age, smoking dose, pathological stage, and histology."}, {"pubmed": 29218606, "text": "PI3K is a signal linker between L-selectin and PSGL-1 in IL-18 transcriptional activation at the promoter level."}, {"pubmed": 29219001, "text": "The role of PI3K in cancer has been well established, and mutations of PIK3CA, the gene coding for catalytic subunit p110alpha of PI3K, are found in approximately 30% human cancers. we review the structures and activation modes of PI3Ks and its implications in angiogenesis, extracellular matrix remodeling and tumor immunity."}, {"pubmed": 29224720, "text": "CTNNB1 mutations were found in 60% of Basal cell adenoma but not in basal cell adenocarcinoma. None of the tested cases had PIK3CA mutations. CTNNB1 mutation trended to be more common in those cases having a predominant tubular or tubulotrabecular patterns."}, {"pubmed": 29231959, "text": "We detected the same PIK3CA mutation in her affected tissue, urine, and tumor, indicating Wilms tumors probably arise from PIK3CA mutant cells in patients with CLOVES. No urine sample from a participant with Klippel-Trenaunay (KTS) had detectable PIK3CA mutations."}, {"pubmed": 29239720, "text": "By monitoring single-cell dynamics in each of these contexts, the authors identified PI3K/Akt regulation of glycolysis as a multifaceted modulator of single-cell metabolic dynamics that is required to maintain metabolic stability in proliferating cells."}, {"pubmed": 29242214, "text": "PIK3CA gene fusion and expression is associated with poor outcome in the hormone receptor-positive breast cancer."}, {"pubmed": 29259101, "text": "Oncogenic PIK3CA alters methionine and cysteine utilization, partly by inhibiting xCT to contribute to the methionine dependency phenotype in human breast cancer cells."}, {"pubmed": 29305742, "text": "High PIK3CA expression is associated with metastasis in colon cancer."}, {"pubmed": 29328485, "text": "High PI3K expression is associated with cervical cancer."}, {"pubmed": 29345357, "text": "The pooled analysis confirmed that the presence of a PIK3CA mutation represents an independent negative prognostic factor (HR = 1.67, 95%CI: 1.15-2.43; P = 0.007) in BC, as previously reported. As PI3K signaling is also a result of other pathways' hyperactivation."}, {"pubmed": 29346025, "text": "Inflammatory stress displayed by endothelial cells derived from lymphatic malformation is consistent with errors in lipid metabolism that may be linked to PIK3CA acquired mutations."}, {"pubmed": 29353467, "text": "High Resolution Melting Analysis can be used as a rapid and sensitive method for mutation screening. Dysregulation of PIK3CA gene in bladder cancer reveals its potentials as a mechanistic link for cancer development, which in turn suggests its special use in interventional studies for targeted therapy"}, {"pubmed": 29380640, "text": "PIK3CA mutation is associated with decreased risk of peritoneal metastases in chemo-resistant metastatic colorectal cancer."}, {"pubmed": 29388061, "text": "KRAS wild-type metastatic colorectal cancer patients with mutant type phosphatidylinositol 3-kinases receiving an epidermal growth factor receptor monoclonal antibody (anti-EGFR) inhibitor as first-line therapy have significantly lower overall response rate, shorter progression-free survival and overall survival."}, {"pubmed": 29434452, "text": "Double mutation of PIK3CA and TP53 is an independent predictive factor for overall survival in stage II/III colorectal cancer patients receiving 5-FU-based chemotherapy."}, {"pubmed": 29446767, "text": "We identified a total of five distinct mutations in PIK3CA (NM_006218.2), including one hotspot mutation (c.1624G>A;p.Glu542Lys); two recurrent, strong (gain of function) mutations (c.3140A>T;p.His1047Leu, c.1258T>C;p.Cys420Arg); one previously described mutation in patients with macrodactyly (c.344G>C;p.Arg115Pro); and one novel somatic PIK3CA mutation (c.248T>C; p.Phe83Ser) not previously described"}, {"pubmed": 29470143, "text": "In this large pooled analysis, PIK3CA mutations were significantly associated with a better IDFS, DDFS, and OS, but had a lesser prognostic effect after adjustment for other prognostic factors."}, {"pubmed": 29496665, "text": "We report the first characterization of clinical acquired resistance to MEKi + CDK4i, identifying a rare preexisting PIK3CA(E545K) subpopulation that expands upon therapy and exhibits drug resistance."}, {"pubmed": 29506489, "text": "High PIK3CA expression is associated with head and neck carcinoma."}, {"pubmed": 29508857, "text": "biomarkers that are predictive of a response, such as PIK3CA mutations for inhibitors of the PI3K catalytic subunit alpha isoform, must be identified and analytically and clinically validated.. we review the current experience with anticancer therapies that target the PI3K-AKT-mTOR pathway."}, {"pubmed": 29516089, "text": "These results suggest that in addition to overgrowth of bone and soft tissue, gain of function variants in PIK3CA may predispose to overgrowth of scar tissue, resulting in the formation of abnormal scars such as keloids or hypertrophic scars."}, {"pubmed": 29537649, "text": "Our results indicate that low-grade adenosquamous carcinoma of the breast of the breast is a low-grade triple-negative breast cancer that harbours a basal-like phenotype with no androgen receptor expression, and shows a high rate of PIK3CA mutations"}, {"pubmed": 29540052, "text": "High frequency of somatic PIK3CA mutations was detected in Chinese breast cancer patients and associated with poor prognosis. The prevalence of the PIK3CA mutation was 46.5% (236/507), and 35 patients carried two or three variants of PIK3CA gene."}, {"pubmed": 29549527, "text": "Study shows that ARQ092 counteracts overactivation of PI3K signal pathway in primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum."}, {"pubmed": 29556349, "text": "Six mutations located at the BRAF, KRAS, and PIK3CA genes have been detected in colorectal cancer patients using a novel multiplex surface enhanced Raman spectroscopy-multiplex PCR method."}, {"pubmed": 29575819, "text": "In early breast cancer, PIK3CA mutations seem to identify HER2+ patients who are less likely to reach pCR. The clinical implications of PIK3CA mutations tend to vary between exon 9 and exon 20. This mechanism should be explored in further studies."}, {"pubmed": 29578286, "text": "Herein, we present a case of PROS that reflects the great variability of cutaneous manifestations associated with this disease spectrum, many of which were found in our patient."}, {"pubmed": 29581176, "text": "Results show PIK3CA mutation correlates with poor prostate cancer prognosis and causes prostate cancer in mice. Moreover, PIK3CA mutation and PTEN loss coexist in prostate cancer and can cooperate in vivo to accelerate tumorigenesis and facilitate castration-resistant prostate cancer."}, {"pubmed": 29598951, "text": "High expression of PIK3CA in HNSCC primary tumors identifies patients at high risk for recurrence. In these tumors, progression could rely on the Hippo-YAP pathway instead of the canonical Akt/mTOR pathway"}, {"pubmed": 29603332, "text": "We validated the presence of IDH2 R172 hotspot mutations and PIK3CA hotspot mutations in 100% and 67% of solid papillary breast carcinoma with reverse polarity tested, respectively"}, {"pubmed": 29636477, "text": "The PIK3CA and PIK3R1 impactful mutations exhibit a mutually exclusive pattern, leading to oncogenesis and hyperactivity of PI3K pathway in breast cancer."}, {"pubmed": 29661094, "text": "Our results indicate that a high proportion of isolated macrodactyly patients carry a pathogenic PIK3CA mutation."}, {"pubmed": 29666387, "text": "This study determined the mutation frequencies and prognostic values of KRAS exon 2, 3 and 4, NRAS exon 2 and 3, PIK3CA exon 9 and 20, and BRAF exon 15 by PCR and direct sequencing in 353 colorectal cancer patients from two Chinese clinical centers."}, {"pubmed": 29689598, "text": "These results showed high concordance between detection of PIK3CA mutations in tumor tissue and in corresponding serum circulating tumor DNA."}, {"pubmed": 29689710, "text": "higher frequency of ESR1 and PIK3CA mutations in the plasma than in the serum in 33 MBC patients; therefore, serum samples should not be considered the preferred source of cfDNA."}, {"pubmed": 29704890, "text": "This study detected gain-of-function mutations in exon 20 of PI3KCA gene in 11% of gastric cancer patients."}, {"pubmed": 29708279, "text": "9p21.3 (CDKN2A) loss and PIK3CA mutation characterize a subgroup of metaplastic breast cancers with myoepithelial and spindle cell differentiation."}, {"pubmed": 29714670, "text": "In patients without PIK3CA alteration, TP53 nonfunctional mutations are associated with poor prognosis."}, {"pubmed": 29729098, "text": "TRAF6 is a novel PIK3CA regulator whose deregulated overexpression represents a mechanism for PI3K overactivation in tumors."}, {"pubmed": 29739299, "text": "High PI3K expression is associated with metastasis in ovarian cancer."}, {"pubmed": 29762822, "text": "Linc-ROR is highly expressed in the ectopic endometrium of adenomyosis, and it can promote the proliferative activity of endometrial cells by activating the PI3K-Akt pathway."}, {"pubmed": 29793946, "text": "Taselisib plus fulvestrant had clinical activity irrespective of PIK3CA mutation status, with numerically higher objective response rate and clinical benefit rate in patients with PIK3CA-mutated (vs. -MND) locally advanced or metastatic HER2-negative, HR-positive breast cancer. No new safety signals were reported."}, {"pubmed": 29880907, "text": "AR + /FOXA1 + expression defines a luminal-like TNBC subgroup affected with a worse outcome compared to other TNBC and a higher risk of late recurrences. This subgroup appears enriched in PIK3CA mutations, suggesting a role for PI3K inhibitors in this subgroup."}, {"pubmed": 29902261, "text": "PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in varied disease states of penile cancer"}, {"pubmed": 29902570, "text": "The crucial role of p110beta and the more subtle role of p110alpha in the production of PIP3 molecular species following platelet stimulation has been demonstrated."}, {"pubmed": 29905413, "text": "PIK3CA mutation in gastric cancer is a rare finding. It is strongly associated with the microsatellite instability (MSI) molecular subgroup, presenting a worse outcome than other MSI patients. A completely different outcome is associated with the mutation in exon 9 compared to the mutation in exon 20, with the latter being more favorable."}, {"pubmed": 29932233, "text": "IL1B promotes the nuclear translocaiton of S100A4 protein in gastric cancer cells and the cell's stem-like properties through PI3K pathway."}, {"pubmed": 29950119, "text": "These results suggest that the classical metabolic PI3K pathway and not the canonical proliferation ERK pathway is involved in the insulin/insulin-like growth factor-1-induced increase in crypt proliferation in obese humans, which may contribute to abnormal tissue renewal and function."}, {"pubmed": 29950425, "text": "pK15-dependent signaling may occur from intracellular vesicles and rely on the endocytotic machinery. Specifically, a class II PI3K, PI3K-C2alpha, is recruited by pK15 and involved in pK15-dependent intracellular signaling and viral reactivation from latency."}, {"pubmed": 29970482, "text": "Data suggest that receptor-tyrosine kinase HEK2 (EphB3) and phosphatidylinositol 3-kinase catalytic alpha polypeptide (PIK3CA) are cooperating oncogenes that contribute toward its pathogenesis."}, {"pubmed": 29970892, "text": "PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer."}, {"pubmed": 29975751, "text": "a subset of PIK3CAmut promote tumorigenesis"}, {"pubmed": 29980193, "text": "LASP1 may function as an oncogene in glioblastoma and regulate cell proliferation and chemosensitivity in a PI3K/AKT-dependent mechanism."}, {"pubmed": 29985963, "text": "Results show that activating PIK3CA mutations in lymphatic malformations are specifically localized in lymphatic endothelial cells (LECs); identified a new mutation in exon 10 and a Glu109 deletion of the gene and show that several kinase inhibitors have the potential to block LEC proliferation."}, {"pubmed": 30018674, "text": "in Stage I colorectal cancer presence of KRAS mutations, that of simultaneous mutations in PIK3CA gene, or that of multiple KRAS mutations was significantly associated with shorter cancer specific survival; PIK3CA or multiple KRAS mutations were associated with nodal micrometastases and poorly differentiated clusters G3 as well"}, {"pubmed": 30025897, "text": "To investigate the reasons for which miR-375 holds a special place among circulating miRNAs in Acute myocardial infarction (MI), enrichment and network analyses of miR-375 target genes and their interactions were carried out. PIK3CA and TP53 genes, regulated by miR-375, were identified as the key players of MI disease module."}, {"pubmed": 30032537, "text": "A high proportion of isolated macrodactyly patients carry a PIK3CA mutation."}, {"pubmed": 30047470, "text": "PIK3CA overexpression is associated with esophageal squamous cell cancer."}, {"pubmed": 30066935, "text": "High PIK3CA expression is associated with metastasis via epithelialmesenchymal transition carcinoma in colorectal cancer."}, {"pubmed": 30075505, "text": "Survival analyses revealed that PIK3CA mutation was a significant prognostic factor for poor overall survival [multivariate adjusted hazard ratio (HR), 3.9; 95% confidence interval (95% CI), 1.3-11.8; P = .017] and cancer-specific survival (multivariate adjusted HR, 3.6; 95% CI, 1.2-11.0; P = .024) in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin."}, {"pubmed": 30106118, "text": "miR152 may have an important role in pancreatic beta cell function, and established an association between miR152 and the PI3Kalpha axis."}, {"pubmed": 30108165, "text": "Study identified a novel F977Y kinase domain PIK3CA mutation exclusively present in a recurrent cell line of head and neck squamous cell carcinoma (HNSCC), potentially conferring resistance to PI3K inhibitors."}, {"pubmed": 30115035, "text": "Multivariate analyses revealed that the PIK3CA mutation and clinical T stage were independent favorable prognostic factors (hazard ratio 0.34, 95% confidence interval: 0.12-0.96, p = 0.042). PIK3CA mutations were significantly associated with APC alterations (p = 0.0007) and BRAF mutations (p = 0.0090)."}, {"pubmed": 30180809, "text": "This overgrowth syndrome is unique and is caused by the somatic PIK3CA mutation c.3140A>G."}, {"pubmed": 30197175, "text": "PIK3CA mutations are found in benign overgrowth syndromes, collectively known as PIK3CA-related overgrowth spectrum. (Review)"}, {"pubmed": 30212483, "text": "findings provided a comprehensive mutation profiling of AKT1, PIK3CA, PTEN and TP53 genes in Chinese breast cancer patients, which have potential implications in clinical management."}, {"pubmed": 30217308, "text": "High PIK3CA expression is associated with gastric cancer."}, {"pubmed": 30218719, "text": "High PI3K expression is associated with periodontitis."}, {"pubmed": 30227836, "text": "In this study, we used the Ion Personal Genome Machine (PGM) and Ion Torrent Ampliseq Cancer panel to sequence hotspot regions from PIK3CA, AKT and PTEN genes to identify genetic mutations in 39 samples of TNBC subtype from Moroccan patients and to correlate the results with clinical-pathologic data"}, {"pubmed": 30341384, "text": "These results demonstrate the dynamical and structural effects induced by the p110alpha E545K mutation in atomic level detail and indicate a possible mechanism for the loss of regulation that E545K confers on PI3Kalpha."}, {"pubmed": 30361395, "text": "Letter: PIK3CA mutation, in particular, mutation of exon 9, has a significant positive association with KRAS mutation in colorectal cancer."}, {"pubmed": 30403311, "text": "Chromatin immunoprecipitation and luciferase reporter gene assays together demonstrated that SOX2 trans-activates PIK3CA and OPA1."}, {"pubmed": 30442683, "text": "these associations may reflect features of the somatic copy-number alteration-high subgroup of uterine corpus endometrial carcinoma rather than effects of PIK3CA amplification itself"}, {"pubmed": 30496799, "text": "there is a difference in PIK3CA mutation, COX-2 expression, and paraneoplastic thromboembolism between ovarian clear cell carcinomas with a different stroma."}, {"pubmed": 30499025, "text": "H2O2 induces oxidative stress to breast cancer tumor cell line MCF-7 in a dose dependent manner. Over-expression of p110alpha protein restores pro-survival effects against H2O2 induced apoptosis and increase phosphorylated proto-oncogene proteins c-akt levels."}, {"pubmed": 30528264, "text": "Via the miR-183-5p/PIK3CA regulatory axis."}, {"pubmed": 30542723, "text": "Levels of miR381 were decreased in clear cell and endometrioid carcinoma ovarian cancer. Experimentally induced upregulation of miR381 led to a decrease in the level of PIK3CA in ovarian cancer cells and inhibition of ovarian cancer cells proliferation and migration."}, {"pubmed": 30547809, "text": "Findings provide evidence that the PI3K E542K and E545K/beta-catenin/SIRT3 signaling axis regulates glucose metabolism and proliferation in cervical cancers with PIK3CA mutations."}, {"pubmed": 30582216, "text": "Data suggest that overexpression of phosphatidylinositol 3-kinase (PI3K), protein kinase B (PKB), and mammalian target of rapamycin (mTOR) proteins is an important indicator of poor survival in nasopharyngeal carcinoma (NPC)."}, {"pubmed": 30582951, "text": "High PIK3CA expression is associated with hepatocellular carcinoma."}, {"pubmed": 30590030, "text": "The RAS-PI3K interaction is an important signaling node and potential therapeutic target in EGFR-mutant lung cancer."}, {"pubmed": 30591517, "text": "Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly."}, {"pubmed": 30630630, "text": "Authors used six whole-exome-sequenced primary HGSOC/USC cell-lines and three xenografts overexpressing HER2/neu and harboring mutated or wild-type PIK3CA/PIK3R1 genes to evaluate the role of PI3K-mutations as potential mechanism of resistance to afatinib."}, {"pubmed": 30652258, "text": "In ER+/HER2- invasive ductal carcinomas of the breast, glucose uptake is independently associated with PIK3CA mutations."}, {"pubmed": 30666840, "text": "PIK3CA silencing inhibited Nalm-6 cell proliferation and invasion, and promoted their apoptosis and sensitivity to chemotherapeutic drugs, potentially through regulation of the PI3K/AKT signaling pathway."}, {"pubmed": 30671946, "text": "Authors found that continuously activating PIK3CA(H1047R) conferred human mammary epithelial MCF-10A cells to cellular senescence upon serum-starvation. Similarly, breast cancer T47D and HCC1954 cells harboring H1047R mutation were senescent when cells were deprived of serum."}, {"pubmed": 30683736, "text": "Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer."}, {"pubmed": 30747208, "text": "The expression levels of ARID1A and PIK3CA in gastric cancer were significantly associated with the depth of invasion of gastric cancer."}, {"pubmed": 30776175, "text": "Gene alterations, such as TP53 mutation, PIK3CA mutation, ERBB2 amplification and CCND1 amplification, and MAPK pathway alteration were associated with pCR in our study."}, {"pubmed": 30789657, "text": "Compared with invasive ductal breast cancer , mucinous breast cancer had a lower genomic instability and a decreased prevalence of PIK3CA mutations"}, {"pubmed": 30806788, "text": "Patients with somatic co-mutation of TP53 and PIK3CA were associated with unfavorable survival compared with non-carriers. Co-mutation of TP53 and PIK3CA could be used as a potential prognosis marker in post-neoadjuvant chemotherapy breast cancer patients."}, {"pubmed": 30842251, "text": "Involving MNK targeting to sensitize medulloblastoma CSCs to PI3Kalpha inhibition."}, {"pubmed": 30844755, "text": "PIK3CA mutations could be essential specifically in early stages of breast carcinogenesis."}, {"pubmed": 30851247, "text": "The ARID1A and PIK3CA were the most frequently mutated genes. Specifically, ARID1A mutations and PIK3CA mutations were detected in 77.8% and 66.7% of ovarian clear cell carcinoma patients, respectively. Mutations in other genes, including MLH1 (6.3%) and CREBBP (6.3%), were detected in the Taiwanese population."}, {"pubmed": 30853353, "text": "Study found that PIK3CA mutations and copy-number gains of chromosome 22q11 were more frequent in a Chinese cohort than in The Cancer Genome Atlas."}, {"pubmed": 30855339, "text": "Oncogenic mutations on PIK3CA causing lymphatic malformations and venous malformations are also frequently found in epithelial cancer."}, {"pubmed": 30888406, "text": "Neither PIK3CA mutations nor Fc-gamma-receptor polymorphisms were associated with sTILs. sTILs may have utility as a prognostic biomarker identifying HER2-positive early breast cancer at low recurrence risk."}, {"pubmed": 30894053, "text": "GORASP2/GRASP55 collaborates with the PtdIns3K UVRAG complex to facilitate autophagosome-lysosome fusion."}, {"pubmed": 30919936, "text": "Early activating somatic PIK3CA mutations promote ectopic muscle development and upper limb overgrowth."}, {"pubmed": 30920860, "text": "PIK3CA mutations might be involved in GC development and might be used as favorable prognostic factor in GC population with low PIK3CA mutations prevalence."}, {"pubmed": 30944457, "text": "Authors propose that inhibition of the WNT pathway, particularly beta-catenin, may bypass resistance to MEK inhibition in human PIK3CA mt colon cancer."}, {"pubmed": 30947633, "text": "Increased PIK3CA expression is associated with Colorectal Cancer."}, {"pubmed": 30948643, "text": "Investigated the role of mutational activation of PI3-kinase p110 subunit alpha (PIK3CA) in cancer and in overgrowth disorders known as PIK3CA-related overgrowth spectrum (PROS) by engineering isogenic human induced pluripotent stem cells (iPSCs) with heterozygous or homozygous knockin of PIK3CA."}, {"pubmed": 30952761, "text": "The current data show that PIK3CA mutations appear to play an important role in carcinogenesis and tumor aggressiveness in Epstein-Barr virus-associated gastric cancer (EBV-GC), and also support the concept that exon 9 mutation of PIK3CA is a prognostic indicator for predicting patient outcomes and a rationale for therapeutic targeting in EBV-GC."}, {"pubmed": 30975125, "text": "Study data from human hepatocellular carcinoma (HCC) liver samples, human HCC cells, and Sgk3 knockout mice model suggest that SGK3 plays a role in transducing helical domain mutant PIK3CA signaling during liver tumor development."}, {"pubmed": 30991934, "text": "Data show that most of the cell lines which exhibited enhanced dependency on RNA guanine-7 methyltransferase (RNMT) harboured oncogenic mutations in phosphatidylinositol 3-kinase catalytic 110-KD alpha (PI3Kalpha)."}, {"pubmed": 31010589, "text": "The data suggest that tumourigenic alterations in the PI3K/AKT-pathway are indispensable in hidradenoma papilliferum (HP) and establish a homogenous morphomolecular entity with a functionally converging and selecting tumourigenic mechanism."}, {"pubmed": 31036078, "text": "PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma."}, {"pubmed": 31094929, "text": "Breast adenomyoepitheliomas are genetically heterogeneous exhibiting recurrent mutually exclusive mutations of PIK3CA and AKT1 in a majority of cases."}, {"pubmed": 31104677, "text": "The study shows a high concordance of KRAS, NRAS, BRAF and PIK3CA gene mutations in plasma against mutation status in tumor tissue."}, {"pubmed": 31112530, "text": "results indicate that tumor cell PIK3CA-AKT signaling limits T cell recognition and clearance of pancreatic cancer cells. Strategies that target this pathway may yield an effective immunotherapy for this cancer."}, {"pubmed": 31139940, "text": "Multiplex PCR analysis of apocrine lesions shows frequent PI3K-AKT pathway mutations in both benign and malignant apocrine breast tumors."}, {"pubmed": 31164688, "text": "Establishment and genomic characterization of gingivobuccal carcinoma cell lines with smokeless tobacco associated genetic alterations and oncogenic PIK3CA mutation."}, {"pubmed": 31230400, "text": "TERT and concurrent PIK3CA mutations predict worse overall survival in poorly differentiated thyroid carcinoma (PDTC)/ anaplastic thyroid carcinoma (ATC) patients."}, {"pubmed": 31250151, "text": "Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1."}, {"pubmed": 31254443, "text": "PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study."}, {"pubmed": 31270600, "text": "PIK3CA expression in triple negative breast cancer is not associated with specific clinical or diagnostic features. Further molecular studies and meta-analysis are warranted to clarify the prognostic and predictive role of PIK3CA protein expression."}, {"pubmed": 31288947, "text": "Interaction between PIK3CA rs2699887 SNP and age, number of liveborn, tobacco, alcohol, a family history of ovarian cancer and other factors are associated with ovarian cancer risk. Interaction between PIK3CA rs3976507 and rs6443626 loci, and factors such as BMI, number of liveborn, tobacco, alcohol, and family history of ovarian cancer are associated with ovarian cancer risk."}, {"pubmed": 31297647, "text": "Our study provides a proof of concept and attests of the feasibility of cfDNA analysis for patients with ER+ locally advanced or metastatic BC. Early identification of this population with cfDNA PIK3CA mutations allows the identification of a population affected by an unfavorable prognosis."}, {"pubmed": 31350972, "text": "PIK3CA gene mutation is associated with cervical Squamous Cell Carcinoma."}, {"pubmed": 31391455, "text": "Study utilized human endometrial epithelial cells to elucidate the consequences of ARID1A loss and PIK3CAH1047R in vitro and discover a mechanism by which ARID1A and PIK3CA mutations result in a partial epithelial-to-mesenchymal transition phenotype capable of collective invasion into the uterine myometrium."}, {"pubmed": 31393349, "text": "THE DIAGNOSIS AND RELAPSE PREDICTION OF PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER WITH FGFR3,TP53 AND PIK3CA GENE MUTATION POSSESSED HIGH ACCURACY"}, {"pubmed": 31402321, "text": "The study met one of its primary endpoints: the addition of taselisib to letrozole was associated with a higher proportion of patients achieving an objective response in all randomly assigned patients (66 [39%] of 168 patients in the placebo group vs 83 [50%] of 166 in the taselisib group; odds ratio [OR] 1.55, 95% CI 1.00-2.38; p=0.049) and in the PIK3CA-mutant subset"}, {"pubmed": 31445671, "text": "Upregulation of PIK3CA lead to the clonal amplification of tumor cells during progression of invasive Colorectal Adenocarcinoma."}, {"pubmed": 31472672, "text": "PIK3CA expression may play an important role in tumor immune microenvironment and could alter fraction of tumor associated neutrophils in uterine corpus endometrial carcinoma ."}, {"pubmed": 31481664, "text": "PIK3CA mutations in lipomatosis of nerve with or without nerve territory overgrowth."}, {"pubmed": 31490637, "text": "Predisposition to thrombosis is likely multifactorial with risk factors including chronic stasis within vascular malformations, stasis from impaired mobility (e.g., following surgery), decreased anticoagulant proteins, and effects of AKT1 and PIK3CA variants on vascular endothelium"}, {"pubmed": 31513749, "text": "Talc-sensitive cells have higher mRNA and protein expression of PI3K catalytic subunit alpha. Both PI3Kalpha and -beta mediate talc-induced cell death and IL-6 secretion in lung carcinoma cells."}, {"pubmed": 31536475, "text": "Genotype correlates with clinical severity in PIK3CA-associated lymphatic malformations."}, {"pubmed": 31554385, "text": "High PIK3CA Expression of PTEN is associated with Breast Cancer."}, {"pubmed": 31594701, "text": "NSAID therapy for PIK3CA-Altered colorectal, breast, and head and neck cancer."}, {"pubmed": 31600013, "text": "Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma."}, {"pubmed": 31629932, "text": "Expression of miR-337-3p is down-regulated in epithelial ovarian cancer (EOC) tissues and low expression of miR-337-3p is correlated with advanced pathological grade for patients. PIK3CA and PIK3CB were revealed to be direct targets of miR-337-3p. In vivo investigation confirmed that miR-337-3p is a tumor suppressor that control expression of PIK3CA and PIK3CB encoded protein: p110alpha and p110beta."}, {"pubmed": 31630434, "text": "Soft tissue angiomatosis: another PIK3CA-related disorder."}, {"pubmed": 31638167, "text": "Study investigated the presence of FGFR3 and PIK3CA mutations in neuroblastomas (NBs) and tested NB cell lines for sensitivity to FGFR and PI3K inhibitors. Following treatment with FGFR and PI3K inhibitors, a decrease in viability and proliferation was observed in the majority, but not all, the cell lines. Study findings demonstrate that FGFR3 and PIK3CA mutations are uncommon in patients with NB."}, {"pubmed": 31680442, "text": "Integrative transcriptomic and proteomic analysis reveals CD9/ITGA4/PI3K-Akt axis mediates trabecular meshwork cell apoptosis in human glaucoma."}, {"pubmed": 31699932, "text": "this study identified double mutations in cis as a distinctive and relatively common genomic alteration in PIK3CA, the most frequently mutated oncogene in human cancer"}, {"pubmed": 31711466, "text": "PIK3CA mutation is associated with lung cancer risk."}, {"pubmed": 31729162, "text": "Growth hormone deficiency in megalencephaly-capillary malformation syndrome: An association with activating mutations in PIK3CA."}, {"pubmed": 31746363, "text": "Knockdown of Ski decreases osteosarcoma cell proliferation and migration by suppressing the PI3K/Akt signaling pathway."}, {"pubmed": 31747025, "text": "PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation."}, {"pubmed": 31749428, "text": "Phosphatidylinositol 3-kinase Glu545Lys and His1047Tyr Mutations are not Associated with T2D."}, {"pubmed": 31781598, "text": "The neoantigen-associated mutations PIK3CA (p.H1047R) and TP53 (p.R175H) are common across several cancer types, indicating their potential usage."}, {"pubmed": 31810385, "text": "LINC01518 knockdown inhibited tumorigenicity in ESCC cells by suppression of PIK3CA/Akt pathway through upregulating miR-1-3p"}, {"pubmed": 31814034, "text": "Bladder cancer cellsecreted exosomal miR21 activates the PI3K/AKT pathway in macrophages to promote cancer progression."}, {"pubmed": 31831213, "text": "Defining How Oncogenic and Developmental Mutations of PIK3R1 Alter the Regulation of Class IA Phosphoinositide 3-Kinases."}, {"pubmed": 31831300, "text": "Mutational status of PIK3ca oncogene in oral cancer-In the new age of PI3K inhibitors."}, {"pubmed": 31909475, "text": "Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants."}, {"pubmed": 31954697, "text": "our study revealed a crucial regulatory network of LINC00152/miR-139/PIK3CA axis in the tumorigenesis of hepatocellular carcinoma"}, {"pubmed": 31970497, "text": "PIK3CA mutations and specific treatment: do not forget lessons from RAS mutations and EGFR targeting."}, {"pubmed": 31980592, "text": "PIK3CA gene mutations in the helical domain correlate with high tumor mutation burden and poor prognosis in metastatic breast carcinomas with late-line therapies."}, {"pubmed": 31983154, "text": "BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model."}, {"pubmed": 31992579, "text": "Detecting mosaic variants in patients with somatic overgrowth syndromes using cell-free circulating DNA and deep sequencing."}, {"pubmed": 32052902, "text": "Putative functional variants of PI3K/AKT/mTOR pathway are associated with knee osteoarthritis susceptibility."}, {"pubmed": 32088208, "text": "Juvenile papillomatosis of the breast (Swiss cheese disease) has frequent associations with PIK3CA and/or AKT1 mutations."}, {"pubmed": 32112900, "text": "Pik3ca mutations significantly enhance the growth of SHH medulloblastoma and lead to metastatic tumour growth in a novel mouse model."}, {"pubmed": 32123305, "text": "Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis."}, {"pubmed": 32161312, "text": "Co-inhibition of BET proteins and PI3Kalpha triggers mitochondrial apoptosis in rhabdomyosarcoma cells."}, {"pubmed": 32186774, "text": "miR10a increases the cisplatin resistance of lung adenocarcinoma circulating tumor cells via targeting PIK3CA in the PI3K/Akt pathway."}, {"pubmed": 32234362, "text": "A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR(+)/HER2(-) Metastatic Breast Cancer."}, {"pubmed": 32323827, "text": "MicroRNA3633p inhibits cell proliferation and induces apoptosis in retinoblastoma cells via the Akt/mTOR signaling pathway by targeting PIK3CA."}, {"pubmed": 32350708, "text": "Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation."}, {"pubmed": 32365913, "text": "Mutation-Associated Phenotypic Heterogeneity in Novel and Canonical PIK3CA Helical and Kinase Domain Mutants."}, {"pubmed": 32367667, "text": "Survival prediction model for non-small cell lung cancer based on somatic mutations."}, {"pubmed": 32404150, "text": "Frequency and spectrum of PIK3CA somatic mutations in breast cancer."}, {"pubmed": 32410843, "text": "Clinicopathological Characteristics of PIK3CA Mutation and Amplification in Korean Patients with Breast Cancers."}, {"pubmed": 32413215, "text": "Clinical overlap between CLAPO syndrome and macrocephaly-capillary malformation syndrome."}, {"pubmed": 32415497, "text": "TRPC1 inhibits the proliferation and migration of estrogen receptor-positive Breast cancer and gives a better prognosis by inhibiting the PI3K/AKT pathway."}, {"pubmed": 32417393, "text": "miR-155 facilitates calcium oxalate crystal-induced HK-2 cell injury via targeting PI3K associated autophagy."}, {"pubmed": 32451180, "text": "Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer."}, {"pubmed": 32461963, "text": "The Predictive Role of PIK3CA Mutation Status on PI3K Inhibitors in HR+ Breast Cancer Therapy: A Systematic Review and Meta-Analysis."}, {"pubmed": 32513927, "text": "Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation."}, {"pubmed": 32606397, "text": "PI3K activation is enhanced by FOXM1D binding to p110 and p85 subunits."}, {"pubmed": 32616873, "text": "Comprehensive genomic profiling reveals ubiquitous KRAS mutations and frequent PIK3CA mutations in ovarian seromucinous borderline tumor."}, {"pubmed": 32632138, "text": "Activating PIK3CA mutation promotes osteogenesis of bone marrow mesenchymal stem cells in macrodactyly."}, {"pubmed": 32652112, "text": "Identifying oncogenic drivers associated with increased risk of late distant recurrence in postmenopausal, estrogen receptor-positive, HER2-negative early breast cancer: results from the BIG 1-98 study."}, {"pubmed": 32653099, "text": "PIK3CA mutation and CNV status and post-chemoradiotherapy survival in patients with cervical cancer."}, {"pubmed": 32662895, "text": "Frequent activating PIK3CA mutations in sporadic angiolipoma."}, {"pubmed": 32683364, "text": "PIK3CA Mutations and Their Impact on Survival Outcomes of Patients with Cervical Cancer: A Systematic Review."}, {"pubmed": 32705244, "text": "miR1425p inhibits pancreatic cancer cell migration and invasion by targeting PIK3CA."}, {"pubmed": 32732866, "text": "Activating PIK3CA mutation promotes adipogenesis of adipose-derived stem cells in macrodactyly via up-regulation of E2F1."}, {"pubmed": 32778138, "text": "Detailed analysis of phenotypes and genotypes in megalencephaly-capillary malformation-polymicrogyria syndrome caused by somatic mosaicism of PIK3CA mutations."}, {"pubmed": 32823607, "text": "Enforced C-Src Activation Causes Compartmental Dysregulation of PI3K and PTEN Molecules in Lipid Rafts of Tongue Squamous Carcinoma Cells by Attenuating Rac1-Akt-GLUT-1-Mediated Sphingolipid Synthesis."}, {"pubmed": 32843527, "text": "PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2(+) Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype."}, {"pubmed": 32876734, "text": "A novel method for isolating lymphatic endothelial cells from lymphatic malformations and detecting PIK3CA somatic mutation in these isolated cells."}, {"pubmed": 32892196, "text": "Comprehensive Immuno-Molecular Profiles for Liposarcoma: Roles of Programmed Death Ligand 1, Microsatellite Instability, and PIK3CA."}, {"pubmed": 32901329, "text": "Cerebellar dysplasia related to PIK3CA mutation: a three-case series."}, {"pubmed": 32908885, "text": "Clinical Significance of PIK3CA Gene in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis."}, {"pubmed": 32929011, "text": "PIK3CA C-terminal frameshift mutations are novel oncogenic events that sensitize tumors to PI3K-alpha inhibition."}, {"pubmed": 32946066, "text": "RP11-462C24.1 suppresses proliferation and invasion of colorectal carcinoma cells by regulating HSP70 through PI3K/AKT signaling pathway."}, {"pubmed": 32976773, "text": "Metabolic Imaging Detects Resistance to PI3Kalpha Inhibition Mediated by Persistent FOXM1 Expression in ER(+) Breast Cancer."}, {"pubmed": 32988919, "text": "Predictive Role of TP53, PIK3CA and MLL2 in ER+ HER2+ Breast Bancer: Biomarker Analysis of Neo-ALL-IN [NCT 01275859]."}, {"pubmed": 33047659, "text": "Clinical-Pathologic Analysis of Breast Cancer With PIK3CA Mutations in Chinese Women."}, {"pubmed": 33049397, "text": "PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients."}, {"pubmed": 33054853, "text": "Phenotypic and genetic spectrum of isolated macrodactyly: somatic mosaicism of PIK3CA and AKT1 oncogenic variants."}, {"pubmed": 33139939, "text": "Phosphatidylinositol-3-OH kinase signalling is spatially organized at endosomal compartments by microtubule-associated protein 4."}, {"pubmed": 33166334, "text": "Prediction of PIK3CA mutations from cancer gene expression data."}, {"pubmed": 33189828, "text": "A novel carcinogenic PI3Kalpha mutation suggesting the role of helical domain in transmitting nSH2 regulatory signals to kinase domain."}, {"pubmed": 33288731, "text": "Phosphorylation and Driver Mutations in PI3Kalpha and PTEN Autoinhibition."}, {"pubmed": 33290961, "text": "The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma."}, {"pubmed": 33375766, "text": "N-Phenyl-6-Chloro-4-Hydroxy-2-Quinolone-3-CarboxAmides: Molecular Docking, Synthesis, and Biological Investigation as Anticancer Agents."}, {"pubmed": 33386585, "text": "PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing."}, {"pubmed": 33400797, "text": "Divergent molecular profile of PIK3CA gene in arsenic-associated bladder carcinoma."}, {"pubmed": 33428122, "text": "Relationship between TSHR, BRAF and PIK3CA gene copy number variations and thyroid nodules."}, {"pubmed": 33526718, "text": "Distinct epithelial-to-mesenchymal transitions induced by PIK3CA (H1047R) and PIK3CB."}, {"pubmed": 33537093, "text": "Hypoxia-induced Nur77 activates PI3K/Akt signaling via suppression of Dicer/let-7i-5p to induce epithelial-to-mesenchymal transition."}, {"pubmed": 33539876, "text": "Biophysical and Structural Characterization of Novel RAS-Binding Domains (RBDs) of PI3Kalpha and PI3Kgamma."}, {"pubmed": 33602685, "text": "Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer."}, {"pubmed": 33606974, "text": "Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis."}, {"pubmed": 33671468, "text": "Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer."}, {"pubmed": 33689479, "text": "Inhibition of P110alpha and P110delta catalytic subunits of PI3 kinase reverses impaired arterial healing after injury in hypercholesterolemic male mice."}, {"pubmed": 33723394, "text": "PI3K activation promotes resistance to eribulin in HER2-negative breast cancer."}, {"pubmed": 33723724, "text": "Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations."}, {"pubmed": 33729480, "text": "Somatic MAP3K3 and PIK3CA mutations in sporadic cerebral and spinal cord cavernous malformations."}, {"pubmed": 33744168, "text": "The Landscape of PIK3CA Mutations in Colorectal Cancer."}, {"pubmed": 33785733, "text": "PI3Kalpha inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma."}, {"pubmed": 33794206, "text": "Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study."}, {"pubmed": 33811903, "text": "MEX3A promotes development and progression of breast cancer through regulation of PIK3CA."}, {"pubmed": 33827485, "text": "Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer."}, {"pubmed": 33834328, "text": "Correlation between SNPs of PIK3CA, ERBB2 3'UTR, and their interactions with environmental factors and the risk of epithelial ovarian cancer."}, {"pubmed": 33887328, "text": "Pharmacological and cell-specific genetic PI3Kalpha inhibition worsens cardiac remodeling after myocardial infarction."}, {"pubmed": 33910229, "text": "PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism."}, {"pubmed": 33922925, "text": "Secretion of Mutant DNA and mRNA by the Exosomes of Breast Cancer Cells."}, {"pubmed": 33947692, "text": "A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA-Mutated HER2-Positive Metastatic Breast Cancer."}, {"pubmed": 33952589, "text": "High frequency of PIK3CA and TERT promoter mutations in fibromatosis-like spindle cell carcinomas."}, {"pubmed": 33954864, "text": "Spectrum of PIK3CA/AKT mutations across molecular subtypes of triple-negative breast cancer."}, {"pubmed": 34012039, "text": "Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy."}, {"pubmed": 34023498, "text": "The role of different PI3K protein subtypes in the metastasis, angiogenesis and clinical prognosis of hepatocellular carcinoma."}, {"pubmed": 34033220, "text": "Pancreatic cancer intrinsic PI3Kalpha activity accelerates metastasis and rewires macrophage component."}, {"pubmed": 34035258, "text": "INPP4B promotes PI3Kalpha-dependent late endosome formation and Wnt/beta-catenin signaling in breast cancer."}, {"pubmed": 34036385, "text": "QPCT regulation by CTCF leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesis."}, {"pubmed": 34072735, "text": "Detection of PIK3CA Gene Mutation in Head and Neck Squamous Cell Carcinoma Using Droplet Digital PCR and RT-qPCR."}, {"pubmed": 34102393, "text": "Effect of PIK3CA variants on glioma-related epilepsy and response to treatment."}, {"pubmed": 34108622, "text": "Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations."}, {"pubmed": 34172890, "text": "Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma."}, {"pubmed": 34185934, "text": "Quadruple-editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS-mutated colorectal cancer cells."}, {"pubmed": 34217313, "text": "Analysis of EGFR, KRAS, and PIK3CA gene mutation rates and clinical distribution in patients with different types of lung cancer."}, {"pubmed": 34244973, "text": "Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation."}, {"pubmed": 34268930, "text": "Investigation of somatic PIK3CA gene mutations in breast cancer patients."}, {"pubmed": 34326682, "text": "Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway."}, {"pubmed": 34344439, "text": "Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA."}, {"pubmed": 34377593, "text": "Association of PIK3CA mutation and PTEN loss with expression of CD274 (PD-L1) in colorectal carcinoma."}, {"pubmed": 34397726, "text": "Aberrant PTEN, PIK3CA, pMAPK, and TP53 expression in human scalp and face angiosarcoma."}, {"pubmed": 34402524, "text": "Kaposiform hemangioendothelioma further broadens the phenotype of PIK3CA-related overgrowth spectrum."}, {"pubmed": 34421886, "text": "Predictive Value of the TP53/PIK3CA/ATM Mutation Classifier for Patients With Bladder Cancer Responding to Immune Checkpoint Inhibitor Therapy."}, {"pubmed": 34479035, "text": "PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers."}, {"pubmed": 34496175, "text": "Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations."}, {"pubmed": 34507989, "text": "Cancer-associated mutations in the p85alpha N-terminal SH2 domain activate a spectrum of receptor tyrosine kinases."}, {"pubmed": 34519764, "text": "Double PIK3CA Alterations and Parallel Evolution in Colorectal Cancers."}, {"pubmed": 34580062, "text": "A PLCB1-PI3K-AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression."}, {"pubmed": 34591642, "text": "A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity."}, {"pubmed": 34606700, "text": "Aberrant muscular hyperplasia of the hand and PIK3CA related overgrowth spectrum disorders. A case series study.\", trans \"Hiperplasia muscular aberrante de la mano y sindromes de sobrecrecimiento relacionados con el PIK3CA. Serie de casos."}, {"pubmed": 34619871, "text": "[PIK3CA copy number gain in esophageal squamous cell carcinoma and its prognostic significance]."}, {"pubmed": 34643313, "text": "Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub-analysis of the ProfiLER protocol."}, {"pubmed": 34655667, "text": "EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition."}, {"pubmed": 34697060, "text": "DNA Methylation Profiles of Ovarian Clear Cell Carcinoma."}, {"pubmed": 34709960, "text": "CBX2 Induces Glioma Cell Proliferation and Invasion Through the Akt/PI3K Pathway."}, {"pubmed": 34751411, "text": "PIK3CA mutation affects the proliferation of colorectal cancer cells through the PI3K-MEK/PDK1-GPT2 pathway."}, {"pubmed": 34754095, "text": "Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients."}, {"pubmed": 34849446, "text": "Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease."}, {"pubmed": 34876602, "text": "Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors."}, {"pubmed": 34887309, "text": "Cerebrofacial vascular metameric syndrome is caused by somatic pathogenic variants in PIK3CA."}, {"pubmed": 34911971, "text": "Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients."}, {"pubmed": 34990021, "text": "PIP3 abundance overcomes PI3K signaling selectivity in invadopodia."}, {"pubmed": 35013169, "text": "A mass spectrometric method for in-depth profiling of phosphoinositide regioisomers and their disease-associated regulation."}, {"pubmed": 35013316, "text": "Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions."}, {"pubmed": 35094709, "text": "PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibfibroipose vascular anomaly (FAVA)."}, {"pubmed": 35122151, "text": "Activating PIK3CA postzygotic mutations in segmental overgrowth of muscles with bone involvement in the body extremities."}, {"pubmed": 35180531, "text": "Comparison of mutational profiles between triple-negative and hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancers in T2N0-1M0 stage: Implications of TP53 and PIK3CA mutations in Korean early-stage breast cancers."}, {"pubmed": 35193694, "text": "Introduction and expression of PIK3CA(E545K) in a papillary thyroid cancer BRAF(V600E) cell line leads to a dedifferentiated aggressive phenotype."}, {"pubmed": 35253277, "text": "Intertumor and intratumor heterogeneity of PIK3CA mutations in extramammary Paget's disease."}, {"pubmed": 35253909, "text": "Mutations in the telomerase reverse transcriptase promoter and PIK3CA gene are common events in penile squamous cell carcinoma of Italian and Ugandan patients."}, {"pubmed": 35272946, "text": "PIK3CA-related overgrowth: silver bullets from the cancer arsenal?"}, {"pubmed": 35273332, "text": "Myoepithelial progenitors as founder cells of hyperplastic human breast lesions upon PIK3CA transformation."}, {"pubmed": 35277182, "text": "Circ-ZEB1 promotes PIK3CA expression by silencing miR-199a-3p and affects the proliferation and apoptosis of hepatocellular carcinoma."}, {"pubmed": 35317488, "text": "AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients biopsies and matched urine."}, {"pubmed": 35357905, "text": "PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer."}, {"pubmed": 35435290, "text": "Mutation patterns and prognostic analysis of BRAF/KRAS/PIK3CA in colorectal cancer."}, {"pubmed": 35459184, "text": "CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells."}, {"pubmed": 35468270, "text": "Analysis of PIK3CA Mutation Concordance and Frequency in Primary and Different Distant Metastatic Sites in Breast Cancer."}, {"pubmed": 35484264, "text": "Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA."}, {"pubmed": 35595465, "text": "Absence of PIK3CA mutation in primary mucinous ovarian carcinoma: An analysis of 20 Taiwanese cases by FemtoPath PIK3CA mutation screen kit."}, {"pubmed": 35619132, "text": "PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN."}, {"pubmed": 35689797, "text": "Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations."}, {"pubmed": 35718818, "text": "Reciprocal regulation of Daxx and PIK3CA promotes colorectal cancer cell growth."}, {"pubmed": 35767139, "text": "Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer."}, {"pubmed": 35778737, "text": "Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population."}, {"pubmed": 35787784, "text": "Genomic landscape of lymphatic malformations: a case series and response to the PI3Kalpha inhibitor alpelisib in an N-of-1 clinical trial."}, {"pubmed": 35914729, "text": "Loss of PTEN Expression, PIK3CA Mutations, and Breast Cancer Survival in the Nurses' Health Studies."}, {"pubmed": 35951471, "text": "Hippo-YAP signaling activation and cross-talk with PI3K in oral cancer: A retrospective cohort study."}, {"pubmed": 36097803, "text": "PIK3CA Mutation is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients."}, {"pubmed": 36131248, "text": "PIK3CA mutation status, progression and survival in advanced HR + /HER2- breast cancer: a meta-analysis of published clinical trials."}, {"pubmed": 36177801, "text": "Energy balance-related factors in childhood and adolescence and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status."}, {"pubmed": 36243681, "text": "PIK3CA mutations associated with a poor postoperative prognosis in patients with pulmonary pleomorphic carcinoma: a retrospective cohort study."}, {"pubmed": 36279023, "text": "PIK3CA-mutations in breast cancer."}, {"pubmed": 36346122, "text": "PIK3CA somatic mutations as potential biomarker for immunotherapy in elder or TP53 mutated gastric cancer patients."}, {"pubmed": 36438913, "text": "Long non-coding RNA ncRuPAR regulates gastric cancer cell proliferation and apoptosis via phosphoinositide 3-kinase/protein kinase B signaling."}, {"pubmed": 36458889, "text": "Clinical and functional characterization of germline PIK3CA variants in patients with PIK3CA-related overgrowth spectrum disorders."}, {"pubmed": 36469488, "text": "JCAD promotes arterial thrombosis through PI3K/Akt modulation: a translational study."}, {"pubmed": 36480834, "text": "[PIK3CA gene mutations in Chinese women with HR[+]/HER2[-] breast cancer]."}, {"pubmed": 36516931, "text": "Predictive and prognostic value of PIK3CA mutations in HER2-positive breast cancer treated with tyrosine kinase inhibitors: A systematic review and meta-analysis."}, {"pubmed": 36544080, "text": "HMGB1 promotes Ox-LDL-induced endothelial cell damage by inhibiting PI3K/Akt signaling pathway."}, {"pubmed": 36563059, "text": "An integrated investigation of structural and pathway alteration caused by PIK3CA and TP53 mutations identified in cfDNA of metastatic breast cancer."}, {"pubmed": 36567775, "text": "Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma."}, {"pubmed": 36595567, "text": "Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations."}, {"pubmed": 36635288, "text": "Oncogenic mutations of PIK3CA lead to increased membrane recruitment driven by reorientation of the ABD, p85 and C-terminus."}, {"pubmed": 36661655, "text": "Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal Cancer."}, {"pubmed": 36788078, "text": "Early Triple-Negative Breast Cancers in a Singapore Cohort Exhibit High PIK3CA Mutation Rates Associated With Low PD-L1 Expression."}, {"pubmed": 36791204, "text": "Microphysiological model of PIK3CA-driven vascular malformations reveals a role of dysregulated Rac1 and mTORC1/2 in lesion formation."}, {"pubmed": 36799863, "text": "Dysregulation of Mitochondrial Translation Caused by CBFB Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer."}, {"pubmed": 36843384, "text": "Frequent PIK3CA mutation in normal endometrial gland drives spheroid formation and may be involved in stem cell propagation."}, {"pubmed": 36898331, "text": "Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer."}, {"pubmed": 36931626, "text": "PI3Kalpha Translocation Mediates Nuclear PtdIns(3,4,5)P3 Effector Signaling in Colorectal Cancer."}, {"pubmed": 36934165, "text": "PIK3CA and PIK3R1 tumor mutational landscape in a pan-cancer patient cohort and its association with pathway activation and treatment efficacy."}, {"pubmed": 36943861, "text": "PIK3CA mutations and their impact on survival outcomes of patients with endometrial cancer: A systematic review and meta-analysis."}, {"pubmed": 36951936, "text": "CDK12 Promotes the Proliferation, Migration, and Angiogenesis of Gastric Carcinoma via Activating the PI3K/AKT/mTOR Signaling Pathway."}, {"pubmed": 36974808, "text": "PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy."}, {"pubmed": 36976740, "text": "[Landscape of KRAS, BRAF, and PIK3CA Mutations and Clinical Features of EBV-Associated and Microsatellite Unstable Gastric Cancer]."}, {"pubmed": 37067587, "text": "PIK3CA mutation testing as a valuable molecular surrogate for lipomatosis of the median nerve: clinicopathological and molecular analysis of six cases."}, {"pubmed": 37106324, "text": "The impact of PIK3CA mutations and PTEN expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patients."}, {"pubmed": 37170094, "text": "PIK3CA mutation in endometriotic epithelial cells promotes viperin-dependent inflammatory response to insulin."}, {"pubmed": 37172903, "text": "Localized Endometrial Proliferations of Pregnancy are Clonal Glandular Outgrowths Characterized by PTEN Loss and PIK3CA Pathogenic Variants."}, {"pubmed": 37195967, "text": "PIK3CA mutations in breast cancer: A Tunisian series."}, {"pubmed": 37265453, "text": "Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer."}, {"pubmed": 37272638, "text": "Expression and Correlation Research of MicroRNA10a-5p and PIK3CA in Middle Ear Cholesteatoma."}, {"pubmed": 37272756, "text": "Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21-CDK4/6-Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance."}, {"pubmed": 37318009, "text": "Loss of PI3Kalpha Mediates Protection From Myocardial Ischemia-Reperfusion Injury Linked to Preserved Mitochondrial Function."}, {"pubmed": 37341201, "text": "Association between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapy."}, {"pubmed": 37341658, "text": "PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma."}, {"pubmed": 37344660, "text": "Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer."}, {"pubmed": 37392328, "text": "Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis."}, {"pubmed": 37498306, "text": "Lipid-correlated alterations in the transcriptome are enriched in several specific pathways in the postmortem prefrontal cortex of Japanese patients with schizophrenia."}, {"pubmed": 37593912, "text": "Knockdown of BUB1 inhibits tumor necrosis factor-alpha-induced proliferation and migration of rheumatoid arthritis synovial fibroblasts by regulating PI3K/Akt pathway."}, {"pubmed": 37628868, "text": "Clinical, Pathological and Molecular Insights on KRAS, NRAS, BRAF, PIK3CA and TP53 Mutations in Metastatic Colorectal Cancer Patients from Northeastern Romania."}, {"pubmed": 37658401, "text": "Somatic mutation spectrum of a Chinese cohort of pediatrics with vascular malformations."}, {"pubmed": 37705207, "text": "Microcystic lymphatic malformations in Turner syndrome are due to somatic mosaicism of PIK3CA."}, {"pubmed": 37712948, "text": "Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibition."}, {"pubmed": 37784176, "text": "Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis."}, {"pubmed": 37839360, "text": "NOTCH1 and PIK3CA mutation are related to HPV-associated vulvar squamous cell carcinoma."}, {"pubmed": 37916958, "text": "Allosteric PI3Kalpha Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations."}, {"pubmed": 37949664, "text": "Molecular characterization of 13 patients with PIK3CA-related overgrowth spectrum using a targeted deep sequencing approach."}, {"pubmed": 37961947, "text": "Evaluation of tumor-infiltrating lymphocytes, PD-L1, and PIK3CA mutations and association with prognosis in HER2-positive early stage breast cancer."}, {"pubmed": 37965796, "text": "Oncogenic PIK3CA recruits myeloid-derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5-lipoxygenase-dependent arachidonic acid pathway."}, {"pubmed": 37968472, "text": "APC/PIK3CA mutations and beta-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells."}, {"pubmed": 37980588, "text": "The p110alpha/DeltaNp63alpha complex mutations in triple-negative breast cancer: Potential targets for transcriptional-based therapies."}, {"pubmed": 37983855, "text": "Mucinous cystadenocarcinoma of the breast harbours TRPS1 expressions and PIK3CA alterations."}, {"pubmed": 38015548, "text": "Mutational and expressional association of the PIK3CA gene with the risk of breast cancer in the Pakistani population."}, {"pubmed": 38017109, "text": "Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer."}, {"pubmed": 38117494, "text": "Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer."}, {"pubmed": 38194422, "text": "PIK3CA regulates development of diabetes retinopathy through the PI3K/Akt/mTOR pathway."}, {"pubmed": 38238254, "text": "PIK3CA mutation status in apocrine carcinoma arising in apocrine gland hyperplasia/apocrine nevus: A study of four cases."}, {"pubmed": 38432445, "text": "PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities."}, {"pubmed": 38466449, "text": "PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer."}, {"pubmed": 38582077, "text": "Cryo-EM structures reveal two allosteric inhibition modes of PI3Kalpha[H1047R] involving a re-shaping of the activation loop."}, {"pubmed": 38822093, "text": "PIK3CA mutations in endocrine-resistant breast cancer."}, {"pubmed": 38842935, "text": "PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis."}, {"pubmed": 38891994, "text": "Genetic Insights into Colorectal Cancer: Evaluating PI3K/AKT Signaling Pathway Genes Expression."}], "genomic_pos": {"chr": "3", "end": 179240093, "ensemblgene": "ENSG00000121879", "start": 179148114, "strand": 1}, "genomic_pos_hg19": {"chr": "3", "end": 178957881, "start": 178865902, "strand": 1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001525", "qualifier": "involved_in", "term": "angiogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001889", "qualifier": "involved_in", "term": "liver development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001932", "qualifier": "involved_in", "term": "regulation of protein phosphorylation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0001944", "pubmed": 19200708, "qualifier": "involved_in", "term": "vasculature development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006006", "qualifier": "involved_in", "term": "glucose metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006909", "qualifier": "involved_in", "term": "phagocytosis"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007173", "qualifier": "involved_in", "term": "epidermal growth factor receptor signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0008286", "pubmed": 19200708, "qualifier": "involved_in", "term": "insulin receptor signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0010592", "qualifier": "involved_in", "term": "positive regulation of lamellipodium assembly"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010629", "qualifier": "involved_in", "term": "negative regulation of gene expression"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014823", "qualifier": "involved_in", "term": "response to activity"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014870", "qualifier": "involved_in", "term": "response to muscle inactivity"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0016242", "pubmed": 23778976, "qualifier": "involved_in", "term": "negative regulation of macroautophagy"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0016310", "pubmed": 25327288, "qualifier": "acts_upstream_of_or_within", "term": "phosphorylation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0016477", "qualifier": "involved_in", "term": "cell migration"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030036", "qualifier": "involved_in", "term": "actin cytoskeleton organization"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0030168", "pubmed": 21035500, "qualifier": "involved_in", "term": "platelet activation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030835", "qualifier": "involved_in", "term": "negative regulation of actin filament depolymerization"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0031295", "qualifier": "involved_in", "term": "T cell costimulation"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0032008", "pubmed": 23778976, "qualifier": "involved_in", "term": "positive regulation of TOR signaling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032869", "pubmed": 24529379, "qualifier": "involved_in", "term": "cellular response to insulin stimulus"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0035994", "qualifier": "involved_in", "term": "response to muscle stretch"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0036092", "qualifier": "involved_in", "term": "phosphatidylinositol-3-phosphate biosynthetic process"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0038084", "pubmed": 30496354, "qualifier": "involved_in", "term": "vascular endothelial growth factor signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0040014", "qualifier": "involved_in", "term": "regulation of multicellular organism growth"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043201", "qualifier": "involved_in", "term": "response to L-leucine"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0043276", "pubmed": 23778976, "qualifier": "involved_in", "term": "anoikis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043457", "qualifier": "involved_in", "term": "regulation of cellular respiration"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0043491", "qualifier": "involved_in", "term": "phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0043491", "pubmed": 30496354, "qualifier": "involved_in", "term": "phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043491", "pubmed": 30568254, "qualifier": "involved_in", "term": "phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043524", "qualifier": "involved_in", "term": "negative regulation of neuron apoptotic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0043542", "pubmed": 19200708, "qualifier": "involved_in", "term": "endothelial cell migration"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0046854", "qualifier": "involved_in", "term": "phosphatidylinositol phosphate biosynthetic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048009", "qualifier": "involved_in", "term": "insulin-like growth factor receptor signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0048015", "qualifier": "involved_in", "term": "phosphatidylinositol-mediated signaling"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048661", "qualifier": "involved_in", "term": "positive regulation of smooth muscle cell proliferation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0050852", "qualifier": "involved_in", "term": "T cell receptor signaling pathway"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0051897", "pubmed": 30496354, "qualifier": "involved_in", "term": "positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0055119", "qualifier": "involved_in", "term": "relaxation of cardiac muscle"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0060048", "pubmed": 19147653, "qualifier": "involved_in", "term": "cardiac muscle contraction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060612", "qualifier": "involved_in", "term": "adipose tissue development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071333", "qualifier": "involved_in", "term": "cellular response to glucose stimulus"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0071464", "pubmed": 30568254, "qualifier": "involved_in", "term": "cellular response to hydrostatic pressure"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071548", "qualifier": "involved_in", "term": "response to dexamethasone"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0086003", "qualifier": "involved_in", "term": "cardiac muscle cell contraction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0097009", "qualifier": "involved_in", "term": "energy homeostasis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0110053", "qualifier": "involved_in", "term": "regulation of actin filament organization"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0141068", "qualifier": "involved_in", "term": "autosome genomic imprinting"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1903544", "qualifier": "involved_in", "term": "response to butyrate"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1905477", "pubmed": 28676499, "qualifier": "involved_in", "term": "positive regulation of protein localization to membrane"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:2000270", "qualifier": "involved_in", "term": "negative regulation of fibroblast apoptotic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:2000811", "pubmed": 22402981, "qualifier": "involved_in", "term": "negative regulation of anoikis"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:2000811", "pubmed": 22402981, "qualifier": "involved_in", "term": "negative regulation of anoikis"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005942", "qualifier": "part_of", "term": "phosphatidylinositol 3-kinase complex"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005943", "qualifier": "part_of", "term": "phosphatidylinositol 3-kinase complex, class IA"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005943", "pubmed": 22402981, "qualifier": "part_of", "term": "phosphatidylinositol 3-kinase complex, class IA"}, {"evidence": "IPI", "gocategory": "CC", "id": "GO:0005943", "pubmed": 19805105, "qualifier": "part_of", "term": "phosphatidylinositol 3-kinase complex, class IA"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0005943", "pubmed": [20379207, 22402981], "qualifier": "part_of", "term": "phosphatidylinositol 3-kinase complex, class IA"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005944", "qualifier": "part_of", "term": "phosphatidylinositol 3-kinase complex, class IB"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0014704", "qualifier": "located_in", "term": "intercalated disc"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0030027", "qualifier": "located_in", "term": "lamellipodium"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0048471", "qualifier": "located_in", "term": "perinuclear region of cytoplasm"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0004674", "qualifier": "enables", "term": "protein serine/threonine kinase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [10490823, 16043515, 17475214, 18079394, 19380743, 19411071, 19574958, 19805105, 20018188, 20713702, 21706016, 22402981, 23643389, 23676467, 24189400, 25253337, 25814554, 26496610, 28514442, 30568254, 32814053, 34591612, 34591642], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005524", "qualifier": "enables", "term": "ATP binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0016301", "pubmed": 25327288, "qualifier": "enables", "term": "kinase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0016303", "qualifier": "enables", "term": "1-phosphatidylinositol-3-kinase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0016303", "pubmed": 2174051, "qualifier": "enables", "term": "1-phosphatidylinositol-3-kinase activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0016303", "qualifier": "enables", "term": "1-phosphatidylinositol-3-kinase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0016303", "pubmed": 19200708, "qualifier": "enables", "term": "1-phosphatidylinositol-3-kinase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0030295", "qualifier": "enables", "term": "protein kinase activator activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0035005", "qualifier": "enables", "term": "1-phosphatidylinositol-4-phosphate 3-kinase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0043560", "qualifier": "enables", "term": "insulin receptor substrate binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0046934", "pubmed": 28676499, "qualifier": "enables", "term": "1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0046934", "qualifier": "enables", "term": "1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0106310", "qualifier": "enables", "term": "protein serine kinase activity"}]}, "homologene": {"genes": [[6239, 174762], [7955, 561737], [8364, 100144924], [9031, 424971], [9544, 709959], [9598, 460858], [9606, 5290], [9615, 488084], [9913, 282306], [10090, 18706], [10116, 170911]], "id": 21249}, "interpro": [{"desc": "Phosphatidylinositol 3-kinase, adaptor-binding domain", "id": "IPR003113", "short_desc": "PI3K_ABD"}, {"desc": "Phosphatidylinositol 3-kinase Ras-binding (PI3K RBD) domain", "id": "IPR000341", "short_desc": "PI3K_Ras-bd_dom"}, {"desc": "Phosphatidylinositol 3-/4-kinase, catalytic domain", "id": "IPR000403", "short_desc": "PI3/4_kinase_cat_dom"}, {"desc": "Phosphoinositide 3-kinase, accessory (PIK) domain", "id": "IPR001263", "short_desc": "PI3K_accessory_dom"}, {"desc": "C2 phosphatidylinositol 3-kinase-type domain", "id": "IPR002420", "short_desc": "PI3K-type_C2_dom"}, {"desc": "Protein kinase-like domain superfamily", "id": "IPR011009", "short_desc": "Kinase-like_dom_sf"}, {"desc": "Phosphatidylinositol kinase", "id": "IPR015433", "short_desc": "PI_Kinase"}, {"desc": "Armadillo-type fold", "id": "IPR016024", "short_desc": "ARM-type_fold"}, {"desc": "Phosphatidylinositol 3/4-kinase, conserved site", "id": "IPR018936", "short_desc": "PI3/4_kinase_CS"}, {"desc": "Ubiquitin-like domain superfamily", "id": "IPR029071", "short_desc": "Ubiquitin-like_domsf"}, {"desc": "C2 domain superfamily", "id": "IPR035892", "short_desc": "C2_domain_sf"}, {"desc": "Phosphatidylinositol 3-/4-kinase, catalytic domain superfamily", "id": "IPR036940", "short_desc": "PI3/4_kinase_cat_sf"}, {"desc": "PI3Kalpha, catalytic domain", "id": "IPR037704", "short_desc": "PI3Kalpha_dom"}, {"desc": "Phosphoinositide 3-kinase, accessory (PIK) domain superfamily", "id": "IPR042236", "short_desc": "PI3K_accessory_sf"}], "ipi": ["IPI00031386", "IPI00946100", "IPI00946104"], "map_location": "3q26.32", "name": "phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha", "other_names": ["PI3-kinase p110 subunit alpha", "mutant phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha", "phosphatidylinositol 3-kinase, catalytic, 110-KD, alpha", "phosphatidylinositol 3-kinase, catalytic, alpha polypeptide", "phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform", "phosphatidylinositol-4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha", "phosphoinositide 3-kinase alpha", "phosphoinositide-3-kinase, catalytic, alpha polypeptide", "ptdIns-3-kinase subunit p110-alpha", "serine/threonine protein kinase PIK3CA"], "pantherdb": {"HGNC": "8975", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1206581", "ortholog_type": "LDO", "panther_family": "PTHR10048", "taxid": 10090, "uniprot_kb": "P42337"}, {"Ensembl": "ENSRNOG00000056810", "ortholog_type": "O", "panther_family": "PTHR10048", "taxid": 10116, "uniprot_kb": "A0A0G2K5T3"}, {"RGD": "620916", "ortholog_type": "LDO", "panther_family": "PTHR10048", "taxid": 10116, "uniprot_kb": "A0A0G2K344"}, {"Ensembl": "ENSGALG00000008934", "ortholog_type": "LDO", "panther_family": "PTHR10048", "taxid": 9031, "uniprot_kb": "F6SW23"}, {"Ensembl": "ENSDARG00000075456", "ortholog_type": "LDO", "panther_family": "PTHR10048", "taxid": 7955, "uniprot_kb": "F1QAD7"}, {"WormBase": "WBGene00000090", "ortholog_type": "O", "panther_family": "PTHR10048", "taxid": 6239, "uniprot_kb": "Q94125"}, {"dictyBase": "DDB_G0268548", "ortholog_type": "O", "panther_family": "PTHR10048", "taxid": 352472, "uniprot_kb": "Q55FX5"}, {"dictyBase": "DDB_G0283081", "ortholog_type": "O", "panther_family": "PTHR10048", "taxid": 352472, "uniprot_kb": "P54674"}, {"dictyBase": "DDB_G0282625", "ortholog_type": "O", "panther_family": "PTHR10048", "taxid": 352472, "uniprot_kb": "Q54S78"}, {"dictyBase": "DDB_G0275011", "ortholog_type": "O", "panther_family": "PTHR10048", "taxid": 352472, "uniprot_kb": "P54675"}, {"dictyBase": "DDB_G0278727", "ortholog_type": "O", "panther_family": "PTHR10048", "taxid": 352472, "uniprot_kb": "P54673"}], "uniprot_kb": "P42336"}, "pathway": {"biocarta": [{"id": "achpathway", "name": "role of nicotinic acetylcholine receptors in the regulation of apoptosis"}, {"id": "aktpathway", "name": "akt signaling pathway"}, {"id": "arfpathway", "name": "tumor suppressor arf inhibits ribosomal biogenesis"}, {"id": "badpathway", "name": "regulation of bad phosphorylation"}, {"id": "bcellsurvivalpathway", "name": "b cell survival pathway"}, {"id": "biopeptidespathway", "name": "bioactive peptide induced signaling pathway"}, {"id": "cdc42racpathway", "name": "role of pi3k subunit p85 in regulation of actin organization and cell migration"}, {"id": "crebpathway", "name": "transcription factor creb and its extracellular signals"}, {"id": "ctcfpathway", "name": "ctcf: first multivalent nuclear factor"}, {"id": "ctla4pathway", "name": "the co-stimulatory signal during t-cell activation"}, {"id": "cxcr4pathway", "name": "cxcr4 signaling pathway"}, {"id": "ecmpathway", "name": "erk and pi-3 kinase are necessary for collagen binding in corneal epithelia"}, {"id": "edg1pathway", "name": "phospholipids as signalling intermediaries"}, {"id": "egfpathway", "name": "egf signaling pathway"}, {"id": "eif4pathway", "name": "regulation of eif-4e and p70s6 kinase"}, {"id": "erk5pathway", "name": "role of erk5 in neuronal survival pathway"}, {"id": "fcer1pathway", "name": "fc epsilon receptor i signaling in mast cells"}, {"id": "gcrpathway", "name": "corticosteroids and cardioprotection"}, {"id": "ghpathway", "name": "growth hormone signaling pathway"}, {"id": "gleevecpathway", "name": "inhibition of cellular proliferation by gleevec"}, {"id": "gsk3pathway", "name": "inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages"}, {"id": "hcmvpathway", "name": "human cytomegalovirus and map kinase pathways"}, {"id": "hdacpathway", "name": "control of skeletal myogenesis by hdac and calcium/calmodulin-dependent kinase (camk)"}, {"id": "her2pathway", "name": "role of erbb2 in signal transduction and oncology"}, {"id": "igf1mtorpathway", "name": "skeletal muscle hypertrophy is regulated via akt-mtor pathway"}, {"id": "igf1pathway", "name": "igf-1 signaling pathway"}, {"id": "igf1rpathway", "name": "multiple antiapoptotic pathways from igf-1r signaling lead to bad phosphorylation"}, {"id": "il2rbpathway", "name": "il-2 receptor beta chain in t cell activation"}, {"id": "il7pathway", "name": "il-7 signal transduction"}, {"id": "insulinpathway", "name": "insulin signaling pathway"}, {"id": "longevitypathway", "name": "the igf-1 receptor and longevity"}, {"id": "mtorpathway", "name": "mtor signaling pathway"}, {"id": "nfatpathway", "name": "nfat and hypertrophy of the heart "}, {"id": "ngfpathway", "name": "nerve growth factor pathway (ngf)"}, {"id": "nkcellspathway", "name": "ras-independent pathway in nk cell-mediated cytotoxicity"}, {"id": "no1pathway", "name": "actions of nitric oxide in the heart"}, {"id": "par1pathway", "name": "thrombin signaling and protease-activated receptors"}, {"id": "pdgfpathway", "name": "pdgf signaling pathway"}, {"id": "plcpathway", "name": "phospholipase c signaling pathway"}, {"id": "ptenpathway", "name": "pten dependent cell cycle arrest and apoptosis"}, {"id": "rac1pathway", "name": "rac1 cell motility signaling pathway"}, {"id": "raccycdpathway", "name": "influence of ras and rho proteins on g1 to s transition"}, {"id": "raspathway", "name": "ras signaling pathway"}, {"id": "tcrpathway", "name": "t cell receptor signaling pathway"}, {"id": "tffpathway", "name": "trefoil factors initiate mucosal healing"}, {"id": "tpopathway", "name": "tpo signaling pathway"}, {"id": "trkapathway", "name": "trka receptor signaling pathway"}, {"id": "vegfpathway", "name": "vegf hypoxia and angiogenesis"}], "humancyc": [{"id": "PWY-6352", "name": "3-phosphoinositide biosynthesis"}, {"id": "PWY-6371", "name": "superpathway of inositol phosphate compounds"}], "kegg": [{"id": "hsa00562", "name": "Inositol phosphate metabolism - Homo sapiens (human)"}, {"id": "hsa04012", "name": "ErbB signaling pathway - Homo sapiens (human)"}, {"id": "hsa04014", "name": "Ras signaling pathway - Homo sapiens (human)"}, {"id": "hsa04015", "name": "Rap1 signaling pathway - Homo sapiens (human)"}, {"id": "hsa04024", "name": "cAMP signaling pathway - Homo sapiens (human)"}, {"id": "hsa04062", "name": "Chemokine signaling pathway - Homo sapiens (human)"}, {"id": "hsa04066", "name": "HIF-1 signaling pathway - Homo sapiens (human)"}, {"id": "hsa04068", "name": "FoxO signaling pathway - Homo sapiens (human)"}, {"id": "hsa04070", "name": "Phosphatidylinositol signaling system - Homo sapiens (human)"}, {"id": "hsa04071", "name": "Sphingolipid signaling pathway - Homo sapiens (human)"}, {"id": "hsa04072", "name": "Phospholipase D signaling pathway - Homo sapiens (human)"}, {"id": "hsa04140", "name": "Autophagy - animal - Homo sapiens (human)"}, {"id": "hsa04150", "name": "mTOR signaling pathway - Homo sapiens (human)"}, {"id": "hsa04151", "name": "PI3K-Akt signaling pathway - Homo sapiens (human)"}, {"id": "hsa04152", "name": "AMPK signaling pathway - Homo sapiens (human)"}, {"id": "hsa04210", "name": "Apoptosis - Homo sapiens (human)"}, {"id": "hsa04211", "name": "Longevity regulating pathway - Homo sapiens (human)"}, {"id": "hsa04213", "name": "Longevity regulating pathway - multiple species - Homo sapiens (human)"}, {"id": "hsa04218", "name": "Cellular senescence - Homo sapiens (human)"}, {"id": "hsa04360", "name": "Axon guidance - Homo sapiens (human)"}, {"id": "hsa04370", "name": "VEGF signaling pathway - Homo sapiens (human)"}, {"id": "hsa04380", "name": "Osteoclast differentiation - Homo sapiens (human)"}, {"id": "hsa04510", "name": "Focal adhesion - Homo sapiens (human)"}, {"id": "hsa04550", "name": "Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human)"}, {"id": "hsa04611", "name": "Platelet activation - Homo sapiens (human)"}, {"id": "hsa04613", "name": "Neutrophil extracellular trap formation - Homo sapiens (human)"}, {"id": "hsa04620", "name": "Toll-like receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa04625", "name": "C-type lectin receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa04630", "name": "JAK-STAT signaling pathway - Homo sapiens (human)"}, {"id": "hsa04650", "name": "Natural killer cell mediated cytotoxicity - Homo sapiens (human)"}, {"id": "hsa04660", "name": "T cell receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa04662", "name": "B cell receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa04664", "name": "Fc epsilon RI signaling pathway - Homo sapiens (human)"}, {"id": "hsa04666", "name": "Fc gamma R-mediated phagocytosis - Homo sapiens (human)"}, {"id": "hsa04668", "name": "TNF signaling pathway - Homo sapiens (human)"}, {"id": "hsa04670", "name": "Leukocyte transendothelial migration - Homo sapiens (human)"}, {"id": "hsa04722", "name": "Neurotrophin signaling pathway - Homo sapiens (human)"}, {"id": "hsa04725", "name": "Cholinergic synapse - Homo sapiens (human)"}, {"id": "hsa04750", "name": "Inflammatory mediator regulation of TRP channels - Homo sapiens (human)"}, {"id": "hsa04810", "name": "Regulation of actin cytoskeleton - Homo sapiens (human)"}, {"id": "hsa04910", "name": "Insulin signaling pathway - Homo sapiens (human)"}, {"id": "hsa04914", "name": "Progesterone-mediated oocyte maturation - Homo sapiens (human)"}, {"id": "hsa04915", "name": "Estrogen signaling pathway - Homo sapiens (human)"}, {"id": "hsa04917", "name": "Prolactin signaling pathway - Homo sapiens (human)"}, {"id": "hsa04919", "name": "Thyroid hormone signaling pathway - Homo sapiens (human)"}, {"id": "hsa04923", "name": "Regulation of lipolysis in adipocytes - Homo sapiens (human)"}, {"id": "hsa04926", "name": "Relaxin signaling pathway - Homo sapiens (human)"}, {"id": "hsa04929", "name": "GnRH secretion - Homo sapiens (human)"}, {"id": "hsa04930", "name": "Type II diabetes mellitus - Homo sapiens (human)"}, {"id": "hsa04931", "name": "Insulin resistance - Homo sapiens (human)"}, {"id": "hsa04932", "name": "Non-alcoholic fatty liver disease - Homo sapiens (human)"}, {"id": "hsa04933", "name": "AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human)"}, {"id": "hsa04935", "name": "Growth hormone synthesis, secretion and action - Homo sapiens (human)"}, {"id": "hsa04960", "name": "Aldosterone-regulated sodium reabsorption - Homo sapiens (human)"}, {"id": "hsa04973", "name": "Carbohydrate digestion and absorption - Homo sapiens (human)"}, {"id": "hsa05010", "name": "Alzheimer disease - Homo sapiens (human)"}, {"id": "hsa05017", "name": "Spinocerebellar ataxia - Homo sapiens (human)"}, {"id": "hsa05020", "name": "Prion disease - Homo sapiens (human)"}, {"id": "hsa05100", "name": "Bacterial invasion of epithelial cells - Homo sapiens (human)"}, {"id": "hsa05131", "name": "Shigellosis - Homo sapiens (human)"}, {"id": "hsa05132", "name": "Salmonella infection - Homo sapiens (human)"}, {"id": "hsa05135", "name": "Yersinia infection - Homo sapiens (human)"}, {"id": "hsa05142", "name": "Chagas disease - Homo sapiens (human)"}, {"id": "hsa05146", "name": "Amoebiasis - Homo sapiens (human)"}, {"id": "hsa05160", "name": "Hepatitis C - Homo sapiens (human)"}, {"id": "hsa05161", "name": "Hepatitis B - Homo sapiens (human)"}, {"id": "hsa05162", "name": "Measles - Homo sapiens (human)"}, {"id": "hsa05163", "name": "Human cytomegalovirus infection - Homo sapiens (human)"}, {"id": "hsa05164", "name": "Influenza A - Homo sapiens (human)"}, {"id": "hsa05165", "name": "Human papillomavirus infection - Homo sapiens (human)"}, {"id": "hsa05166", "name": "Human T-cell leukemia virus 1 infection - Homo sapiens (human)"}, {"id": "hsa05167", "name": "Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human)"}, {"id": "hsa05168", "name": "Herpes simplex virus 1 infection - Homo sapiens (human)"}, {"id": "hsa05169", "name": "Epstein-Barr virus infection - Homo sapiens (human)"}, {"id": "hsa05170", "name": "Human immunodeficiency virus 1 infection - Homo sapiens (human)"}, {"id": "hsa05171", "name": "Coronavirus disease - COVID-19 - Homo sapiens (human)"}, {"id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)"}, {"id": "hsa05203", "name": "Viral carcinogenesis - Homo sapiens (human)"}, {"id": "hsa05205", "name": "Proteoglycans in cancer - Homo sapiens (human)"}, {"id": "hsa05206", "name": "MicroRNAs in cancer - Homo sapiens (human)"}, {"id": "hsa05210", "name": "Colorectal cancer - Homo sapiens (human)"}, {"id": "hsa05211", "name": "Renal cell carcinoma - Homo sapiens (human)"}, {"id": "hsa05212", "name": "Pancreatic cancer - Homo sapiens (human)"}, {"id": "hsa05213", "name": "Endometrial cancer - Homo sapiens (human)"}, {"id": "hsa05214", "name": "Glioma - Homo sapiens (human)"}, {"id": "hsa05215", "name": "Prostate cancer - Homo sapiens (human)"}, {"id": "hsa05218", "name": "Melanoma - Homo sapiens (human)"}, {"id": "hsa05220", "name": "Chronic myeloid leukemia - Homo sapiens (human)"}, {"id": "hsa05221", "name": "Acute myeloid leukemia - Homo sapiens (human)"}, {"id": "hsa05222", "name": "Small cell lung cancer - Homo sapiens (human)"}, {"id": "hsa05223", "name": "Non-small cell lung cancer - Homo sapiens (human)"}, {"id": "hsa05224", "name": "Breast cancer - Homo sapiens (human)"}, {"id": "hsa05225", "name": "Hepatocellular carcinoma - Homo sapiens (human)"}, {"id": "hsa05226", "name": "Gastric cancer - Homo sapiens (human)"}, {"id": "hsa05230", "name": "Central carbon metabolism in cancer - Homo sapiens (human)"}, {"id": "hsa05231", "name": "Choline metabolism in cancer - Homo sapiens (human)"}, {"id": "hsa05235", "name": "PD-L1 expression and PD-1 checkpoint pathway in cancer - Homo sapiens (human)"}, {"id": "hsa05415", "name": "Diabetic cardiomyopathy - Homo sapiens (human)"}, {"id": "hsa05417", "name": "Lipid and atherosclerosis - Homo sapiens (human)"}, {"id": "hsa05418", "name": "Fluid shear stress and atherosclerosis - Homo sapiens (human)"}], "netpath": [{"id": "Pathway_Alpha6Beta4Integrin", "name": "Alpha6Beta4Integrin"}, {"id": "Pathway_EGFR1", "name": "EGFR1"}, {"id": "Pathway_IL2", "name": "IL2"}, {"id": "Pathway_IL4", "name": "IL4"}, {"id": "Pathway_KitReceptor", "name": "KitReceptor"}, {"id": "Pathway_TGF_beta_Receptor", "name": "TGF_beta_Receptor"}], "pid": [{"id": "a6b1_a6b4_integrin_pathway", "name": "a6b1 and a6b4 Integrin signaling"}, {"id": "angiopoietinreceptor_pathway", "name": "Angiopoietin receptor Tie2-mediated signaling"}, {"id": "ar_nongenomic_pathway", "name": "Nongenotropic Androgen signaling"}, {"id": "avb3_integrin_pathway", "name": "Integrins in angiogenesis"}, {"id": "avb3_opn_pathway", "name": "Osteopontin-mediated events"}, {"id": "bcr_5pathway", "name": "BCR signaling pathway"}, {"id": "cd40_pathway", "name": "CD40/CD40L signaling"}, {"id": "cdc42_pathway", "name": "CDC42 signaling events"}, {"id": "cxcr3pathway", "name": "CXCR3-mediated signaling events"}, {"id": "cxcr4_pathway", "name": "CXCR4-mediated signaling events"}, {"id": "ecadherin_keratinocyte_pathway", "name": "E-cadherin signaling in keratinocytes"}, {"id": "ecadherin_nascentaj_pathway", "name": "E-cadherin signaling in the nascent adherens junction"}, {"id": "epha2_fwdpathway", "name": "EPHA2 forward signaling"}, {"id": "ephbfwdpathway", "name": "EPHB forward signaling"}, {"id": "ephrinbrevpathway", "name": "Ephrin B reverse signaling"}, {"id": "er_nongenomic_pathway", "name": "Plasma membrane estrogen receptor signaling"}, {"id": "erbb1_downstream_pathway", "name": "ErbB1 downstream signaling"}, {"id": "erbb1_internalization_pathway", "name": "Internalization of ErbB1"}, {"id": "erbb2erbb3pathway", "name": "ErbB2/ErbB3 signaling events"}, {"id": "erbb4_pathway", "name": "ErbB4 signaling events"}, {"id": "fak_pathway", "name": "Signaling events mediated by focal adhesion kinase"}, {"id": "faspathway", "name": "FAS (CD95) signaling pathway"}, {"id": "fcer1pathway", "name": "Fc-epsilon receptor I signaling in mast cells"}, {"id": "fgf_pathway", "name": "FGF signaling pathway"}, {"id": "gmcsf_pathway", "name": "GMCSF-mediated signaling events"}, {"id": "hedgehog_2pathway", "name": "Signaling events mediated by the Hedgehog family"}, {"id": "ifngpathway", "name": "IFN-gamma pathway"}, {"id": "igf1_pathway", "name": "IGF1 pathway"}, {"id": "il1pathway", "name": "IL1-mediated signaling events"}, {"id": "il23pathway", "name": "IL23-mediated signaling events"}, {"id": "il2_1pathway", "name": "IL2-mediated signaling events"}, {"id": "il2_pi3kpathway", "name": "IL2 signaling events mediated by PI3K"}, {"id": "il2_stat5pathway", "name": "IL2 signaling events mediated by STAT5"}, {"id": "il3_pathway", "name": "IL3-mediated signaling events"}, {"id": "il4_2pathway", "name": "IL4-mediated signaling events"}, {"id": "il5_pathway", "name": "IL5-mediated signaling events"}, {"id": "il6_7pathway", "name": "IL6-mediated signaling events"}, {"id": "insulin_pathway", "name": "Insulin Pathway"}, {"id": "kitpathway", "name": "Signaling events mediated by Stem cell factor receptor (c-Kit)"}, {"id": "lymphangiogenesis_pathway", "name": "VEGFR3 signaling in lymphatic endothelium"}, {"id": "met_pathway", "name": "Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)"}, {"id": "ncadherinpathway", "name": "N-cadherin signaling events"}, {"id": "nectin_pathway", "name": "Nectin adhesion pathway"}, {"id": "nephrin_neph1_pathway", "name": "Nephrin/Neph1 signaling in the kidney podocyte"}, {"id": "netrin_pathway", "name": "Netrin-mediated signaling events"}, {"id": "nfkappabatypicalpathway", "name": "Atypical NF-kappaB pathway"}, {"id": "p75ntrpathway", "name": "p75(NTR)-mediated signaling"}, {"id": "pdgfrapathway", "name": "PDGFR-alpha signaling pathway"}, {"id": "pdgfrbpathway", "name": "PDGFR-beta signaling pathway"}, {"id": "pi3kcipathway", "name": "Class I PI3K signaling events"}, {"id": "pi3kplctrkpathway", "name": "Trk receptor signaling mediated by PI3K and PLC-gamma"}, {"id": "ptp1bpathway", "name": "Signaling events mediated by PTP1B"}, {"id": "reelinpathway", "name": "Reelin signaling pathway"}, {"id": "ret_pathway", "name": "Signaling events regulated by Ret tyrosine kinase"}, {"id": "s1p_s1p2_pathway", "name": "S1P2 pathway"}, {"id": "shp2_pathway", "name": "SHP2 signaling"}, {"id": "tcptp_pathway", "name": "Signaling events mediated by TCPTP"}, {"id": "thrombin_par1_pathway", "name": "PAR1-mediated thrombin signaling events"}, {"id": "trail_pathway", "name": "TRAIL signaling pathway"}, {"id": "trkrpathway", "name": "Neurotrophic factor-mediated Trk receptor signaling"}, {"id": "vegfr1_2_pathway", "name": "Signaling events mediated by VEGFR1 and VEGFR2"}, {"id": "vegfr1_pathway", "name": "VEGFR1 specific signals"}], "reactome": [{"id": "R-HSA-109582", "name": "Hemostasis"}, {"id": "R-HSA-109704", "name": "PI3K Cascade"}, {"id": "R-HSA-112399", "name": "IRS-mediated signalling"}, {"id": "R-HSA-114604", "name": "GPVI-mediated activation cascade"}, {"id": "R-HSA-1226099", "name": "Signaling by FGFR in disease"}, {"id": "R-HSA-1227986", "name": "Signaling by ERBB2"}, {"id": "R-HSA-1227990", "name": "Signaling by ERBB2 in Cancer"}, {"id": "R-HSA-1236382", "name": "Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants"}, {"id": "R-HSA-1236394", "name": "Signaling by ERBB4"}, {"id": "R-HSA-1250342", "name": "PI3K events in ERBB4 signaling"}, {"id": "R-HSA-1257604", "name": "PIP3 activates AKT signaling"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-1280218", "name": "Adaptive Immune System"}, {"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1433557", "name": "Signaling by SCF-KIT"}, {"id": "R-HSA-1483255", "name": "PI Metabolism"}, {"id": "R-HSA-1483257", "name": "Phospholipid metabolism"}, {"id": "R-HSA-1500931", "name": "Cell-Cell communication"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-1643713", "name": "Signaling by EGFR in Cancer"}, {"id": "R-HSA-1660499", "name": "Synthesis of PIPs at the plasma membrane"}, {"id": "R-HSA-166520", "name": "Signaling by NTRKs"}, {"id": "R-HSA-166520", "name": "Signaling by NTRKs"}, {"id": "R-HSA-168249", "name": "Innate Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-177929", "name": "Signaling by EGFR"}, {"id": "R-HSA-180292", "name": "GAB1 signalosome"}, {"id": "R-HSA-1839117", "name": "Signaling by cytosolic FGFR1 fusion mutants"}, {"id": "R-HSA-1839124", "name": "FGFR1 mutant receptor activation"}, {"id": "R-HSA-186763", "name": "Downstream signal transduction"}, {"id": "R-HSA-186797", "name": "Signaling by PDGF"}, {"id": "R-HSA-187037", "name": "Signaling by NTRK1 (TRKA)"}, {"id": "R-HSA-190236", "name": "Signaling by FGFR"}, {"id": "R-HSA-194138", "name": "Signaling by VEGF"}, {"id": "R-HSA-194138", "name": "Signaling by VEGF"}, {"id": "R-HSA-194315", "name": "Signaling by Rho GTPases"}, {"id": "R-HSA-1963642", "name": "PI3K events in ERBB2 signaling"}, {"id": "R-HSA-198203", "name": "PI3K/AKT activation"}, {"id": "R-HSA-199418", "name": "Negative regulation of the PI3K/AKT network"}, {"id": "R-HSA-201556", "name": "Signaling by ALK"}, {"id": "R-HSA-202403", "name": "TCR signaling"}, {"id": "R-HSA-202424", "name": "Downstream TCR signaling"}, {"id": "R-HSA-202733", "name": "Cell surface interactions at the vascular wall"}, {"id": "R-HSA-2029480", "name": "Fcgamma receptor (FCGR) dependent phagocytosis"}, {"id": "R-HSA-2029485", "name": "Role of phospholipids in phagocytosis"}, {"id": "R-HSA-210993", "name": "Tie2 Signaling"}, {"id": "R-HSA-2172127", "name": "DAP12 interactions"}, {"id": "R-HSA-2219528", "name": "PI3K/AKT Signaling in Cancer"}, {"id": "R-HSA-2219530", "name": "Constitutive Signaling by Aberrant PI3K in Cancer"}, {"id": "R-HSA-2404192", "name": "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"}, {"id": "R-HSA-2424491", "name": "DAP12 signaling"}, {"id": "R-HSA-2428924", "name": "IGF1R signaling cascade"}, {"id": "R-HSA-2428928", "name": "IRS-related events triggered by IGF1R"}, {"id": "R-HSA-2454202", "name": "Fc epsilon receptor (FCERI) signaling"}, {"id": "R-HSA-2730905", "name": "Role of LAT2/NTAL/LAB on calcium mobilization"}, {"id": "R-HSA-372790", "name": "Signaling by GPCR"}, {"id": "R-HSA-373753", "name": "Nephrin family interactions"}, {"id": "R-HSA-388396", "name": "GPCR downstream signalling"}, {"id": "R-HSA-388841", "name": "Costimulation by the CD28 family"}, {"id": "R-HSA-389356", "name": "CD28 co-stimulation"}, {"id": "R-HSA-389357", "name": "CD28 dependent PI3K/Akt signaling"}, {"id": "R-HSA-416476", "name": "G alpha (q) signalling events"}, {"id": "R-HSA-422475", "name": "Axon guidance"}, {"id": "R-HSA-4420097", "name": "VEGFA-VEGFR2 Pathway"}, {"id": "R-HSA-4420097", "name": "VEGFA-VEGFR2 Pathway"}, {"id": "R-HSA-449147", "name": "Signaling by Interleukins"}, {"id": "R-HSA-449147", "name": "Signaling by Interleukins"}, {"id": "R-HSA-451927", "name": "Interleukin-2 family signaling"}, {"id": "R-HSA-512988", "name": "Interleukin-3, Interleukin-5 and GM-CSF signaling"}, {"id": "R-HSA-512988", "name": "Interleukin-3, Interleukin-5 and GM-CSF signaling"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-5637810", "name": "Constitutive Signaling by EGFRvIII"}, {"id": "R-HSA-5637812", "name": "Signaling by EGFRvIII in Cancer"}, {"id": "R-HSA-5637815", "name": "Signaling by Ligand-Responsive EGFR Variants in Cancer"}, {"id": "R-HSA-5654687", "name": "Downstream signaling of activated FGFR1"}, {"id": "R-HSA-5654689", "name": "PI-3K cascade:FGFR1"}, {"id": "R-HSA-5654695", "name": "PI-3K cascade:FGFR2"}, {"id": "R-HSA-5654696", "name": "Downstream signaling of activated FGFR2"}, {"id": "R-HSA-5654708", "name": "Downstream signaling of activated FGFR3"}, {"id": "R-HSA-5654710", "name": "PI-3K cascade:FGFR3"}, {"id": "R-HSA-5654716", "name": "Downstream signaling of activated FGFR4"}, {"id": "R-HSA-5654720", "name": "PI-3K cascade:FGFR4"}, {"id": "R-HSA-5654736", "name": "Signaling by FGFR1"}, {"id": "R-HSA-5654738", "name": "Signaling by FGFR2"}, {"id": "R-HSA-5654741", "name": "Signaling by FGFR3"}, {"id": "R-HSA-5654743", "name": "Signaling by FGFR4"}, {"id": "R-HSA-5655253", "name": "Signaling by FGFR2 in disease"}, {"id": "R-HSA-5655291", "name": "Signaling by FGFR4 in disease"}, {"id": "R-HSA-5655302", "name": "Signaling by FGFR1 in disease"}, {"id": "R-HSA-5655332", "name": "Signaling by FGFR3 in disease"}, {"id": "R-HSA-5663202", "name": "Diseases of signal transduction by growth factor receptors and second messengers"}, {"id": "R-HSA-5673001", "name": "RAF/MAP kinase cascade"}, {"id": "R-HSA-5683057", "name": "MAPK family signaling cascades"}, {"id": "R-HSA-5684996", "name": "MAPK1/MAPK3 signaling"}, {"id": "R-HSA-6806834", "name": "Signaling by MET"}, {"id": "R-HSA-6811558", "name": "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"}, {"id": "R-HSA-74751", "name": "Insulin receptor signalling cascade"}, {"id": "R-HSA-74752", "name": "Signaling by Insulin receptor"}, {"id": "R-HSA-76002", "name": "Platelet activation, signaling and aggregation"}, {"id": "R-HSA-8851907", "name": "MET activates PI3K/AKT signaling"}, {"id": "R-HSA-8853659", "name": "RET signaling"}, {"id": "R-HSA-8939211", "name": "ESR-mediated signaling"}, {"id": "R-HSA-9006115", "name": "Signaling by NTRK2 (TRKB)"}, {"id": "R-HSA-9006335", "name": "Signaling by Erythropoietin"}, {"id": "R-HSA-9006335", "name": "Signaling by Erythropoietin"}, {"id": "R-HSA-9006925", "name": "Intracellular signaling by second messengers"}, {"id": "R-HSA-9006931", "name": "Signaling by Nuclear Receptors"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-9009391", "name": "Extra-nuclear estrogen signaling"}, {"id": "R-HSA-9012999", "name": "RHO GTPase cycle"}, {"id": "R-HSA-9013149", "name": "RAC1 GTPase cycle"}, {"id": "R-HSA-9013404", "name": "RAC2 GTPase cycle"}, {"id": "R-HSA-9027276", "name": "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"}, {"id": "R-HSA-9027276", "name": "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"}, {"id": "R-HSA-9028335", "name": "Activated NTRK2 signals through PI3K"}, {"id": "R-HSA-9034015", "name": "Signaling by NTRK3 (TRKC)"}, {"id": "R-HSA-912526", "name": "Interleukin receptor SHC signaling"}, {"id": "R-HSA-912631", "name": "Regulation of signaling by CBL"}, {"id": "R-HSA-912631", "name": "Regulation of signaling by CBL"}, {"id": "R-HSA-9603381", "name": "Activated NTRK3 signals through PI3K"}, {"id": "R-HSA-9607240", "name": "FLT3 Signaling"}, {"id": "R-HSA-9664565", "name": "Signaling by ERBB2 KD Mutants"}, {"id": "R-HSA-9665348", "name": "Signaling by ERBB2 ECD mutants"}, {"id": "R-HSA-9669938", "name": "Signaling by KIT in disease"}, {"id": "R-HSA-9670439", "name": "Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"}, {"id": "R-HSA-9671555", "name": "Signaling by PDGFR in disease"}, {"id": "R-HSA-9673767", "name": "Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants"}, {"id": "R-HSA-9673770", "name": "Signaling by PDGFRA extracellular domain mutants"}, {"id": "R-HSA-9675108", "name": "Nervous system development"}, {"id": "R-HSA-9680350", "name": "Signaling by CSF1 (M-CSF) in myeloid cells"}, {"id": "R-HSA-9682385", "name": "FLT3 signaling in disease"}, {"id": "R-HSA-9700206", "name": "Signaling by ALK in cancer"}, {"id": "R-HSA-9703465", "name": "Signaling by FLT3 fusion proteins"}, {"id": "R-HSA-9703648", "name": "Signaling by FLT3 ITD and TKD mutants"}, {"id": "R-HSA-9716542", "name": "Signaling by Rho GTPases, Miro GTPases and RHOBTB3"}, {"id": "R-HSA-9725370", "name": "Signaling by ALK fusions and activated point mutants"}, {"id": "R-HSA-9842640", "name": "Signaling by LTK in cancer"}, {"id": "R-HSA-9842663", "name": "Signaling by LTK"}], "smpdb": [{"id": "SMP00011", "name": "Inositol Metabolism"}, {"id": "SMP00320", "name": "Intracellular Signalling Through Adenosine Receptor A2a and Adenosine"}, {"id": "SMP00321", "name": "Intracellular Signalling Through Adenosine Receptor A2b and Adenosine"}, {"id": "SMP00358", "name": "Fc Epsilon Receptor I Signaling in Mast Cells"}, {"id": "SMP00463", "name": "Phosphatidylinositol Phosphate Metabolism"}, {"id": "SMP00582", "name": "Joubert syndrome"}], "wikipathways": [{"id": "WP1403", "name": "AMP-activated protein kinase (AMPK) signaling"}, {"id": "WP1449", "name": "Regulation of toll-like receptor signaling pathway"}, {"id": "WP1539", "name": "Angiogenesis"}, {"id": "WP1544", "name": "MicroRNAs in cardiomyocyte hypertrophy"}, {"id": "WP1982", "name": "Sterol regulatory element-binding proteins (SREBP) signaling"}, {"id": "WP2032", "name": "Thyroid stimulating hormone (TSH) signaling pathway"}, {"id": "WP2037", "name": "Prolactin Signaling Pathway"}, {"id": "WP2038", "name": "Regulation of Microtubule Cytoskeleton"}, {"id": "WP2112", "name": "IL17 signaling pathway"}, {"id": "WP2203", "name": "Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway"}, {"id": "WP2261", "name": "Glioblastoma signaling pathways"}, {"id": "WP2865", "name": "IL1 and megakaryocytes in obesity"}, {"id": "WP3", "name": "Phytochemical activity on NRF2 transcriptional activation"}, {"id": "WP306", "name": "Focal Adhesion"}, {"id": "WP313", "name": "Signaling of Hepatocyte Growth Factor Receptor"}, {"id": "WP3286", "name": "Copper homeostasis"}, {"id": "WP3303", "name": "RAC1-PAK1-p38-MMP2 Pathway"}, {"id": "WP3651", "name": "Pathways affected in adenoid cystic carcinoma"}, {"id": "WP3844", "name": "PI3K-AKT-mTOR signaling pathway and therapeutic opportunities"}, {"id": "WP3863", "name": "T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection"}, {"id": "WP3888", "name": "VEGFA-VEGFR2 Signaling Pathway"}, {"id": "WP3915", "name": "Angiopoietin Like Protein 8 Regulatory Pathway"}, {"id": "WP3929", "name": "Chemokine signaling pathway"}, {"id": "WP3932", "name": "Focal Adhesion-PI3K-Akt-mTOR-signaling pathway"}, {"id": "WP3937", "name": "Microglia Pathogen Phagocytosis Pathway"}, {"id": "WP395", "name": "IL-4 signaling pathway"}, {"id": "WP4136", "name": "Fibrin Complement Receptor 3 Signaling Pathway"}, {"id": "WP4141", "name": "PI3K-AKT-mTOR - VitD3 signaling"}, {"id": "WP4155", "name": "Endometrial cancer"}, {"id": "WP4172", "name": "PI3K-Akt signaling pathway"}, {"id": "WP4217", "name": "Ebola Virus Pathway on Host"}, {"id": "WP4223", "name": "Ras signaling"}, {"id": "WP4239", "name": "Epithelial to mesenchymal transition in colorectal cancer"}, {"id": "WP4255", "name": "Non-small cell lung cancer"}, {"id": "WP4262", "name": "Breast cancer pathway"}, {"id": "WP4263", "name": "Pancreatic adenocarcinoma pathway"}, {"id": "WP4357", "name": "NRF2-ARE regulation"}, {"id": "WP4396", "name": "Nonalcoholic fatty liver disease"}, {"id": "WP4481", "name": "Resistin as a regulator of inflammation"}, {"id": "WP4483", "name": "Relationship between inflammation, COX-2 and EGFR"}, {"id": "WP4539", "name": "Synaptic signaling pathways associated with autism spectrum disorder"}, {"id": "WP4558", "name": "Overview of interferons-mediated signaling pathway"}, {"id": "WP4564", "name": "Neural Crest Cell Migration during Development"}, {"id": "WP4565", "name": "Neural Crest Cell Migration in Cancer"}, {"id": "WP4566", "name": "Translation inhibitors in chronically activated PDGFRA cells"}, {"id": "WP4582", "name": "Cancer immunotherapy by CTLA4 blockade"}, {"id": "WP4658", "name": "Small cell lung cancer"}, {"id": "WP4659", "name": "Gastrin signaling pathway"}, {"id": "WP4666", "name": "Hepatitis B infection"}, {"id": "WP4674", "name": "Head and Neck Squamous Cell Carcinoma"}, {"id": "WP4685", "name": "Melanoma"}, {"id": "WP4746", "name": "Thyroid hormones production and their peripheral downstream signaling effects"}, {"id": "WP4747", "name": "Netrin-UNC5B signaling pathway"}, {"id": "WP4787", "name": "Osteoblast differentiation"}, {"id": "WP4806", "name": "EGFR Tyrosine Kinase Inhibitor Resistance"}, {"id": "WP481", "name": "Insulin Signaling"}, {"id": "WP4829", "name": "mBDNF and proBDNF regulation of GABA neurotransmission"}, {"id": "WP4838", "name": "Regucalcin in proximal tubule epithelial kidney cells"}, {"id": "WP4871", "name": "Kisspeptin-kisspeptin receptor system in the ovary"}, {"id": "WP5074", "name": "Kallmann,s Syndrome"}, {"id": "WP51", "name": "Regulation of Actin Cytoskeleton"}, {"id": "WP524", "name": "G13 Signaling Pathway"}, {"id": "WP673", "name": "ErbB signaling pathway"}, {"id": "WP710", "name": "DNA damage response (only ATM dependent)"}, {"id": "WP712", "name": "Estrogen signaling pathway"}, {"id": "WP75", "name": "Toll-like Receptor Signaling Pathway"}]}, "pdb": ["2ENQ", "2RD0", "3HHM", "3HIZ", "3ZIM", "4JPS", "4L1B", "4L23", "4L2Y", "4OVU", "4OVV", "4TUU", "4TV3", "4WAF", "4YKN", "4ZOP", "5DXH", "5DXT", "5FI4", "5ITD", "5SW8", "5SWG", "5SWO", "5SWP", "5SWR", "5SWT", "5SX8", "5SX9", "5SXA", "5SXB", "5SXC", "5SXD", "5SXE", "5SXF", "5SXI", "5SXJ", "5SXK", "5UBR", "5UK8", "5UKJ", "5UL1", "5XGH", "5XGI", "5XGJ", "6GVF", "6GVG", "6GVH", "6GVI", "6NCT", "6OAC", "6PYS", "6VO7", "7JIU", "7K6M", "7K6N", "7K6O", "7K71", "7L1B", "7L1C", "7L1D", "7MLK", "7MYN", "7MYO", "7PG5", "7PG6", "7R9V", "7R9Y", "7RRG", "7TZ7", "8AM0", "8BFU", "8DCP", "8DCX", "8DD4", "8DD8", "8EXL", "8EXO", "8EXU", "8EXV", "8GUA", "8GUB", "8GUD", "8ILR", "8ILS", "8ILV", "8OW2", "8SBC", "8SBJ", "8TDU", "8TGD", "8TS7", "8TS8", "8TS9", "8TSA", "8TSB", "8TSC", "8TSD", "8TU6", "8V8H", "8V8I", "8V8J", "8V8U", "8V8V", "8W9A", "8W9B"], "pfam": ["PF00454", "PF00613", "PF00792", "PF00794", "PF02192"], "pharmgkb": "PA33308", "pharos": {"target_id": 17816, "tdl": "Tclin"}, "pir": "I38110", "prosite": ["PS50290", "PS51544", "PS51545", "PS51546", "PS51547"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF220715", "relationship": "is"}, {"id": "GNF224187", "relationship": "is"}, {"id": "GNF254179", "relationship": "is"}, {"id": "GNF254180", "relationship": "is"}, {"id": "GNF254181", "relationship": "is"}, {"id": "GNF254182", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF030664", "relationship": "similar to"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF087420", "relationship": "is"}, {"id": "GNF087421", "relationship": "is"}, {"id": "GNF087422", "relationship": "is"}, {"id": "GNF087423", "relationship": "is"}, {"id": "GNF087757", "relationship": "is"}, {"id": "GNF087758", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF052347", "relationship": "is"}, {"id": "GNF057117", "relationship": "is"}, {"id": "GNF057453", "relationship": "is"}, {"id": "GNF061825", "relationship": "is"}, {"id": "GNF061964", "relationship": "is"}, {"id": "GNF072531", "relationship": "is"}, {"id": "GNF075186", "relationship": "is"}, {"id": "GNF075238", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF062581", "relationship": "is"}, {"id": "GNF062582", "relationship": "is"}, {"id": "GNF071209", "relationship": "is"}, {"id": "GNF071210", "relationship": "is"}, {"id": "GNF071661", "relationship": "is"}, {"id": "GNF071662", "relationship": "is"}], "Invitrogen_IVTHSSIPKv2": [{"id": "GNF323956", "relationship": "is"}, {"id": "GNF323957", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF334883", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF094622", "relationship": "is"}, {"id": "GNF110515", "relationship": "is"}, {"id": "GNF134279", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000003.12", "NC_060927.1", "NG_012113.2"], "protein": ["NP_006209.2", "XP_006713721.1", "XP_054202817.1", "XP_054202818.1", "XP_054202819.1", "XP_054202820.1", "XP_054202821.1", "XP_054202822.1", "XP_054202823.1"], "rna": ["NM_006218.4", "XM_006713658.5", "XM_054346842.1", "XM_054346843.1", "XM_054346844.1", "XM_054346845.1", "XM_054346846.1", "XM_054346847.1", "XM_054346848.1"], "translation": [{"protein": "XP_054202821.1", "rna": "XM_054346846.1"}, {"protein": "XP_054202818.1", "rna": "XM_054346843.1"}, {"protein": "XP_054202819.1", "rna": "XM_054346844.1"}, {"protein": "XP_054202820.1", "rna": "XM_054346845.1"}, {"protein": "XP_006713721.1", "rna": "XM_006713658.5"}, {"protein": "NP_006209.2", "rna": "NM_006218.4"}, {"protein": "XP_054202822.1", "rna": "XM_054346847.1"}, {"protein": "XP_054202823.1", "rna": "XM_054346848.1"}, {"protein": "XP_054202817.1", "rna": "XM_054346842.1"}]}, "reporter": {"HG-U133_Plus_2": ["204369_at", "231854_at", "235980_at"], "HG-U95Av2": "40704_at", "HG-U95B": ["41969_at", "55954_at"], "HTA-2_0": ["TC03000951.hg.1", "TC03002674.hg.1"], "HuEx-1_0": ["2653840", "3935881"], "HuGene-1_1": "8084016", "HuGene-2_1": ["16948209", "17122920", "17122922"]}, "summary": "Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016].", "symbol": "PIK3CA", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1335212"}, "unigene": ["Hs.715194", "Hs.553498", "Hs.732394"], "uniprot": {"Swiss-Prot": "P42336", "TrEMBL": ["A0A6Q8PGV1", "Q4LE51", "A0A2R8Y2F6", "C9J951", "C9JAM9", "A0A6Q8PGN9"]}, "wikipedia": {"url_stub": "P110?"}}